Professor Naveed Sattar

  • Professor of Metabolic Medicine (Institute of Cardiovascular and Medical Sciences)
  • Associate Academic (Institute of Health and Wellbeing)
  • Associate (School of Medicine)

telephone: 01413303419
email: Naveed.Sattar@glasgow.ac.uk

Research interests

  • Naveed Sattar graduated in medicine in 1990 from the University of Glasgow and became Professor of Metabolic Medicine in 2005. He is clinically active.
  • He has published extensively in CVD biomarker, and diabetes-related research including work on obesity and related complications. He has epidemiological and risk factor expertise, spanning several pathways. He also has expertise in the CVD-inflammation and has contributed to important trials, mechanistic studies and relevant guidelines in this field.
  • He leads a large biomarker group, mentors several junior colleagues and collaborates widely with groups in the UK and internationally. He is also involved in several clinical trials in areas covering diabetes, obesity, and CVD risk and contributes to national and international guidelines in the above areas.
  • He has published over 500 papers (H-Index 70 Web of Science, 88 on Google Scholar), is on advisory board for Diabetologia and The Lancet, Diabetes and Endocrinology, and on the International Advisory Board for UK Biobank.
  • He has been awarded national and international prizes including the 2011 Minkowski prize awarded by the European Association for Study of Diabetes and is amongst the world most cited academics in clinical medicine as reported in Thomson Reuters Highly Cited Researcher 2014 report.

Member:

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Cardiac biomarkers and the prediction of CVD in Scotland
    Scottish Executive Health Department
    2015 - 2017
     
  • REMOVAL study: REducing with Metformin microvascular Outcomes and VAscular complications in T1DM
    Juvenile Diabetes Foundation
    2015 - 2016
     
  • The use of proton nuclear magnetic resonance to investigate dyslipidaemia and small molecule accumulation in chronic kidney disease (ISSF Catalyst)
    Wellcome Trust
    2014 - 2015
     
  • A randomised parallel group double blind placebo-controlled trial of low dose adjunctive alteplase during primary PCI (T-TIME)
    National Institute for Health Research
    2014 - 2017
     
  • Serum Chloride - epidemiology and genetic dissection of a novel marker of cardiovascular risk
    British Heart Foundation
    2014 - 2017
     
  • British Regional Heart Study (BRHS): a long-term prospective investigation of cardiovascular disease (causes, pathways, prediction and prevention) among older British men.
    British Heart Foundation
    2014 - 2019
     
  • SurgiCal Obesity Treatment Study (SCOTS)
    National Institute for Health Research
    2014 - 2026
     
  • Understanding the associations of physical activity and sedentary behaviours on established and novel markers of cardiovascular risk in older age
    British Heart Foundation
    2014 - 2015
     
  • Southall blood sample analysis collaboration - UCL
    NHS Greater Glasgow & Clyde, Endowment Funds Office
    2014 - 2018
     
  • Proposal of NDA work for the South Asian Health Foundation
    South Asian Heart Foundation
    2014 - 2016
     
  • In Situ Nanoparticle Assemblies for Healthcare Diagnostics and Therapy
    Engineering & Physical Sciences Research Council
    2014 - 2018
     
  • Seniors - understanding sedentary behaviour
    Medical Research Council
    2014 - 2017
     
  • Explaining excess winter mortality from CHD: analysis of UK based prospective studies
    British Heart Foundation
    2014 - 2016
     
  • REMOVAL study: REducing with Metformin microvascular Outcomes and VAscular complications in T1DM
    Juvenile Diabetes Foundation
    2014 - 2015
     
  • The UPBEAT RCT mother-child study. Stratifying and treating obese pregnant women to prevent adverse pregnancy, perinatal and longer term outcomes
    Medical Research Council
    2014 - 2017
     
  • Reversal of T2DM to normal glucose tolerance using non-surgical weight management with low-energy-liquid-diet and long-term maintenance, within routine NHS care.
    Diabetes UK
    2014 - 2018
     
  • Sedentary behaviour in older adults: investigating a new therapeutic paradigm
    Medical Research Council
    2013 - 2016
     
  • The effect of metformin therapy on NT-proBNP levels in non-diabetic patients with established coronary heart disease
    NHS Greater Glasgow and Clyde
    2013 - 2014
     
  • Pilot project to establish a Scottish wide bio-resource for type 2 diabetes - scoT2bio
    NHS Endowment Funds
    2013 - 2014
     
  • MRC APBI STratification and Extreme Response Mechanism IN Diabetes - MASTERMIND (MRC Stratifying Medicine Pilot)
    Medical Research Council
    2013 - 2015
     
  • Assessing the predictive value of quantitative high-throughput NMR metabolomic analysis for CVD events in a major study of diabetes: ADVANCE
    Chest, Heart & Stroke, Scotland
    2013 - 2015
     
  • Cardiac biomarkers and CVD risk screening: a cost-effective public health measure?
    British Heart Foundation
    2013 - 2016
     
  • REMOVAL study: REducing with Metformin microvascular Outcomes and VAscular complications in T1DM
    Juvenile Diabetes Foundation
    2013 - 2014
     
  • REMOVAL study: REducing with Metformin microvascular Outcomes and VAscular complications in T1DM
    Juvenile Diabetes Foundation
    2013 - 2014
     
  • Increasing physical activity in stroke survivors using STARFISH, an interactive mobile phone application
    Chest, Heart & Stroke, Scotland
    2013 - 2013
     
  • Analysis of bloods samples in the Pakistan Risk of Myocardial Infarction Study (PROMIS)
    NHS Greater Glasgow & Clyde, Endowment Funds Office
    2012 - 2014
     
  • Exploring the potential role for allostatic load markers in risk assessment of patients presenting with depressive symptoms
    Scottish Executive Health Department
    2012 - 2015
     
  • Modifiable early life determinants of adolescent NAFLD and its association with metabolic and vascular traits
    British Heart Foundation
    2012 - 2014
     
  • Do measures in cord blood predict long term offspring phenotype?
    Wellcome Trust
    2012 - 2015
     
  • Metabolic Medicine Research Group Fund
    NHS Greater Glasgow & Clyde, Endowment Funds Office
    2012 - 2013
     
  • SurgiCal Obesity Treatment Study (SCOTS)
    National Institute for Health Research
    2012 - 2026
     
  • Patterns of weight changes after diagnosis in patients with Type 2 Diabetes and their relationship with metabolic and cardiovascular outcomes
    Scottish Executive Health Department
    2012 - 2012
     
  • The menopausal transition and healthy ageing and wellbeing
    Medical Research Council
    2011 - 2016
     
  • TRUST: Multi-modal effects of thyroid hormone replacement for untreated older adults with subclinical hypothyroidism; a randomised placebo-controlled trial
    European Commission
    2011 - 2016
     
  • The application of a high-throughput NMR metabolomics system to the study of insulin resistance (ISSF Catalyst)
    Wellcome Trust
    2011 - 2014
     
  • Novel risk markers for cardiovascular disease: studying outcomes and determinants in the National Survey of Health and Development (1946 British Birth Cohort)
    Medical Research Council
    2011 - 2013
     
  • The relationship of the menopausal transition to healthy aging and chronic disease risk
    Wellcome Trust
    2011 - 2016
     
  • How do you plan NHS weight management services? Who are the eligible population and who benefits most?
    NHS Education for Scotland
    2011 - 2016
     
  • Maternal thyroid status and offspring development
    Scottish Executive Health Department
    2011 - 2013
     
  • Testing novel predictors of atherosclerosis progression in the relationship between insulin sensitivity and Cardiovascular disease (RISC) study
    NHS Greater Glasgow and Clyde
    2011 - 2012
     
  • A randomised controlled trial of the effect of remote ischaemic conditioning on coronary endothelial function in patients with angina
    Chest, Heart & Stroke, Scotland
    2011 - 2013
     
  • REMOVAL study: REducing with Metformin microvascular Outcomes and VAscular complications in T1DM
    Juvenile Diabetes Foundation
    2011 - 2012
     
  • The impact of adiposity on risk profiles and the emerging arterial phenotype in the young
    British Heart Foundation
    2011 - 2014
     
  • Biological, demographic, cognitive and social determinants of health outcomes in older people: results from within-study and extended follow-up of the PROSPER trial.
    Scottish Executive Health Department
    2010 - 2013
     
  • Vitamin D as a (causal) determinant of insulin resistance and diabetes? An analysis of three UK based prospective studies
    Diabetes UK
    2010 - 2012
     
  • Predictors of complications in patients with diabetes (Action In Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) Biomarker Studies)
    National Health and Medical Research Council
    2010 - 2013
     
  • Maternal lipotoxic response in obese pregnancy
    Wellbeing of Women
    2010 - 2012
     
  • Vitamin D levels and intake and cardiovascular events in the West of Scotland? A 14-year follow up of the MIDSPAN family study
    Chest, Heart & Stroke, Scotland
    2010 - 2011
     
  • NT-proBNP as a predictor of vascular events in WOSCOPS: using modern epidemiological techniques to test clinical utility of a biomarker
    British Heart Foundation
    2010 - 2012
     
  • Improving Pregnancy Outcome in Obese Women - the UK Pregnancies: Better Eating and Activity Trial (UPBEAT)
    Scottish Executive Health Department
    2010 - 2013
     
  • The intrauterine environment and differences in adiposity and insulin resistance between South Asian and European populations
    British Heart Foundation
    2009 - 2011
     
  • Assessing vascular disease, and its association with insulin resistance and adiposity in South Asians
    Chest, Heart & Stroke, Scotland
    2009 - 2011
     
  • Reykjavik Study Analysis.
    British Heart Foundation
    2009 - 2010
     
  • The public health importance of Vitamin D: determining causal effects of intrauterine and lifetime exposure to Vitamin D
    MRC
    2009 - 2013
     
  • The utility of biomarkers for non-alcoholic fatty liver disease in adolescents
    MRC
    2009 - 2012
     
  • Obstetric, lifestyle and genetic determinants of atherosclerosis, fat mass, insulin, glucose and lipid levels in women in early middle-age
    British Heart Foundation
    2008 - 2011
     
  • Effect of metformin on progression of carotid atherosclerosis in non-diabetic patients with CHD optimally treated with conventional risk reducing agents
    Scottish Executive Health Department
    2008 - 2012
     
  • Improving pregnancy outcome in obese women
    National Institute for Health Research
    2008 - 2012
     
  • Testing novel metabolic and inflammatory predictors of CVD [cardiovascular disease]and stroke events, and all cause mortality in WOSCOPS [West of Scotland Coronary Prevention Study ]...
    Chest, Heart & Stroke, Scotland
    2008 - 2009
     
  • Do fatty acids upregulate inflammatory gene expression? A proof of concept study
    Tenovus-Scotland
    2008 - 2008
     
  • Reliable evaluation of the predictive value of NT-BNP measurement in coronary heart disease
    Evelyn Trust
    2008 - 2009
     
  • Early pregnancy metabolic and inflammatory changes and their relationship to successful pregnancy
    Wellbeing of Women
    2007 - 2010
     
  • Genetic and environmental determinants of arterial function in childhood - insight into causal pathways from the avon longitudinal study...
    British Heart Foundation
    2007 - 2009
     
  • Proinflammatory cytokines as biomarkers for risk of stroke
    Scottish Executive Health Department
    2007 - 2007
     
  • Maternal over nutrition and offspring fat mass, metabolic and vascular function
    National Institute of Health (USA)
    2007 - 2009
     
  • Evidence of risk for the development of premature cardiovascular disease in juvenile idiopathic arthritis?
    Scottish Executive Health Department
    2007 - 2010
     
  • Impaired skeletal muscle oxidative capacity as a mechanism for greater insulin resistance in South Asians?
    Diabetes UK
    2007 - 2009
     
  • Maternal over nutrition and offspring fat mass, metabolic and vascular function
    NHS Greater Glasgow & Clyde, Endowment Funds Office
    2007 - 2007
     
  • Clarifying the causes and consequences of childhood obesity
    Scottish Executive Health Department
    2006 - 2006
     
  • Inflammation and haemostatic dysfunction - novel risk factors for cognitive decline in older patients with vascular risk factors or disease
    Scottish Executive Health Department
    2006 - 2008
     
  • Programming of later adiposity, glucose tolerance and cardiovascular risk in offspring of mothers with type 1 diabetes
    British Heart Foundation
    2006 - 2009
     
  • Biobank analysis on various projects
    NHS Greater Glasgow & Clyde, Endowment Funds Office
    2005 - 2007
     
  • Factors determining physical and mental well being in affluent and deprived communities in Glasgow
    Glasgow Centre for Population Health
    2005 - 2007
     
  • Investigating the frequency and causes of anaemia in patients with chronic heart failure
    Scottish Executive Health Department
    2005 - 2009
     
  • Insulin sensitization as a novel mechanism to lessen ischaemic burden in non-diabetic patients with chronic stable angina - a pilot study
    British Heart Foundation
    2005 - 2007
     
  • Optical biosensors in human and animal health
    BBSRC
    2005 - 2007
     
  • Biobank Analysis on Prosper
    NHS Greater Glasgow & Clyde, Endowment Funds Office
    2005 - 2006
     
  • Relevance of inflammation sensitive pathways to stroke, coronary events and cognitive decline in the elderly in PROSPER
    Chest, Heart & Stroke, Scotland
    2004 - 2005
     
  • Adipocyte lipolysis as a candidate pathway in the pathogenesis of pre-eclampsia
    British Heart Foundation
    2004 - 2008
     
  • Predictors and pattern of transition to type 2 diabetes - novel insights from the West of Scotland coronary prevention study
    Diabetes UK
    2004 - 2005
     
  • Inflammation, adiposity and endothelial markers as predictors of vascular risk in the elderly
    NHS Greater Glasgow & Clyde, Endowment Funds Office
    2004 - 2005
     
  • The effects of metformin on vascular function and adipocyte AMPK activation in type 2 diabetes
    British Heart Foundation
    2004 - 2006
     
  • Pathways to cardiovascular risk: the role of leptin and adiponectin
    British Heart Foundation
    2004 - 2005
     
  • A role for novel candidate pathways in cerebrovascular disease and cognitive decline in the elderly?
    The Stroke Association
    2003 - 2005
     

Additional information

Prizes, Awards and Distinctions

  • 2011: European Association for Study of Diabetes - awarded the Minkowski Lecture
  • 2011: Diabetes UK - awarded the Dorothy Hodgkin Lecture
  • 2006: British Atherosclerosis Society - awarded the John French Lecture
  • 2006: Universities of Glasgow/Strathclyde and Royal College of Physicians & Surgeons, Glasgow - Professor Tom Gibson Award
  • 2005: Diabetes UK - awarded the RD Lawrence Lecture
  • 2002: Professors Prize - in Clinical Biochemistry

Publications

List by: Type | Date

Jump to: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000
Number of items: 504.

2015

Mccallum, L. et al. (2015) Longitudinal blood pressure control, long-term mortality and predictive utility of serum liver enzymes and bilirubin in hypertensive patients. Hypertension, 66(1), pp. 37-43. 25941342. (doi:10.1161/HYPERTENSIONAHA.114.04915)

Mccallum, L. et al. (2015) Longitudinal blood pressure control, long-term mortality, and predictive utility of serum liver enzymes and bilirubin in hypertensive patients. Hypertension, (doi:10.1161/HYPERTENSIONAHA.114.04915) (PMID:25941342) (PMCID:PMC4461392)

Ferguson, L., and Sattar, N. (2015) Endothelial function measures: not for clinical prime time? International Journal of Clinical Practice, 69(6), pp. 624-625. (doi:10.1111/ijcp.12642) (PMID:26010940)

Anderson, E.L., Howe, L.D., Fraser, A., Macdonald-Wallis, C., Callaway, M.P., Sattar, N., Day, C., Tilling, K., and Lawlor, D.A. (2015) Childhood energy intake is associated with nonalcoholic fatty liver disease in adolescents. Journal of Nutrition, 145(5), pp. 983-989. (doi:10.3945/jn.114.208397) (PMID:25788585) (PMCID:PMC4410498)

Tillin, T. et al. (2015) Diabetes risk and amino acid profiles: cross-sectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall And Brent REvisited) study. Diabetologia, 58(5), pp. 968-979. (doi:10.1007/s00125-015-3517-8) (PMID:25693751) (PMCID:PMC4392114)

Malik, M. O. et al. (2015) Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland. Diabetologia, 58(4), pp. 716-725. (doi:10.1007/s00125-015-3492-0)

Ghouri, N., Purves, D., Deans, K. A., Logan, G., McConnachie, A., Wilson, J., Gill, J. M. R., and Sattar, N. (2015) An investigation of two-dimensional ultrasound carotid plaque presence and intima media thickness in middle-aged South Asian and European men living in the United Kingdom. PLoS ONE, 10(4), e0123317. (doi:10.1371/journal.pone.0123317) (PMID:25884221) (PMCID:PMC4401566)

McInnes, I. B. et al. (2015) Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study. Annals of the Rheumatic Diseases, 74(4), pp. 694-702. (doi:10.1136/annrheumdis-2013-204345) (PMID:24368514) (PMCID:PMC4392313)

Santangeli, L., Sattar, N., and Huda, S. H. (2015) Impact of maternal obesity on perinatal and childhood outcomes. Best Practice and Research: Clinical Obstetrics and Gynaecology, 29(3), pp. 438-448. (doi:10.1016/j.bpobgyn.2014.10.009) (PMID:25497183)

Eastwood, S. V., Tillin, T., Dehbi, H.-M., Wright, A., Forouhi, N. G., Godsland, I., Whincup, P., Sattar, N., Hughes, A. D., and Chaturvedi, N. (2015) Ethnic differences in associations between fat deposition and incident diabetes and underlying mechanisms: The SABRE study. Obesity, 23(3), pp. 699-706. (doi:10.1002/oby.20997) (PMID:25645144)

Nightingale, C. M. et al. (2015) Birthweight and risk markers for type 2 diabetes and cardiovascular disease in childhood: the child heart and health study in England (CHASE). Diabetologia, 58(3), pp. 474-484. (doi:10.1007/s00125-014-3474-7) (PMID:25520157) (PMCID:4320299)

Patel, S., Lawlor, D. A., Ferreira, D. L.S., Hughes, A. D., Chaturvedi, N., Callaway, M., Day, C., Sattar, N., and Fraser, A. (2015) The association of nonalcoholic fatty liver disease with central and peripheral blood pressure in adolescence. Journal of Hypertension, 33(3), pp. 546-553. (doi:10.1097/HJH.0000000000000445) (PMID:25426570) (PMCID:PMC4318641)

Wurtz, P. et al. (2015) Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation, 131(9), pp. 774-785. (doi:10.1161/CIRCULATIONAHA.114.013116) (PMID:25573147)

Jani, B. D., McLean, G., Nicholl, B. I., Barry, S. J.E., Sattar, N., Mair, F. S., and Cavanagh, J. (2015) Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers. Frontiers in Human Neuroscience, 9(Art 18), (doi:10.3389/fnhum.2015.00018)

Preiss, D., and Sattar, N. (2015) Classification of reported statin intolerance. Current Opinion in Lipidology, 26(1), pp. 65-66. (doi:10.1097/MOL.0000000000000149) (PMID:25551804)

Livingstone, S. J. et al. (2015) Estimated life expectancy in a Scottish cohort With type 1 diabetes, 2008-2010. JAMA: Journal of the American Medical Association, 313(1), pp. 37-44. (doi:10.1001/jama.2014.16425)

Wade, K. H. et al. (2015) Variation in the SLC23A1 gene does not influence cardiometabolic outcomes to the extent expected given its association with L-ascorbic acid. American Journal of Clinical Nutrition, 101(1), pp. 202-209. (doi:10.3945/ajcn.114.092981)

Jones, R., Hardy, R., Sattar, N., Deanfield, J. E., Hughes, A., Kuh, D., Murray, E. T., Whincup, P. H., and Thomas, C. (2015) Novel coronary heart disease risk factors at 60–64 years and life course socioeconomic position: the 1946 British birth cohort. Atherosclerosis, 238(1), pp. 70-76. (doi:10.1016/j.atherosclerosis.2014.11.011)

Swerdlow, D. I. et al. (2015) HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet, 385(9965), pp. 351-361. (doi:10.1016/S0140-6736(14)61183-1)

Brown, C. E. et al. (2015) Urinary proteomic biomarkers to predict cardiovascular events. Proteomics Clinical Applications, 9(5-6), pp. 610-617. (doi:10.1002/prca.201400195) (PMID:25786980)

Burska, A.N., Sakthiswary, R., and Sattar, N. (2015) Effects of tumour necrosis factor antagonists on insulin sensitivity/resistance in rheumatoid arthritis: a systematic review and meta-analysis. PLoS ONE, 10(6), e0128889. (doi:10.1371/journal.pone.0128889) (PMID:26110878) (PMCID:PMC4482317)

Carrick, D. et al. (2015) Pathophysiology of left ventricular remodeling in survivors of ST-segment elevation myocardial infarction. JACC: Cardiovascular Imaging, (In Press)

Carrick, D. et al. (2015) Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison to contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. European Heart Journal, (Accepted for Publication)

Jackson, C. et al. (2015) Combined free light chains are novel predictors of prognosis in heart failure. JACC: Heart Failure, (In Press)

Kristensen, S. L., McInnes, I., and Sattar, N. (2015) Psoriasis, psoriatic arthritis and cardiovascular risk: are we closer to a clinical recommendation? Annals of the Rheumatic Diseases, 74(2), pp. 321-322. (doi:10.1136/annrheumdis-2014-206617)

Locke, A. E. et al. (2015) Genetic studies of body mass index yield new insights for obesity biology. Nature, 518(7538), pp. 197-206. (doi:10.1038/nature14177) (PMID:25673413) (PMCID:PMC4382211)

Logue, J. et al. (2015) SurgiCal Obesity Treatment Study (SCOTS): protocol for a national prospective cohort study of patients undergoing bariatric surgery in Scotland. BMJ Open, 5(5), e008106. (doi:10.1136/bmjopen-2015-008106) (PMID:26002692) (PMCID:PMC4442215)

Poortvliet, R. K.E. et al. (2015) Biological correlates of blood pressure variability in elderly at high risk of cardiovascular disease. American Journal of Hypertension, 28(4), pp. 469-479. (doi:10.1093/ajh/hpu181) (PMID:25298176)

Preiss, D. et al. (2015) The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. European Heart Journal, (doi:10.1093/eurheartj/ehv072) (PMID:25802390) (Early Online Publication)

Preiss, D., and Sattar, N. (2015) Does the LDL receptor play a role in the risk of developing type 2 diabetes? JAMA: Journal of the American Medical Association, 313(10), pp. 1016-1017. (doi:10.1001/jama.2015.1275) (PMID:25756436)

van Leeuwen, E. M. et al. (2015) Genome of the Netherlands population-specific imputations identify an ABCA6 variant associated with cholesterol levels. Nature Communications, 6, 6065. (doi:10.1038/ncomms7065) (PMID:25751400) (PMCID:PMC4366498)

2014

Lawlor, D. A., West, J., Fairley, L., Nelson, S. M., Bhopal, R. S., Tuffnell, D., Freeman, D. J., Wright, J., Whitelaw, D. C., and Sattar, N. (2014) Pregnancy glycaemia and cord-blood levels of insulin and leptin in Pakistani and white British mother–offspring pairs: findings from a prospective pregnancy cohort. Diabetologia, 57(12), pp. 2492-2500. (doi:10.1007/s00125-014-3386-6)

Preiss, D. et al. (2014) Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR study. Diabetes, Obesity and Metabolism, 16(12), pp. 1265-1268. (doi:10.1111/dom.12320) (PMID:24861892)

Price, A. H., Welsh, P., Weir, C. J., Feinkohl, I., Robertson, C. M., Morling, J. R., McLachlan, S., Strachan, M. W. J., Sattar, N., and Price, J. F. (2014) N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetologia, 57(12), pp. 2505-2512. (doi:10.1007/s00125-014-3375-9)

Robertson, J., McInnes, I., and Sattar, N. (2014) Response to ‘Interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders’ by Hassan et al. Cytokine, 70(2), p. 198. (doi:10.1016/j.cyto.2014.05.028)

Welsh, P. et al. (2014) Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up. Diabetologia, 57(12), pp. 2513-2520. (doi:10.1007/s00125-014-3383-9)

Preiss, D., McMurray, J. J., and Sattar, N. (2014) Treatment of severe hypertriglyceridaemia. Lancet Diabetes and Endocrinology, 2(11), p. 860. (doi:10.1016/s2213-8587(14)70052-x) (PMID:25439459)

Rankin, N. J., Preiss, D., Welsh, P., Burgess, K. E.V., Nelson, S. M., Lawlor, D. A., and Sattar, N. (2014) The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective. Atherosclerosis, 237(1), pp. 287-300. (doi:10.1016/j.atherosclerosis.2014.09.024)

Welsh, P., and Sattar, N. (2014) Vitamin D genes and mortality. British Medical Journal, 349, g6599. (doi:10.1136/bmj.g6599)

Graves, L., Garnett, S.P., Cowell, C.T., Baur, L.A., Ness, A., Sattar, N., and Lawlor, D.A. (2014) Waist-to-height ratio and cardiometabolic risk factors in adolescence: findings from a prospective birth cohort. Pediatric Diabetes, 9(5), pp. 327-338. (doi:10.1111/j.2047-6310.2013.00192.x) (PMID:23894119) (PMCID:PMC4238826)

Anderson, E. L., Howe, L. D., Fraser, A., Callaway, M. P., Sattar, N., Day, C., Tilling, K., and Lawlor, D. A. (2014) Weight trajectories through infancy and childhood and risk of non-alcoholic fatty liver disease in adolescence: the ALSPAC study. Journal of Hepatology, 61(3), pp. 626-632. (doi:10.1016/j.jhep.2014.04.018)

Lim, S., Choi, S.H., Kim, K.M., Choi, S.I., Chun, E.J., Kim, M.J., Park, K.S., Jang, H.C., and Sattar, N. (2014) The association of rate of weight gain during early adulthood with the prevalence of subclinical coronary artery disease in recently diagnosed type 2 diabetes: the maxwel-cad study. Diabetes Care, 37(9), pp. 2491-2499. (doi:10.2337/dc13-2365)

Ntuk, U., Gill, J., Mackay, D., Sattar, N., and Pell, J. (2014) Ethnic specific obesity cut-offs for diabetes risk: cross-sectional study of 490, 288 UK Biobank participants. Diabetes Care, 37(9), pp. 2500-2507. (doi:10.2337/dc13-2966)

Bell, D., McAllister, D. A., Hughes, K. A., Lone, N., Mills, N. L., Sattar, N., McKnight, J., and Wild, S. H. (2014) Stress hyperglycaemia in hospitalised patients and their 3-year risk of diabetes: a Scottish retrospective cohort study. PLoS Medicine, 11(8), e1001708. (doi:10.1371/journal.pmed.1001708)

Charakida, M., Khan, T., Johnson, W., Finer, N., Woodside, J., Whincup, P. H., Sattar, N., Kuh, D., Hardy, R., and Deanfield, J. (2014) Lifelong patterns of BMI and cardiovascular phenotype in individuals aged 60–64 years in the 1946 British birth cohort study: an epidemiological study. Lancet Diabetes and Endocrinology, 2(8), pp. 648-654. (doi:10.1016/S2213-8587(14)70103-2)

Johnsson, H., Panarelli, M., Cameron, A., and Sattar, N. (2014) Analysis and modelling of cholesterol and high-density lipoprotein cholesterol changes across the range of C-reactive protein levels in clinical practice as an aid to better understanding of inflammation-lipid interactions. Annals of the Rheumatic Diseases, 73(8), pp. 1495-1499. (doi:10.1136/annrheumdis-2013-203293)

Maitland, R.A., Seed, P.T., Briley, A.L., Homsy, M., Thomas, S., Pasupathy, D., Robson, S.C., Nelson, S.M., Sattar, N., and Poston, L. (2014) Prediction of gestational diabetes in obese pregnant women from the UK Pregnancies Better Eating and Activity (UPBEAT) pilot trial. Diabetic Medicine, 31(8), pp. 963-970. (doi:10.1111/dme.12482)

Welsh, P. et al. (2014) Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients With type 2 diabetes? Results from the ADVANCE Trial. Diabetes Care, 37(8), pp. 2202-2210. (doi:10.2337/dc13-2625)

Wijsman, L. W. et al. (2014) N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk. Annals of Neurology, 76(2), pp. 213-222. (doi:10.1002/ana.24203)

Postmus, I. et al. (2014) In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study. Atherosclerosis, 235(1), pp. 58-64. (doi:10.1016/j.atherosclerosis.2014.04.009)

Schernthaner, G., and Sattar, N. (2014) Lessons from SAVOR and EXAMINE: some important answers, but many open questions. Journal of Diabetes and its Complications, 28(4), pp. 430-433. (doi:10.1016/j.jdiacomp.2014.02.011)

Gill, J.M.R., and Sattar, N. (2014) Fruit juice: just another sugary drink? Lancet Diabetes and Endocrinology, 2(6), pp. 444-446. (doi:10.1016/S2213-8587(14)70013-0)

Hillis, G. S., Welsh, P., Chalmers, J., Woodward, M., and Sattar, N. (2014) Response to comment on Hillis et al. The relative and combined ability of high-sensitivity cardiac troponin T and N-Terminal Pro-B-Type natriuretic peptide to predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care 2014;37:295-303. Diabetes Care, 37(6), e154-e154. (doi:10.2337/dc14-0485)

Jones, N.R.V., Fischbacher, C.M., Guthrie, B., Leese, G., Lindsay, R.S., McKnight, J.A., Pearson, D., Philip, S., Sattar, N., and Wild, S.H. (2014) Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008. Diabetic Medicine, 31(6), pp. 640-646. (doi:10.1111/dme.12409) (PMID:24533646) (PMCID:PMC4232871)

Sattar, N. A. et al. (2014) The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice. Atherosclerosis Supplements, 15(1), pp. 1-15. (doi:10.1016/j.atherosclerosissup.2014.04.001)

Estampador, A. C., Pomeroy, J., Renstrom, F., Nelson, S. M., Mogren, I., Persson, M., Sattar, N., Domellof, M., and Franks, P. W. (2014) Infant body composition and adipokine concentrations in relation to maternal gestational weight gain. Diabetes Care, 37(5), pp. 1432-1438. (doi:10.2337/dc13-2265) (PMID:24623025) (PMCID:PMC3994936)

Maki, K. C., Ridker, P. M., Brown, W. V., Grundy, S. M., and Sattar, N. (2014) An assessment by the Statin Diabetes Safety Task Force: 2014 update. Journal of Clinical Lipidology, 8(3), S17-S29. (doi:10.1016/j.jacl.2014.02.012) (PMID:24793439)

Nurmohamed, M. T., Jamnitski, A., Symmons, D., Peters, M. J. L., Sattar, N., and McInnes, I. (2014) Response to: 'The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis' by Gonzalez-Gay et al. Annals of the Rheumatic Diseases, 73(5), e28. (doi:10.1136/annrheumdis-2014-205174)

Welsh, P., and Sattar, N. (2014) Vitamin D and chronic disease prevention. BMJ, 348, g2280. (doi:10.1136/bmj.g2280)

Park, C. M. et al. (2014) Hyperglycemia has a greater impact on left ventricle function in South Asians than in Europeans. Diabetes Care, 37(4), pp. 1124-1131. (doi:10.2337/dc13-1864)

Tillin, T., Sattar, N., Forouhi, N., Hughes, A. D., and Chaturvedi, N. (2014) Comment on Shah et al. Cardiovascular complications and mortality after diabetes diagnosis for South Asian and Chinese patients: a population-based cohort study. Diabetes Care, 37(4), e78-e79. (doi:10.2337/dc13-2490)

Bhopal, R. S. et al. (2014) Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial. Lancet Diabetes and Endocrinology, 2(3), pp. 218-227. (doi:10.1016/S2213-8587(13)70204-3)

Welsh, P., Poulter, N. R. , Chang, C. L., Sever, P. S., and Sattar, N. (2014) The Value of N-Terminal Pro–B-Type Natriuretic Peptide in Determining Antihypertensive Benefit: Observations From the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Hypertension, 63(3), pp. 507-513. (doi:10.1161/HYPERTENSIONAHA.113.02204)

Di Angelantonio, E. et al. (2014) Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA: Journal of the American Medical Association, 311(12), pp. 1225-1233. (doi:10.1001/jama.2014.1873) (PMID:24668104) (PMCID:PMC4386007)

Lawlor, D. A., Callaway, M., Macdonald-Wallis, C., Anderson, E., Fraser, A., Howe, L. D., Day, C., and Sattar, N. (2014) Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a Cross-sectional study of 1874 general population adolescents. Journal of Clinical Endocrinology and Metabolism, 99(3), E410-E417. (doi:10.1210/jc.2013-3612) (PMID:24471572) (PMCID:PMC3955251)

Tillin, T., Hughes, A. D., Whincup, P., Mayet, J., Sattar, N., McKeigue, P. M., and Chaturvedi, N. (2014) QRISK2 validation by ethnic group. Heart, 100(5), p. 437. (doi:10.1136/heartjnl-2013-305333)

Preiss, D., Lloyd, S.M., Ford, I., McMurray, J.J.V., Holman, R.R., Welsh, P., Fisher, M., Packard, C.J., and Sattar, N. (2014) Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes and Endocrinology, 2(2), pp. 116-124. (doi:10.1016/S2213-8587(13)70152-9)

Drewes, Y.M. et al. (2014) Homocysteine levels and treatment effect in the prospective study of pravastatin in the elderly at risk. Journal of the American Geriatrics Society, 62(2), pp. 213-221. (doi:10.1111/jgs.12660)

Sabayan, B., Westendorp, R. G., Grond, J. v. d., Stott, D. J., Sattar, N., van Osch, M. J.P., van Buchem, M. A., and de Craen, A. J.M. (2014) Markers of endothelial dysfunction and cerebral blood flow in older adults. Neurobiology of Aging, 35(2), pp. 373-377. (doi:10.1016/j.neurobiolaging.2013.08.020) (PMID:24054993)

Tillin, T., Sattar, N., Godsland, I.F., Hughes, A.D., Chaturvedi, N., and Forouhi, N.G. (2014) Ethnicity-specific obesity cut-points in the development of Type 2 diabetes - a prospective study including three ethnic groups in the United Kingdom. Diabetic Medicine, 32(2), pp. 226-234. (doi:10.1111/dme.12576) (PMID:25186015)

Wannamethee, S.G., Shaper, A.G., Whincup, P.H., Lennon, L., Papacosta, O., and Sattar, N. (2014) The obesity paradox in men with coronary heart disease and heart failure: the role of muscle mass and leptin. International Journal of Cardiology, 171(1), pp. 49-55. (doi:10.1016/j.ijcard.2013.11.043) (PMID:24331120) (PMCID:PMC3909461)

Goya Wannamethee, S., Welsh, P., Whincup, P. H., Lennon, L., Papacosta, O., and Sattar, N. (2014) N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study. European Journal of Heart Failure, 16(1), pp. 25-32. (doi:10.1093/eurjhf/hft124)

Hillis, G. S. et al. (2014) The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care, 37(1), pp. 295-303. (doi:10.2337/dc13-1165)

Looker, H.C. et al. (2014) Risk stratification for diabetic eye screening: reply to Stratton I. M. and Aldington S. J. Diabetologia, 57(1), pp. 260-261. (doi:10.1007/s00125-013-3099-2)

Tillin, T. et al. (2014) Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a UK tri-ethnic prospective cohort study (SABRE--Southall And Brent revisited). Heart, 100(1), pp. 60-67. (doi:10.1136/heartjnl-2013-304474)

Avery, C.L. et al. (2014) Drug–gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval. Pharmacogenomics Journal, 14(1), pp. 6-13. (doi:10.1038/tpj.2013.4)

Baumert, J. et al. (2014) No evidence for genome-wide interactions on plasma fibrinogen by smoking, alcohol consumption and body mass index: results from meta-analyses of 80,607 subjects. PLoS ONE, 9(12), e111156. (doi:10.1371/journal.pone.0111156)

Bodicoat, D. H. et al. (2014) Body mass index and waist circumference cut-points in multi-ethnic populations from the UK and India: the addition-Leicester, Jaipur heart watch and New Delhi cross-sectional studies. PLoS ONE, 9(3), e90813. (doi:10.1371/journal.pone.0090813)

Briley, A. L. et al. (2014) A complex intervention to improve pregnancy outcome in obese women; the UPBEAT randomised controlled trial. BMC Pregnancy and Childbirth, 14, 74. (doi:10.1186/1471-2393-14-74) (PMID:24533897) (PMCID:PMC3938821)

Deelen, J. et al. (2014) Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age. Human Molecular Genetics, 23(16), pp. 4420-4432. (doi:10.1093/hmg/ddu139)

Donin, A. S., Nightingale, C. M., Owen, C. G., Rudnicka, A. R., Perkin, M. R., Jebb, S. A., Stephen, A. M., Sattar, N., Cook, D. G., and Whincup, P. H. (2014) Regular breakfast consumption and Type 2 Diabetes risk markers in 9- to 10-year-old children in the Child Heart and Health Study in England (CHASE): a cross-sectional analysis. PLoS Medicine, 11(9), e1001703. (doi:10.1371/journal.pmed.1001703)

Holmes, M. V. et al. (2014) Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ, 349, g4164. (doi:10.1136/bmj.g4164)

Huang, J. et al. (2014) Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2. Arteriosclerosis, Thrombosis and Vascular Biology, 34(5), pp. 1093-1101. (doi:10.1161/ATVBAHA.113.302088)

Huda, S. S., Forrest, R., Paterson, N., Jordan, F., Sattar, N., and Freeman, D. J. (2014) In preeclampsia, maternal third trimester subcutaneous adipocyte lipolysis is more resistant to suppression by insulin than in healthy pregnancy. Hypertension, 63(5), pp. 1094-1101. (doi:10.1161/​HYPERTENSIONAHA.113.01824) (PMID:24591340)

Jani, B., Cavanagh, J., Barry, S. J.E., Der, G., Sattar, N., and Mair, F. S. (2014) Revisiting the J shaped curve, exploring the association between cardiovascular risk factors and concurrent depressive symptoms in patients with cardiometabolic disease: findings from a large cross-sectional study. BMC Cardiovascular Disorders, 14, p. 139. (doi:10.1186/1471-2261-14-139)

Jani, B. D., Cavanagh, J., Barry, S., Der, G., Sattar, N., and Mair, F. S. (2014) Association between cardiovascular risk factors and concurrent depressive symptoms in cardiometabolic disease: a cross-sectional study. In: Public Health Science, Glasgow, UK, 19 Nov 2014, S40. (doi:10.1016/S0140-6736(14)62166-8)

McArthur, L., Johnston, L., Sattar, N., Logue, J., and Welsh, P. (2014) Preanalytical study of fetuin-A: effect of sample type, processing speed and freeze-thaw cycles. Annals of Clinical Biochemistry, 52(1), pp. 165-168. (doi:10.1177/0004563214529550)

McCallum, L. et al. (2014) Response to effect of serum chloride on mortality in hypertensive patients. Hypertension, 63(3), e15-e15. (doi:10.1161/HYPERTENSIONAHA.113.02926)

Mirjafari, H. et al. (2014) N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR). Annals of the Rheumatic Diseases, 73(4), pp. 684-690. (doi:10.1136/annrheumdis-2012-202848)

Porter, D., Dale, J., and Sattar, N. (2014) How low to aim in rheumatoid arthritis? Learning from other disciplines. Annals of the Rheumatic Diseases, 73(3), pp. 480-482. (doi:10.1136/annrheumdis-2013-204339)

Postmus, I. et al. (2014) Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins. Nature Communications, 5(5068), (doi:10.1038/ncomms6068)

Sattar, N., Forrest, E., and Preiss, D. (2014) Non-alcoholic fatty liver disease. British Medical Journal, 2014(349), g4596. (doi:10.1136/bmj.g4596) (PMID:25239614) (PMCID:PMC4168663)

Sattar, N., and Gill, J. (2014) Type 2 diabetes as a disease of ectopic fat? BMC Medicine, 12, 123. (doi:10.1186/s12916-014-0123-4) (PMID:25159817) (PMCID:PMC4143560)

Silverwood, R. J., Richards, M., Pierce, M., Hardy, R., Sattar, N., Ferro, C., Savage, C., Kuh, D., and Nitsch, D. (2014) Cognitive and kidney function: results from a British birth cohort reaching retirement age. PLoS ONE, 9(1), e86743. (doi:10.1371/journal.pone.0086743) (PMID:24482683) (PMCID:PMC3901795)

Taylor, A. E. et al. (2014) Stratification by smoking status reveals an association of CHRNA5-A3-B4 genotype with body mass index in never smokers. PLoS Genetics, 10(12), e1004799. (doi:10.1371/journal.pgen.1004799)

Uversky, V.N. et al. (2014) The relation of rapid changes in obesity measures to lipid profile - insights from a nationwide metabolic health survey in 444 Polish cities. PLoS ONE, 9(1), e86837. (doi:10.1371/journal.pone.0086837)

Wallia, S. et al. (2014) Culturally adapting the prevention of diabetes and obesity in South Asians (PODOSA) trial. Health Promotion International, 29(4), pp. 768-779. (doi:10.1093/heapro/dat015)

Wannamethee, S. G., Welsh, P., Papacosta, O., Lennon, L., Whincup, P. H., and Sattar, N. (2014) Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circulation: Heart Failure, 7(5), pp. 732-739. (doi:10.1161/CIRCHEARTFAILURE.114.001272)

West, J., Wright, J., Fairley, L., Sattar, N., Whincup, P., and Lawlor, D. A. (2014) Do ethnic differences in cord blood leptin levels differ by birthweight category? Findings from the Born in Bradford cohort study. International Journal of Epidemiology, 43(1), pp. 249-254. (doi:10.1093/ije/dyt225)

van den Oever, I.A.M., Sattar, N., and Nurmohamed, M.T. (2014) Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system. Annals of the Rheumatic Diseases, 73(6), pp. 954-957. (doi:10.1136/annrheumdis-2013-204767) (PMID:24431395)

2013

Cavanagh, J. et al. (2013) Socioeconomic status and the cerebellar grey matter volume. Data from a well-characterised population sample. Cerebellum, 12(6), pp. 882-891. (doi:10.1007/s12311-013-0497-4)

Preiss, D., and Sattar, N. (2013) Choice of medical therapy to lower triglycerides in those at risk of pancreatitis. Current Opinion in Lipidology, 24(6), pp. 532-533. (doi:10.1097/MOL.0000000000000029)

Sattar, N., and Kitas, G.D. (2013) Rheumatoid arthritis: testing the inflammation–insulin resistance link in clinical trials. Nature Reviews Rheumatology, 9(12), pp. 702-703. (doi:10.1038/nrrheum.2013.178)

Silverwood, R.J., Pierce, M., Hardy, R., Sattar, N., Whincup, P., Ferro, C., Savage, C., Kuh, D., and Nitsch, D. (2013) Low birth weight, later renal function, and the roles of adulthood blood pressure, diabetes, and obesity in a British birth cohort. Kidney International, 84(6), pp. 1262-1270. (doi:10.1038/ki.2013.223)

Sabayan, B., van der Grond, J., Westendorp, R.G., Jukema, J.W., Ford, I., Buckley, B.M., Sattar, N., van Osch, M.J.P., van Buchem, M.A., and de Craen, A.J.M. (2013) Total cerebral blood flow and mortality in old age: a 12-year follow-up study. Neurology, 81(22), pp. 1922-1929. (doi:10.1212/01.wnl.0000436618.48402.da)

Holmes, M.V. et al. (2013) Secretory phospholipase A2-IIA and cardiovascular disease. Journal of the American College of Cardiology, 62(21), pp. 1966-1976. (doi:10.1016/j.jacc.2013.06.044)

McCallum, L. et al. (2013) Serum chloride is an independent predictor of mortality in hypertensive patients. Hypertension, 62(5), pp. 836-843. (doi:10.1161/HYPERTENSIONAHA.113.01793)

Ghouri, N., Purves, D., McConnachie, A., Wilson, J., Gill, J.M.R., and Sattar, N. (2013) Lower cardiorespiratory fitness contributes to increased insulin resistance and fasting glycaemia in middle-aged South Asian compared with European men living in the UK. Diabetologia, 56(10), pp. 2238-2249. (doi:10.1007/s00125-013-2969-y)

Feinkohl, I. et al. (2013) Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care, 36(9), pp. 2779-2786. (doi:10.2337/dc12-2241)

Krishnadas, R. et al. (2013) Socioeconomic deprivation and cortical morphology: psychological, social, and biological determinants of ill health study. Psychosomatic Medicine, 75(7), pp. 616-623. (doi:10.1097/PSY.0b013e3182a151a7)

Logue, J., and Sattar, N. (2013) Body weight and mortality in type 2 diabetes: weighing up the evidence. Diabetes and Metabolism, 39(4), pp. 287-288. (doi:10.1016/j.diabet.2013.06.002)

Robertson, J., Peters, M.J., McInnes, I.B., and Sattar, N. (2013) Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm. Nature Reviews Rheumatology, 9(9), pp. 513-523. (doi:10.1038/nrrheum.2013.91)

Scott, R.A. et al. (2013) Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nature Genetics, 44(9), pp. 991-1005. (doi:10.1038/ng.2385)

Sever, P.S., Poulter, N.R., Chang, C.L., Thom, S.A.M., Hughes, A.D., Welsh, P., and Sattar, N. (2013) Evaluation of C-reactive protein before and on-treatment as a predictor of benefit of atorvastatin. Journal of the American College of Cardiology, 62(8), pp. 717-729. (doi:10.1016/j.jacc.2013.02.098)

Looker, H.C. et al. (2013) Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia, 56(8), pp. 1716-1725. (doi:10.1007/s00125-013-2928-7)

Sattar, N. (2013) Gender aspects in type 2 diabetes mellitus and cardiometabolic risk. Best Practice and Research: Clinical Endocrinology and Metabolism, 27(4), pp. 501-507. (doi:10.1016/j.beem.2013.05.006)

Cleland, S.J., Fisher, B.M., Colhoun, H.M., Sattar, N., and Petrie, J.R. (2013) Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks? Diabetologia, 56(7), pp. 1462-1470. (doi:10.1007/s00125-013-2904-2)

Mooijaart, S.P., Sattar, N., Trompet, S., Lucke, J., Stott, D.J., Ford, I., Jukema, J.W., Westendorp, R.G.J., and de Craen, A.J.M. (2013) Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study. Journal of Internal Medicine, 274(1), pp. 77-85. (doi:10.1111/joim.12052)

Ghouri, N., Gatrad, R., Sattar, N., Dhami, S., and Sheikh, A. (2013) Summer-winter switching of the Ramadan fasts in people with diabetes living in temperate regions. Diabetic Medicine, 29(6), pp. 696-697. (doi:10.1111/j.1464-5491.2011.03519.x)

Nanchen, D. et al. (2013) Resting heart rate and incident heart failure and cardiovascular mortality in older adults: role of inflammation and endothelial dysfunction: the PROSPER study. European Journal of Heart Failure, 15(5), pp. 581-588. (doi:10.1093/eurjhf/hfs195)

Ferguson, L.D., and Sattar, N. (2013) Reducing cardiovascular disease risk in type 2 diabetes: is the focus on glycaemia warranted? Diabetes, Obesity and Metabolism, 15(5), pp. 387-391. (doi:10.1111/dom.12018)

Wannamethee, S.G., Sattar, N., Papcosta, O., Lennon, L., and Whincup, P.H. (2013) Alkaline phosphatase, serum phosphate, and incident cardiovascular disease and total mortality in older men. Arteriosclerosis, Thrombosis and Vascular Biology, 33(5), pp. 1070-1076. (doi:10.1161/ATVBAHA.112.300826)

Tillin, T., Hughes, A.D., Mayet, J., Whincup, P., Sattar, N., Forouhi, N.G., McKeigue, P.M., and Chaturvedi, N. (2013) The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans. Journal of the American College of Cardiology, 61(17), pp. 1777-1786. (doi:10.1016/j.jacc.2012.12.046)

Logue, J., Walker, J.J., Leese, G., Lindsay, R., McKnight, J., Morris, A., Philip, S., Wild, S., and Sattar, N. (2013) Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care, 36(4), pp. 887-893. (doi:10.2337/dc12-0944)

Sattar, N. (2013) Revisiting the links between glycaemia, diabetes and cardiovascular disease. Diabetologia, 56(4), pp. 686-695. (doi:10.1007/s00125-012-2817-5)

Smolen, J.S. et al. (2013) Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions. Annals of the Rheumatic Diseases, 72(4), pp. 482-492. (doi:10.1136/annrheumdis-2012-202469)

Saunders, C., Byrne, C.D., Guthrie, B., Lindsay, R.S., McKnight, J.A., Philip, S., Sattar, N., Walker, J.J., and Wild, S.H. (2013) External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants? Diabetic Medicine, 30(3), pp. 300-308. (doi:10.1111/dme.12047)

Postmus, I., Trompet, S., de Craen, A.J.M., Buckley, B.M., Ford, I., Stott, D.J., Sattar, N., Slagboom, P.E., Westendorp, R.G.J., and Jukema, J.W. (2013) PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population. Journal of Lipid Research, 54(2), pp. 561-566. (doi:10.1194/jlr.P033969)

Sattar, N. (2013) Lipid metabolism. Current Opinion in Lipidology, 24(1), pp. 101-102. (doi:10.1097/MOL.0b013e32835c9495)

Tillin, T., Hughes, A.D., Godsland, I.F., Whincup, P., Forouhi, N.G., Welsh, P., Sattar, N., McKeigue, P.M., and Chaturvedi, N. (2013) Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall and Brent REvisited (SABRE) cohort. Diabetes Care, 36(2), pp. 383-393. (doi:10.2337/dc12-0544)

Peters, M.J.L., Ghouri, N., McKeigue, P., Forouhi, N.G., and Sattar, N. (2013) Circulating IL-6 concentrations and associated anthropometric and metabolic parameters in South Asian men and women in comparison to European whites. Cytokine, 61(1), pp. 29-32. (doi:10.1016/j.cyto.2012.09.002)

Anderson, E.L., Fraser, A., McNally, W., Sattar, N., Lashen, H., Fleming, R., Nelson, S.M., and Lawlor, D.A. (2013) Anti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females. PLoS ONE, 8(5), e64510. (doi:10.1371/journal.pone.0064510)

Celis-Morales, C. A., Ghouri, N., Bailey, M.E.S., Sattar, N., and Gill, J. M.R. (2013) Should physical activity recommendations be ethnicity-specific? Evidence from a cross-sectional study of south Asian and European men. PLoS ONE, 8(12), e82568. (doi:10.1371/journal.pone.0082568)

Douglas, A. et al. (2013) Design and baseline characteristics of the PODOSA (prevention of diabetes and obesity in South Asians) trial: a cluster, randomised lifestyle intervention in Indian and Pakistani adults with impaired glycaemia at high risk of developing type 2 diabetes. BMJ Open, 3(2), e002226-e002226. (doi:10.1136/bmjopen-2012-002226)

Fraser, A., McNally, W., Sattar, N., Anderson, E.L., Lashen, H., Fleming, R., Lawlor, D.A., and Nelson, S.M. (2013) Prenatal exposures and anti-mullerian hormone in female adolescents: the avon longitudinal study of parents and children. American Journal of Epidemiology, 178(9), pp. 1414-1423. (doi:10.1093/aje/kwt137)

Fraser, A., Nelson, S.M., Macdonald-Wallis, C., Sattar, N., and Lawlor, D.A. (2013) Hypertensive disorders of pregnancy and cardiometabolic health in adolescent offspring. Hypertension, 62(3), pp. 614-620. (doi:10.1161/HYPERTENSIONAHA.113.01513)

Jamnitski, A., Symmons, D., Peters, M.J.L., Sattar, N., McInnes, I., and Nurmohamed, M.T. (2013) Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Annals of the Rheumatic Diseases, 72(2), pp. 211-216. (doi:10.1136/annrheumdis-2011-201194)

Krishnadas, R. et al. (2013) Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: results from the psychological, social and biological determinants of ill health (pSoBid) study. NeuroImage: Clinical, 2(2013), pp. 646-657. (doi:10.1016/j.nicl.2013.04.012)

Lloyd, S.M. et al. (2013) Long-term effects of statin treatment in elderly people: Extended follow-up of the PROspective study of Pravastatin in the elderly at risk (PROSPER). PLoS ONE, 8(9), e72642. (doi:10.1371/journal.pone.0072642)

McCarthy, M.I. et al. (2013) A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genetics, 9(2), e1003266. (doi:10.1371/journal.pgen.1003266)

Millar, K. et al. (2013) Personality, socio-economic status and inflammation: cross-sectional, population-based study. PLoS ONE, 8(3), e58256. (doi:10.1371/journal.pone.0058256)

Negandhi, P.H., Ghouri, N., Colhoun, H.M., Fischbacher, C.M., Lindsay, R.S., McKnight, J.A., Petrie, J., Philip, S., Sattar, N., and Wild, S.H. (2013) Ethnic differences in Glycaemic control in people with type 2 diabetes mellitus living in Scotland. PLoS ONE, 8(12), e83292. (doi:10.1371/journal.pone.0083292)

Poston, L. et al. (2013) Developing a complex intervention for diet and activity behaviour change in obese pregnant women (the UPBEAT trial); assessment of behavioural change and process evaluation in a pilot randomised controlled trial. BMC Pregnancy and Childbirth, 13(148), (doi:10.1186/1471-2393-13-148)

Rutter, M.K. et al. (2013) Epidemiological evidence against a role for C-reactive protein causing leptin resistance. European Journal of Endocrinology, 168(1), pp. 101-106. (doi:10.1530/EJE-12-0348)

Sabater-Lleal, M. et al. (2013) Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease. Circulation, 128(12), pp. 1310-1324. (doi:10.1161/CIRCULATIONAHA.113.002251)

Sabayan, B. et al. (2013) Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study. BMJ Open, 347, f4600. (doi:10.1136/bmj.f4600)

Sattar, N., and Taskinen, M.-R. (2013) Statins are diabetogenic – Myth or reality? Atherosclerosis Supplements, 13(1), pp. 1-10. (doi:10.1016/j.atherosclerosissup.2012.06.001)

Verschuren, J.J.W. et al. (2013) Non-homologous end-joining pathway associated with occurrence of myocardial infarction: gene set analysis of genome-wide association study data. PLoS ONE, 8(2), e56262. (doi:10.1371/journal.pone.0056262)

Wannamethee, S.G., Shaper, A.G., Whincup, P.H., Lennon, L., and Sattar, N. (2013) Adiposity, adipokines, and risk of incident stroke in older men. Stroke, 44(1), pp. 3-8. (doi:10.1161/STROKEAHA.112.670331)

Welsh, P., Doolin, O., Willeit, P., Packard, C., Macfarlane, P., Cobbe, S., Gudnason, V., Di Angelantonio, E., Ford, I., and Sattar, N. (2013) N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS. European Heart Journal, 34(6), pp. 443-450. (doi:10.1093/eurheartj/ehs239)

West, J., Lawlor, D.A., Fairley, L., Bhopal, R., Cameron, N., McKinney, P.A., Sattar, N., and Wright, J. (2013) UK-born Pakistani-origin infants are relatively more adipose than white British infants: findings from 8704 mother-offspring pairs in the Born-in-Bradford prospective birth cohort. Journal of Epidemiology and Community Health, 67(7), pp. 544-551. (doi:10.1136/jech-2012-201891)

2012

Charakida, M., Jones, A., Falaschetti, E., Khan, T., Finer, N.,, Sattar, N., Hingorani, A., Lawlor, D.A., Smith, G.D., and Deanfield, J.E. (2012) Childhood obesity and vascular phenotypes. Journal of the American College of Cardiology, 60(25), pp. 2643-2650. (doi:10.1016/j.jacc.2012.08.1017)

Heslehurst, N., Sattar, N., Rajasingam, D., Wilkinson, J., Summerbell, C.D., and Rankin, J. (2012) Existing maternal obesity guidelines may increase inequalities between ethnic groups: a national epidemiological study of 502,474 births in England. BMC Pregnancy and Childbirth, 12, p. 156. (doi:10.1186/1471-2393-12-156)

Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N., Baker, A. H., McInnes, I. B., and Liew, F. Y. (2012) IL-33 reduces the development of atherosclerosis (vol 205, pg 339, 2008). Journal of Experimental Medicine, 209(13), p. 2515. (doi:10.1084/jem.2007186820913c)

McLean, J. et al. (2012) Early life socioeconomic status, chronic physiological stress and hippocampal N-acetyl aspartate concentrations. Behavioural Brain Research, 235(2), pp. 225-230. (doi:10.1016/j.bbr.2012.08.013)

Kennon, B. et al. (2012) Reduced incidence of lower-extremity amputations in people with diabetes in Scotland: a nationwide study. Diabetes Care, 35(12), pp. 2588-2590. (doi:10.2337/dc12-0511)

Labad, J., Price, J.F., Strachan, M.W.J., Deary, I.J., Seckl, J.R., Sattar, N., and Reynolds, R.M. (2012) Serum leptin and cognitive function in people with Type 2 diabetes. Neurobiology of Aging, 33(12), pp. 2938-2941. (doi:10.1016/j.neurobiolaging.2012.02.026)

Packard, C. et al. (2012) Interaction of personality traits with social deprivation in determining mental wellbeing and health behaviours. Journal of Public Health, 34(4), pp. 615-624. (doi:10.1093/pubmed/fds030)

Welsh, P. et al. (2012) Circulating 250HD, dietary vitamin D, PTH, and calcium associations with incident cardiovascular disease and mortality: The MIDSPAN Family Study. Journal of Clinical Endocrinology and Metabolism, 97(12), pp. 4578-4587. (doi:10.1210/jc.2012-2272)

Colhoun, H.M. et al. (2012) Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs. Diabetologia, 55(11), pp. 2929-2937. (doi:10.1007/s00125-012-2668-0)

Jackson, C.A. et al. (2012) Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland. Diabetologia, 55(11), pp. 2938-2945. (doi:10.1007/s00125-012-2667-1)

Lawlor, D.A., Relton, C., Sattar, N., and Nelson, S.M. (2012) Maternal adiposity—a determinant of perinatal and offspring outcomes? Nature Reviews Endocrinology, 8(11), pp. 679-688. (doi:10.1038/nrendo.2012.176)

MacRitchie, N. et al. (2012) Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein e-deficient mice. Arteriosclerosis, Thrombosis and Vascular Biology, 32(11), pp. 2569-2579. (doi:10.1161/ATVBAHA.112.251314)

Miller, A. M. et al. (2012) Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes? PLoS ONE, 7(10), e47830. (doi:10.1371/journal.pone.0047830)

Kaptoge, S. et al. (2012) C-reactive protein, fibrinogen, and cardiovascular disease prediction. New England Journal of Medicine, 367(14), pp. 1310-1320. (doi:10.1056/NEJMoa1107477)

Randeva, H.S., Tan, B.K., Weickert, M.O., Lois, K., Nestler, J.E., Sattar, N., and Lehnert, H. (2012) Cardiometabolic aspects of the polycystic ovary syndrome. Endocrine Reviews, 33(5), pp. 812-841. (doi:10.1210/er.2012-1003)

Livingstone, S.J. et al. (2012) Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Medicine, 9(10), e1001321. (doi:10.1371/journal.pmed.1001321)

Feinkohl, I., Sattar, N., Welsh, P., Reynolds, R. M., Deary, I. J., Strachan, M. W.J., and Price, J. F. (2012) Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes. PLoS ONE, 7(9), e44569. (doi:10.1371/journal.pone.0044569)

Hingorani, A.D., Sofat, R., Morris, R.W., Whincup, P., Lowe, G.D., Mindell, J., Sattar, N., Casas, J.P., and Shah, T. (2012) Is it important to measure or reduce C-reactive protein in people at risk of cardiovascular disease? European Heart Journal, 33(18), pp. 2258-2264. (doi:10.1093/eurheartj/ehs168)

Looker, H.C. et al. (2012) Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia, 55(9), pp. 2335-2342. (doi:10.1007/s00125-012-2596-z)

Knox, S. et al. (2012) 25-hydroxyvitamin D is lower in deprived groups, but is not associated with carotid intima media thickness or plaques: results from pSoBid. Atherosclerosis, 223(2), pp. 437-441. (doi:10.1016/j.atherosclerosis.2012.05.001)

McInnes, I., Lee, J.S., Thompson, L., Giles, J.T., Bathton, J.M., Salmon, J.E., Beaulieu, A.D., Codding, C.E., Delles, C., and Sattar, N. (2012) The effects of tocilizumab treatment on lipids and inflammatory/prothrombotic markers in patients (pts) with rheumatoid arthritis (RA): data from the randomized, controlled, measure study. European Heart Journal, 33(Sup 1), p. 281. (doi:10.1093/eurheartj/ehs281)

Preiss, D. et al. (2012) Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA: Journal of the American Medical Association, 308(8), pp. 804-811. (doi:10.1001/jama.2012.8439)

Sassarini, J., Fox, H., Ferrell, W., Sattar, N., and Lumsden, M.A. (2012) Hot flushes, vascular reactivity and the role of the α-adrenergic system. Climacteric, 15(4), pp. 332-338. (doi:10.3109/13697137.2011.636847)

Di Angelantonio, E. et al. (2012) Lipid-related markers and cardiovascular disease prediction. JAMA: Journal of the American Medical Association, 307(23), pp. 2499-2506. (doi:10.1001/jama.2012.6571)

Sattar, N., Welsh, P., Panarelli, M., and Forouhi, N.G. (2012) Vitamin D testing – authors' reply. Lancet, 379(9827), pp. 1700-1701. (doi:10.1016/S0140-6736(12)60713-2)

Williams, D.M., Fraser, A., Sayers, A., Fraser, W.D., Hingorani, A., Deanfield, J., Davey Smith, G., Sattar, N., and Lawlor, D.A. (2012) Associations of 25-hydroxyvitamin D2 and D3 with cardiovascular risk factors in childhood: cross-sectional findings from the Avon Longitudinal Study of Parents and Children. Journal of Clinical Endocrinology and Metabolism, 97(5), pp. 1563-1571. (doi:10.1210/jc.2011-2335)

Swerdlow, D.I. et al. (2012) The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet, 379(9822), pp. 1214-1224. (doi:10.1016/S0140-6736(12)60110-X)

Verschuren, J.J.W., Wessels, J.A., Trompet, S., Stott, D.J., Sattar, N., Buckley, B., Guchelaar, H.-J., and Jukema, J. (2012) Genetic variation in the SMARCA2 gene is associated with cardiovascular events. Journal of the American College of Cardiology, 59(13), E1393. (doi:10.1016/S0735-1097(12)61394-1)

Nanchen, D. et al. (2012) Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. Journal of Clinical Endocrinology and Metabolism, 97(3), pp. 852-861. (doi:10.1210/jc.2011-1978)

Rao, V. U., Pavlov, A., Klearman, M., Musselman, D., Giles, J., Bathon, J. M., Sattar, N., and Lee, J. S. (2012) Risk factors for major adverse cardiovascular events in rheumatoid arthritis patients treated with the interleukin-6 receptor inhibitor tocilizumab. Journal of the American College of Cardiology, 59(13), E1648. (doi:10.1016/S0735-1097(12)61649-0)

Sayers, A., Lawlor, D.A., Sattar, N., and Tobias, J.H. (2012) The association between insulin levels and cortical bone: findings from a cross-sectional analysis of pQCT parameters in adolescents. Journal of Bone and Mineral Research, 27(3), pp. 610-618. (doi:10.1002/jbmr.1467)

Sever, P. S., Poulter, N. R., Chang, C. L., Hingorani, A., Thom, S. A., Hughes, A. D., Welsh, P., and Sattar, N. (2012) Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial. European Heart Journal, 33(4), pp. 486-494. (doi:10.1093/eurheartj/ehr262)

McGuinness, D. et al. (2012) Socio-economic status is associated with epigenetic differences in the pSoBid cohort. International Journal of Epidemiology, 41(1), pp. 151-160. (doi:10.1093/ije/dyr215)

Talens, R.P., Jukema, J.W., Trompet, S., Kremer, D., Westendorp, R.G.J., Lumey, L.H., Sattar, N., Putter, H., Slagboom, P.E., and Heijmans, B.T. (2012) Hypermethylation at loci sensitive to the prenatal environment is associated with increased incidence of myocardial infarction. International Journal of Epidemiology, 41(1), pp. 106-115. (doi:10.1093/ije/dyr153)

Sattar, N., Welsh, P., Panarelli, M., and Forouhi, N. G. . (2012) Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet, 379(9811), pp. 95-96. (doi:10.1016/S0140-6736(11)61816-3)

Goldenberg, D., Miller, E., Perna, M., Sattar, N., Welsh, P., Roman, M. J., and Salmon, J. E. (2012) Association of N-terminal pro-brain natriuretic peptide with cardiac disease, but not with vascular disease, in systemic lupus erythematosus. Arthritis and Rheumatism, 64(1), pp. 316-317. (doi:10.1002/art.33374)

Johnson, P.C.D., Logue, J., McConnachie, A., Abu-Rmeileh, N.M.E., Hart, C., Upton, M.N., Lean, M.E.J., Sattar, N., and Watt, G. (2012) Intergenerational change and familial aggregation of body mass index. European Journal of Epidemiology, 27(1), pp. 53-61. (doi:10.1007/s10654-011-9639-5)

Patel, S., Fraser, A., Davey Smith, G., Lindsay, R.S., Sattar, N., Nelson, S.M., and Lawlor, D.A. (2012) Associations of gestational diabetes, existing diabetes, and glycosuria with offspring obesity and cardiometabolic outcomes. Diabetes Care, 35(1), pp. 63-71. (doi:10.2337/dc11-1633)

Fraser, A., Nelson, S.M., Macdonald-Wallis, C., Cherry, L., Butler, E., Sattar, N., and Lawlor, D.A. (2012) Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon longitudinal study of parents and children. Circulation, 125(11), pp. 1367-1380. (doi:10.1161/CIRCULATIONAHA.111.044784)

Govan, L. et al. (2012) The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes. Diabetologia, 55(9), pp. 2356-2360. (doi:10.1007/s00125-012-2601-6)

Johnsson, H., McInnes, I.B., and Sattar, N. (2012) Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence. Annals of the Rheumatic Diseases, 71(4), pp. 480-483. (doi:10.1136/annrheumdis-2011-200567)

Labad, J., Price, J.F., Strachan, M.W.J., Fowkes, F.G.R., Deary, I.J., Seckl, J.R., Walker, B.R., Sattar, N., and Reynolds, R.M. (2012) Leptin levels and depressive symptoms in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study. Psychosomatic Medicine, 74(1), pp. 39-45. (doi:10.1097/PSY.0b013e31823ba8af)

Lawlor, D.A., Sattar, N., Sayers, A., and Tobias, J.H. (2012) The association of fasting insulin, glucose, and lipids with bone mass in adolescents: findings from a cross-sectional study. Journal of Clinical Endocrinology and Metabolism, 97(6), pp. 2068-2076. (doi:10.1210/jc.2011-2721)

Logue, J., and Sattar, N. (2012) Don't rush into testing and treating children. British Medical Journal, 345, e6899. (doi:10.1136/bmj.e6899)

Manning, A.K. et al. (2012) A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nature Genetics, 44, pp. 659-669. (doi:10.1038/ng.2274)

Mullen, W., Gonzalez, J., Siwy, J., Franke, J., Sattar, N., Mullan, A., Roberts, S., Delles, C., Mischak, H., and Albalat, A. (2012) A pilot study on the effect of short-term consumption of a polyphenol rich drink on biomarkers of coronary artery disease defined by urinary proteomics. Journal of Agricultural and Food Chemistry, 59(24), pp. 12850-12857. (doi:10.1021/jf203369r)

Poortvliet, R.K.E. et al. (2012) Blood pressure variability and cardiovascular risk in the PROspective study of pravastatin in the elderly at risk (PROSPER). PLoS ONE, 7(12), e52438. (doi:10.1371/journal.pone.0052438)

Preiss, D., and Sattar, N. (2012) Pharmacotherapy: statins and new-onset diabetes—the important questions. Nature Reviews Cardiology, 9(4), pp. 190-192. (doi:10.1038/nrcardio.2012.15)

Preiss, D. et al. (2012) Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). European Journal of Heart Failure, 14(8), pp. 909-915. (doi:10.1093/eurjhf/hfs067)

Sattar, N. (2012) Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities. Diabetic Medicine, 29(1), pp. 5-13. (doi:10.1111/j.1464-5491.2011.03480.x)

Sattar, N., and Freeman, D.J. (2012) Potential mechanisms contributing to gestational diabetes and pre-eclampsia in the obese woman. In: Gillman, M.W. and Poston, L. (eds.) Maternal Obesity. Series: Cambridge medicine. Cambridge University Press: Cambridge, UK, pp. 45-55. ISBN 978107003965 (doi:10.1017/CBO9780511782466)

Sattar, N., and Freeman, D.J. (2012) Potential mechanisms contributing to gestational diabetes and preeclampsia in the obese woman. In: Gillman, M.W. and Poston, L. (eds.) Maternal Obesity. Cambridge University Press . ISBN 9781107003965

Sattar, N., and Preiss, D. (2012) HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards. Diabetologia, 55(6), pp. 1564-1567. (doi:10.1007/s00125-012-2510-8)

Seshasai, S.R.K., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Erqou, S., Sattar, N., and Ray, K.K. (2012) Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Archives of Internal Medicine, 172(3), pp. 209-216. (doi:10.1001/archinternmed.2011.628)

Wannamethee, S.G., Whincup, P.H., Shaper, A.G., Lennon, L., and Sattar, N. (2012) Gamma-glutamyltransferase, hepatic enzymes, and risk of incident heart failure in older men. Arteriosclerosis, Thrombosis and Vascular Biology, 32(3), pp. 830-835. (doi:10.1161/ATVBAHA.111.240457)

Whincup, P.H., Cook, D.G., and Sattar, N. (2012) Response to Letter by Mascitelli et al Regarding Ethnic Differences in Carotid Intima-Media Thickness Between UK Children of Black African-Caribbean and White European Origin. Stroke, 43(10), e104. (doi:10.1161/STROKEAHA.112.666438)

Whincup, P.H. et al. (2012) Ethnic differences in carotid intima-media thickness between UK children of black African-Caribbean and white European origin. Stroke, 43(7), pp. 1747-1754. (doi:10.1161/STROKEAHA.111.644955)

Whiteley, W., Wardlaw, J., Dennis, M., Lowe, G., Rumley, A., Sattar, N., Welsh, P., Green, A., Andrews, M., and Sandercock, P. (2012) The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke, 43(1), pp. 86-91. (doi:10.1161/STROKEAHA.111.634089)

van Sijl, A., Peters, M.J.L., Knol, D.L., Sattar, N., Smulders, Y.M., de Vet, H.C.A., and Nurmohamed, M.T. (2012) Comment on: Letter to the Editor from Payet, Pereira, Soubrier, and Mathieu. Seminars in Arthritis and Rheumatism, 41(4), e6-e6. (doi:10.1016/j.semarthrit.2011.10.001)

2011

Ford, I. et al. (2011) The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. International Journal of Epidemiology, 40(6), pp. 1530-1538. (doi:10.1093/ije/dyr172)

Freathy, R.M. et al. (2011) Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index. International Journal of Epidemiology, 40(6), pp. 1617-28. (doi:10.1093/ije/dyr077)

van Sijl, A.M., Peters, M.J.M., Knol, D.L., de Vet, R.H.C., Sattar, N., Dijkmans, B.A.C., Smulders, Y.M., and Nurmohamed, M.T. (2011) The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis. Seminars in Arthritis and Rheumatism, 41(3), pp. 393-400. (doi:10.1016/j.semarthrit.2011.04.003)

Shyangdan, D., Clar, C., Ghouri, N., Henderson, R., Gurung, T., Preiss, D., Sattar, N., Fraser, A., and Waugh, N. (2011) Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health Technology Assessment, 15(38), pp. 1-110. (doi:10.3310/hta15380)

Pfister, R. et al. (2011) Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies. PLoS Medicine, 8(10), e1001112. (doi:10.1371/journal.pmed.1001112)

Trompet, S. et al. (2011) Replication of LDL SWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses. BMC Medical Genetics, 12, p. 131. (doi:10.1186/1471-2350-12-131)

Welsh, P. et al. (2011) Circulating interleukin-10 and risk of cardiovascular events: a prospective study in the elderly at risk. Arteriosclerosis, Thrombosis and Vascular Biology, 31(10), pp. 2338-2344. (doi:10.1161/ATVBAHA.111.231795)

Mooijaart, S.P. et al. (2011) C-Reactive protein and genetic variants and cognitive decline in old age: the PROSPER Study. PLoS ONE, 6(9), e23890. (doi:10.1371/journal.pone.0023890)

Govan, L. et al. (2011) Achieved levels of HbA1c and likelihood of hospital admission in people with type 1 diabetes in the Scottish population: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetes Care, 34(9), pp. 1992-1997. (doi:10.2337/dc10-2099)

Kooter, A.J., Kostense, P.J., Groenewold, J., Thijs, A., Sattar, N., and Smulders, Y.M. (2011) Integrating information from novel risk factors with calculated risks: the critical impact of risk factor prevalence. Circulation, 124(6), pp. 741-745. (doi:10.1161/CIRCULATIONAHA.111.035725)

Wormser, D., Di Angelantonio, E., Sattar, N., Collins, R., Thompson, S., and Danesh, J. (2011) Body-mass index, abdominal adiposity, and cardiovascular risk – Authors' reply. Lancet, 378(9787), p. 228. (doi:10.1016/S0140-6736(11)61122-7)

Wannamethee, S. G., Welsh, P., Lowe, G. D., Gudnason, V., Di Angelantonio, E., Lennon, L., Rumley, A., Whincup, P. H., and Sattar, N. (2011) N-terminal pro-brain natriuretic peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. Journal of the American College of Cardiology, 58(1), pp. 56-64. (doi:10.1016/j.jacc.2011.02.041)

Welsh, P. et al. (2011) Vitamin D deficiency is common in patients with RA and linked to disease activity, but circulating levels are unaffected by TNF blockade: results from a prospective cohort study. Annals of the Rheumatic Diseases, 70(6), pp. 1165-1167. (doi:10.1136/ard.2010.137265)

Ghouri, N. A., Preiss, D., and Sattar, N. (2011) Reply (Need for a Three-Focused Approach to Nonalcoholic Fatty Liver Disease). Hepatology, 53(5), p. 1774. (doi:10.1002/hep.24138)

Logue, J., Murray, H.M., Welsh, P., Shepherd, J., Packard, C., Macfarlane, P., Cobbe, S., Ford, I., and Sattar, N. (2011) Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation. Heart, 97(7), pp. 564-568. (doi:10.1136/hrt.2010.211201)

Rahimi, K. et al. (2011) Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. British Medical Journal, 342, d1250. (doi:10.1136/bmj.d1250)

Wannamethee, S. G., Shaper, A. G., Whincup, P. H., Lennon, L., and Sattar, N. (2011) Impact of Diabetes on Cardiovascular Disease Risk and All-Cause Mortality in Older Men: Influence of Age at Onset, Diabetes Duration, and Established and Novel Risk Factors. Archives of Internal Medicine, 171(5), pp. 404-410. (doi:10.1001/archinternmed.2011.2)

Wensley, F. et al. (2011) Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ, 342, d548-d548. (doi:10.1136/bmj.d548)

Toms, T. E., Panoulas, V. F., Douglas, K. M. J., Nightingale, P., Smith, J. P., Griffiths, H., Sattar, N., Symmons, D. P. M., and Kitas, G. D. (2011) Are Lipid Ratios Less Susceptible to Change With Systemic Inflammation Than Individual Lipid Components in Patients With Rheumatoid Arthritis? Angiology, 62(2), pp. 167-175. (doi:10.1177/0003319710373749)

Wannamethee, S.G., Welsh, P., Whincup, P.H., Sawar, N., Thomas, M.C., Gudnarsson, V., and Sattar, N. (2011) High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? European Journal of Cardiovascular Prevention and Rehabilitation, 18(1), pp. 65-71. (doi:10.1097/HJR.0b013e32833b09d9)

Khunti, K., Walker, N., Sattar, N., and Davies, M. (2011) Unanswered questions over NHS health checks. British Medical Journal, 2011(342), c6312. (doi:10.1136/bmj.c6312)

Sassarini, J., Fox, H., Ferrell, W., Sattar, N., and Lumsden, M.A. (2011) Vascular function and cardiovascular risk factors in women with severe flushing. Clinical Endocrinology, 74(1), pp. 97-103. (doi:10.1111/j.1365-2265.2010.03921.x)

Altmann-Schneider, I., Trompet, S., de Craen, A. J. M., van Es, A. C. G. M., Jukema, J. W., Stott, D.J., Sattar, N., Westendorp, R. G. J., van Buchem, M. A., and van der Grond, J. (2011) Cerebral Microbleeds Are Predictive of Mortality in the Elderly. Stroke, 42(3), pp. 638-644. (doi:10.1161/STROKEAHA.110.595611)

Asquith, D.L., Miller, A.M., Reilly, J.H., Kerr, S., Welsh, P., Sattar, N., and McInnes, I.B. (2011) Simultaneous activation of the liver X receptors (LXR and LXR) drives murine collagen-induced arthritis disease pathology. Annals of the Rheumatic Diseases, 70(12), pp. 2225-2228. (doi:10.1136/ard.2011.152652)

Barker, A. et al. (2011) Association of Genetic Loci With Glucose Levels in Childhood and Adolescence: A Meta-Analysis of Over 6,000 Children. Diabetes, 60(6), pp. 1805-1812. (doi:10.2337/db10-1575)

Berry, C., and Sattar, N. (2011) Stressed hearts in children with obesity and diabetes: a cause for concern? Diabetologia, 54(4), pp. 715-718. (doi:10.1007/s00125-010-2041-0)

Boyle, J.G., Logan, P.J., Jones, G.C., Small, M., Sattar, N., Connell, J.M.C., Cleland, S.J., and Salt, I.P. (2011) AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study. Diabetologia, 54(7), pp. 1799-1809. (doi:10.1007/s00125-011-2126-4)

Douglas, A. et al. (2011) Recruiting South Asians to a lifestyle intervention trial: experiences and lessons from PODOSA (Prevention of Diabetes & Obesity in South Asians). Trials, 12(220), (doi:10.1186/1745-6215-12-220)

Fraser, A., Tilling, K., Macdonald-Wallis, C., Hughes, R., Sattar, N., Nelson, S.M., and Lawlor, D.A. (2011) Associations of gestational weight gain with maternal body mass index, waist circumference, and blood pressure measured 16 y after pregnancy: the Avon Longitudinal Study of Parents and Children (ALSPAC). American Journal of Clinical Nutrition, 93(6), pp. 1285-1292. (doi:10.3945/ajcn.110.008326)

Freeman, D. et al. (2011) Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). BMC Geriatrics, 11(8), (doi:10.1186/1471-2318-11-8)

Gill, J.M.R. et al. (2011) Sitting time and waist circumference are associated with glycemia in U.K. South Asians: data from 1,228 adults screened for the PODOSA trial. Diabetes Care, 34(5), pp. 1214-1218. (doi:10.2337/dc10-2313)

Gill, J.M.R., and Sattar, N. (2011) Hepatic VLDL overproduction: is hyperinsulinemia or insulin resistance the culprit? Journal of Clinical Endocrinology and Metabolism, 96(7), pp. 2032-2034. (doi:10.1210/jc.2011-0690)

Govan, L. et al. (2011) Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia, 54(8), pp. 2000-2008. (doi:10.1007/s00125-011-2176-7)

Gray, L.J., Yates, T., Davies, M.J., Brady, E., Webb, D.R., Sattar, N., and Khunti, K. (2011) Defining obesity cut-off points for migrant South Asians. PLoS ONE, 6(10), e26464. (doi:10.1371/journal.pone.0026464)

Lawlor, D.A., Macdonald-Wallis, C., Fraser, A., Nelson, S.M., Hingorani, A., Davey Smith, G., Sattar, N., and Deanfield, J. (2011) Cardiovascular biomarkers and vascular function during childhood in the offspring of mothers with hypertensive disorders of pregnancy: findings from the Avon Longitudinal Study of Parents and Children. European Heart Journal, 33(3), pp. 335-345. (doi:10.1093/eurheartj/ehr300)

Logue, J., and Sattar, N. (2011) Childhood obesity: a ticking time bomb for cardiovascular disease? Clinical Pharmacology and Therapeutics, 90(1), pp. 174-178. (doi:10.1038/clpt.2011.88)

Macfarlane, P.W., Murray, H., Sattar, N., Stott, D.J., Ford, I., Buckley, B., Jukema, J.W., Westendorp, R.G.J., and Shepherd, J. (2011) The incidence and risk factors for new onset atrial fibrillation in the PROSPER study. Europace, 13(5), pp. 634-639. (doi:10.1093/europace/eur016)

Makgoba, M., Nelson, S.M., Savvidou, M., Messow, C.-M., Nicolaides, K., and Sattar, N. (2011) First-trimester circulating 25-hydroxyvitamin D levels and development of gestational diabetes mellitus. Diabetes Care, 34(5), pp. 1091-1093. (doi:10.2337/dc10-2264)

Owen, C. G., Rudnicka, A. R., Nightingale, C. M., Mullen, R., Barman, S. A., Sattar, N., Cook, D. G., and Whincup, P. H. (2011) Retinal Arteriolar Tortuosity and Cardiovascular Risk Factors in a Multi-Ethnic Population Study of 10-Year-Old Children; the Child Heart and Health Study in England (CHASE). Arteriosclerosis, Thrombosis and Vascular Biology, 31(8), pp. 1933-1938. (doi:10.1161/​ATVBAHA.111.225219)

Packard, C.J. et al. (2011) Early life socioeconomic adversity is associated in adult life with chronic inflammation, carotid atherosclerosis, poorer lung function and decreased cognitive performance: a cross-sectional, population-based study. BMC Public Health, 11, p. 42. (doi:10.1186/1471-2458-11-42)

Pons, D. et al. (2011) Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studies. Heart, 97(2), pp. 143-150. (doi:10.1136/hrt.2010.199927)

Preiss, D., Khunti, K., and Sattar, N. (2011) Combined cardiovascular and diabetes risk assessment in primary care. Diabetic Medicine, 28(1), pp. 19-22. (doi:10.1111/j.1464-5491.2010.03157.x)

Preiss, D., and Sattar, N. (2011) Statins and the risk of new-onset diabetes: a review of recent evidence. Current Opinion in Lipidology, 22(6), pp. 460-466. (doi:10.1097/MOL.0b013e32834b4994)

Preiss, D., and Sattar, N. (2011) The case for diabetes screening: ADDITION-Europe. Lancet, 378(9786), pp. 106-108. (doi:10.1016/S0140-6736(11)60819-2)

Preiss, D., Sattar, N., and McMurray, J.J. (2011) A systematic review of event rates in clinical trials in diabetes mellitus: The importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design. American Heart Journal, 161(1), p. 210. (doi:10.1016/j.ahj.2010.10.019)

Preiss, D. et al. (2011) Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA: Journal of the American Medical Association, 305(24), pp. 2556-2564. (doi:10.1001/jama.2011.860)

Rezai, M.-R., Wallace, A. M., Sattar, N., Finn, J. D., Wu, F. C. W., and Cruickshank, J. K. (2011) Ethnic Differences in Aortic Pulse Wave Velocity Occur in the Descending Aorta and May Be Related to Vitamin D. Hypertension, 58(2), pp. 247-253. (doi:10.1161/HYPERTENSIONAHA.111.174425)

Sattar, N. (2011) Adiponectin and raised mortality in type 1 diabetes: any credible explanatory mechanisms? Journal of Internal Medicine, 270(4), pp. 339-342. (doi:10.1111/j.1365-2796.2011.02408.x)

Shiels, P.G. et al. (2011) Accelerated telomere attrition is associated with relative household income, diet and inflammation in the pSoBid cohort. PLoS ONE, 6(7), e22521. (doi:10.1371/journal.pone.0022521)

Taylor, A.E., Guthrie, P.A.I., Smith, G.D., Golding, J., Sattar, N., Hingorani, A.D., Deanfield, J.E., and Day, I.N.M. (2011) IQ, Educational Attainment, Memory and Plasma Lipids: Associations with Apolipoprotein E Genotype in 5995 Children. Biological Psychiatry, 70(2), pp. 152-158. (doi:10.1016/j.biopsych.2010.10.033)

Walker, J. J., Livingstone, S. J., Colhoun, H. M., Lindsay, R.S., McKnight, J. A., Morris, A. D., Petrie, J. R., Philip, S., Sattar, N., and Wild, S. H. (2011) Effect of Socioeconomic Status on Mortality Among People With Type 2 Diabetes: A study from the Scottish Diabetes Research Network Epidemiology Group. Diabetes Care, 34(5), pp. 1127-1132. (doi:10.2337/dc10-1862)

Wannamethee, S. G., Papacosta, O., Whincup, P. H., Thomas, M. C., Carson, C., Lawlor, D. A., Ebrahim, S., and Sattar, N. (2011) The potential for a two-stage diabetes risk algorithm combining non-laboratory-based scores with subsequent routine non-fasting blood tests: results from prospective studies in older men and women. Diabetic Medicine, 28(1), pp. 23-30. (doi:10.1111/j.1464-5491.2010.03171.x)

Wannamethee, S.G., Shaper, A.G., Whincup, P.H., Lennon, L., and Sattar, N. (2011) Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease. Journal of the American College of Cardiology, 58(18), pp. 1870-1877. (doi:10.1016/j.jacc.2011.06.057)

Welsh, P., Peters, M.J.L., and Sattar, N. (2011) Is vitamin D in rheumatoid arthritis a magic bullet or a mirage? The need to improve the evidence base prior to calls for supplementation. Arthritis and Rheumatism, 63(7), pp. 1763-1769. (doi:10.1002/art.30341)

Welsh, P., Peters, M.J.L., and Sattar, N. (2011) Vitamin D insufficiency. New England Journal of Medicine, 364(14), pp. 1378-1379.

Whiteley, W. et al. (2011) Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study. Cerebrovascular Diseases, 32(2), pp. 141-147. (doi:10.1159/000328517)

2010

Sharma, G., Wilson, K., van der Walle, C.F., Sattar, N., Petrie, J.R., and Ravi Kumar, M.N.V. (2010) Microemulsions for oral delivery of insulin: Design, development and evaluation in streptozotocin induced diabetic rats. European Journal of Pharmaceutics and Biopharmaceutics, 76(2), pp. 159-169. (doi:10.1016/j.ejpb.2010.07.002)

Miller, A. M., Asquith, D. L., Hueber, A. J., Anderson, L. A., Holmes, W. M., McKenzie, A. N., Xu, D., Sattar, N., McInnes, I. B., and Liew, F. Y. (2010) Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circulation Research, 107(5), pp. 650-658. (doi:10.1161/CIRCRESAHA.110.218867)

Timpson, N.J. et al. (2010) Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-ascorbic acid (vitamin C): evidence from 5 independent studies with >15,000 participants. American Journal of Clinical Nutrition, 92(2), pp. 375-382. (doi:10.3945/ajcn.2010.29438)

Sattar, N. et al. (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet, 375(9716), pp. 735-742. (doi:10.1016/S0140-6736(09)61965-6)

Preiss, D., Sattar, N., and McMurray, J.J. (2010) Event rates in trials of patients with Type 2 diabetes. JAMA: Journal of the American Medical Association, 303(8), pp. 732-733. (doi:10.1001/jama.2010.137)

Asquith, D. L., Miller, A. M., Hueber, A. J., Liew, F. Y., Sattar, N., and McInnes, I. B. (2010) Apolipoprotein E-deficient mice are resistant to the development of collagen-induced arthritis. Arthritis and Rheumatism, 62(2), pp. 472-477. (doi:10.1002/art.27205)

Lawlor, D.A., Fraser, A., Lindsay, R.S., Ness, A., Dabelea, D., Catalano, P., Davey Smith, G., Sattar, N.A., and Nelson, S. (2010) Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort. Diabetologia, 53(1), pp. 89-97. (doi:10.1007/s00125-009-1560-z)

Trompet, S. et al. (2010) Pravastatin and cognitive function in the elderly. Results of the PROSPER study. Journal of Neurology, 257(1), pp. 85-90. (doi:10.1007/s00415-009-5271-7)

Welsh, P. et al. (2010) Unraveling the directional link between adiposity and inflammation: a bidirectional mendelian randomization approach. Journal of Clinical Endocrinology and Metabolism, 95(1), pp. 93-99. (doi:10.1210/jc.2009-1064)

Davidovici, B. B. et al. (2010) Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions. Journal of Investigative Dermatology, 130(7), pp. 1785-1796. (doi:10.1038/jid.2010.103)

Euser, S. M., Sattar, N., Witteman, J. C. M., Bollen, E. L. E. M., Sijbrands, E. J. G., Hofman, A., Perry, I. J., Breteler, M. M. B., and Westendorp, R. G. J. (2010) A Prospective Analysis of Elevated Fasting Glucose Levels and Cognitive Function in Older People: Results From PROSPER and the Rotterdam Study. Diabetes, 59(7), pp. 1601-1607. (doi:10.2337/db09-0568)

Falaschetti, E., Hingorani, A. D., Jones, A., Charakida, M., Finer, N., Whincup, P., Lawlor, D. A., Davey Smith, G., Sattar, N., and Deanfield, J. E. (2010) Adiposity and cardiovascular risk factors in a large contemporary population of pre-pubertal children. European Heart Journal, 31(24), pp. 3063-3072. (doi:10.1093/eurheartj/ehq355)

Fraser, A. et al. (2010) Association of Maternal Weight Gain in Pregnancy With Offspring Obesity and Metabolic and Vascular Traits in Childhood. Circulation, 121(23), pp. 2557-2564. (doi:10.1161/CIRCULATIONAHA.109.906081)

Freeman, D.J., and Sattar, N. (2010) The effect of pregnancy on energy metabolism, body composition and endothelial function. In: Tsatsoulis, A., Wyckoff, J. and Brown, F.M. (eds.) Diabetes in Women. Series: Contemporary diabetes. Humana Press Inc., pp. 207-222. ISBN 9781603272506 (doi:10.1007/978-1-60327-250-6_11)

Geelhoed, J. J. M., Fraser, A., Tilling, K., Benfield, L., Davey Smith, G., Sattar, N., Nelson, S. M., and Lawlor, D. A. (2010) Preeclampsia and Gestational Hypertension Are Associated With Childhood Blood Pressure Independently of Family Adiposity Measures: The Avon Longitudinal Study of Parents and Children. Circulation, 122(12), pp. 1192-1199. (doi:10.1161/CIRCULATIONAHA.110.936674)

Ghouri, N., Preiss, D., and Sattar, N. (2010) Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data. Hepatology, 52(3), pp. 1156-1161. (doi:10.1002/hep.23789)

Hall, L.M.L., Moran, C.N., Milne, G.R., MacFarlane, N.G., Forouhi, N.G., Hariharan, N., Salt, I.P., Sattar, N., and Gill, J.M.R. (2010) Fat oxidation, fitness and skeletal muscle expression of oxidative/lipid metabolism genes in South Asians: implications for insulin resistance? PLoS ONE, 5(12), e14197. (doi:10.1371/journal.pone.0014197)

Hernandez, A.V., Howe, L.D., Tilling, K., Benfield, L., Logue, J., Sattar, N., Ness, A.R., Davey Smith, G., and Lawlor, D.A. (2010) Changes in ponderal index and body mass index across childhood and their associations with fat mass and cardiovascular risk factors at age 15. PLoS ONE, 5(12), e15186. (doi:10.1371/journal.pone.0015186)

Howe, L.D., Galobardes, B., Sattar, N., Hingorani, A.D., Deanfield, J., Ness, A.R., Davey-Smith, G., and Lawlor, D.A. (2010) Are there socioeconomic inequalities in cardiovascular risk factors in childhood, and are they mediated by adiposity? Findings from a prospective cohort study. International Journal of Obesity, 34(7), pp. 1149-1159. (doi:10.1038/ijo.2010.52)

Huda, S. S., Brodie, L.E., and Sattar, N. (2010) Obesity in pregnancy: prevalence and metabolic consequences. Seminars in Fetal and Neonatal Medicine, 15(2), pp. 70-76. (doi:10.1016/j.siny.2009.09.006)

Jarvie, E., Hauguel‑de‑Mouzon, S., Nelson, S.M., Sattar, N., Catalano, P.M., and Freeman, D.J. (2010) Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clinical Science, 119(3), pp. 123-129. (doi:10.1042/CS20090640)

Lawlor, D.A. et al. (2010) Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study. British Medical Journal, 341, c6224. (doi:10.1136/bmj.c6224)

Lindsay, R. S., Nelson, S. M., Walker, J. D., Greene, S. A., Milne, G., Sattar, N., and Pearson, D. W. (2010) Programming of Adiposity in Offspring of Mothers With Type 1 Diabetes at Age 7 Years. Diabetes Care, 33(5), pp. 1080-1085. (doi:10.2337/dc09-1766)

Logue, J., and Sattar, N. (2010) Obesity in Children and Future Cardiometabolic Risk: Are blood tests necessary? Diabetes Care, 33(12), pp. 2711-2712. (doi:10.2337/dc10-1748)

Logue, J., and Sattar, N. (2010) Tackling obesity in adult primary care. Practitioner, 254(1730), pp. 31-32.

Logue, J., Thompson, L., Romanes, F., Wilson, D.C., Thompson, J., and Sattar, N. (2010) Management of obesity: summary of SIGN guideline. British Medical Journal, 340, c154-c154. (doi:10.1136/bmj.c154)

Owen, C.G., Nightingale, C.M., Rudnicka, A. R., Sattar, N., Cook, D. G., Ekelund, U., and Whincup, P. H. (2010) Physical activity, obesity and cardiometabolic risk factors in 9-to 10-year-old UK children of white European, South Asian and black African-Caribbean origin: the Child Heart And health Study in England (CHASE). Diabetologia, 53(8), pp. 1620-1630. (doi:10.1007/s00125-010-1781-1)

Padmanabhan, S. et al. (2010) Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genetics, 6(10), e1001177. (doi:10.1371/journal.pgen.1001177)

Peters, M. J. L. et al. (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Annals of the Rheumatic Diseases, 69(2), pp. 325-331. (doi:10.1136/ard.2009.113696)

Preiss, D., and Sattar, N. (2010) HbA1c: a useful cardiovascular risk marker in those without diabetes? Diabetologia, 53(12), pp. 2468-2469. (doi:10.1007/s00125-010-1902-x)

Preiss, D., Welsh, P., Murray, H., Shepherd, J., Packard, C., Macfarlane, P., Cobbe, S., Ford, I., and Sattar, N. (2010) Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up(dagger). European Heart Journal, 31(10), pp. 1230-1236. (doi:10.1093/eurheartj/ehq095)

Ray, K. K., Seshasai, S. R. K., Erqou, S., Sever, P., Jukema, J. W., Ford, I., and Sattar, N. (2010) Statins and All-Cause Mortality in High-Risk Primary Prevention: A Meta-analysis of 11 Randomized Controlled Trials Involving 65 229 Participants. Archives of Internal Medicine, 170(12), pp. 1024-1031. (doi:10.1001/archinternmed.2010.182)

Ray, K. K., Seshasai, S. R. K., Jukema, W., and Sattar, N. (2010) Are Statins Effective in High-Risk Primary Prevention?--Reply. Archives of Internal Medicine, 170(22), pp. 2043-2044. (doi:10.1001/archinternmed.2010.459)

Ray, K.K., and Sattar, N. (2010) Which risk engines are best to assess CVD risk in diabetes? Reply. Nature Reviews Endocrinology, 6(2), C2. (doi:10.1038/nrendo.2009.100-c2)

Sattar, N., Preiss, D., Welsh, P., Seshasai, S.R.K., and Ray, K.K. (2010) Statins and risk of incident diabetes Reply. Lancet, 375(9732), pp. 2141-2142.

Sattar, N., Welsh, P., Sarwar, N., Danesh, J., Di Angelantonio, E., Gudnason, V., Smith, G. D., Ebrahim, S., and Lawlor, D. A. (2010) NT-proBNP is associated with coronary heart disease risk in healthy older women but fails to enhance prediction beyond established risk factors: Results from the British Women's Heart and Health Study. Atherosclerosis, 209(1), pp. 295-299. (doi:10.1016/j.atherosclerosis.2009.09.016)

Savvidou, M., Nelson, S.M., Makgoba, M., Messow, C.-M., Sattar, N., and Nicolaides, K. (2010) First-trimester prediction of gestational diabetes mellitus: Examining the potential of combining maternal characteristics and laboratory measures. Diabetes, 59(12), pp. 3017-3022. (doi:10.2337/db10-0688)

Sayers, A., Timpson, N.J., Sattar, N., Deanfield, J., Hingorani, A.D., Davey Smith, G., and Tobias, J.H. (2010) Adiponectin and its association with bone mass accrual in childhood. Journal of Bone and Mineral Research, 25(10), pp. 2212-2220. (doi:10.1002/jbmr.116)

Sofat, R. et al. (2010) Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms. Circulation, 121(1), pp. 52-62. (doi:10.1161/CIRCULATIONAHA.109.865444)

Stott, D.J. et al. (2010) Activation of Hemostasis and Decline in Cognitive Function in Older People. Arteriosclerosis, Thrombosis and Vascular Biology, 30(3), pp. 605-611. (doi:10.1161/ATVBAHA.109.199448)

Talwar, D., McConnachie, A., Welsh, P., Upton, M., O'Reilly, D., Davey Smith, G., Watt, G., and Sattar, N. (2010) Which circulating antioxidant vitamins are confounded by socioeconomic deprivation? The MIDSPAN family study. PLoS ONE, 5(6), e11312. (doi:10.1371/journal.pone.0011312)

Wallace, S.M.L., Mäki-Petäjä, K.M., Cheriyan, J., Davidson, E.H., Cherry, L., McEniery, C.M., Sattar, N., Wilkinson, I.B., and Kharbanda, R.K. (2010) Simvastatin prevents inflammation-induced aortic stiffening and endothelial dysfunction. British Journal of Clinical Pharmacology, 70(6), pp. 799-806. (doi:10.1111/j.1365-2125.2010.03745.x)

Wannamethee, S. G., Papacosta, O., Whincup, P. H., Carson, C., Thomas, M. C., Lawlor, D. A., Ebrahim, S., and Sattar, N. (2010) Assessing prediction of diabetes in older adults using different adiposity measures: a 7 year prospective study in 6,923 older men and women. Diabetologia, 53(5), pp. 890-898. (doi:10.1007/s00125-010-1670-7)

Wannamethee, S. G., Shaper, A. G., Rumley, A., Sattar, N., Whincup, P. H., Thomas, M. C., and Lowe, G.D. (2010) Lung Function and Risk of Type 2 Diabetes and Fatal and Nonfatal Major Coronary Heart Disease Events: Possible Associations With Inflammation. Diabetes Care, 33(9), pp. 1990-1996. (doi:10.2337/dc10-0324)

Whincup, P.H., Nightingale, C.M., Owen, C.G., Rudnicka, A.R., Gibb, I., McKay, C.M., Donin, A.S., Sattar, N., Alberti, K.G.M.M., and Cook, D.G. (2010) Early emergence of ethnic differences in type 2 diabetes precursors in the UK: the Child Heart and Health Study in England (CHASE Study). PLoS Medicine, 7(4), e1000263. (doi:10.1371/journal.pmed.1000263)

Yates, T., Davies, M. J., Gorely, T., Talbot, D., Bull, F., Sattar, N., and Khunti, K. (2010) The effect of increased ambulatory activity on markers of chronic low-grade inflammation: evidence from the PREPARE programme randomized controlled trial. Diabetic Medicine, 27(11), pp. 1256-1263. (doi:10.1111/j.1464-5491.2010.03091.x)

Yates, T., Davies, M.J., Gray, L.J., Webb, D., Henson, J., Gill, J.M.R., Sattar, N., and Khunti, K. (2010) Levels of physical activity and relationship with markers of diabetes and cardiovascular disease risk in 5474 white European and South Asian adults screened for type 2 diabetes. Preventive Medicine, 51(3-4), pp. 290-294. (doi:10.1016/j.ypmed.2010.06.011)

Yates, T., Davies, M.J., Gray, L.J., Webb, D., Henson, J., Gill, J.M.R., Sattar, N., and Khunti, K. (2010) Levels of physical activity and relationship with markers of diabetes and cardiovascular disease risk in 5474 white European and South Asian adults screened for type 2 diabetes. Preventive Medicine, 51(3-4), pp. 290-294. (doi:10.1016/j.ypmed.2010.06.011)

2009

Trompet, S. et al. (2009) Apolipoprotein E genotype, plasma cholesterol, and cancer: a mendelian randomization study. American Journal of Epidemiology, 170(11), pp. 1415-1421. (doi:10.1093/aje/kwp294)

Gill, J.M.R., and Sattar, N. (2009) Ceramides: a new player in the inflammation-insulin resistance paradigm? Diabetologia, 52(12), pp. 2475-2477. (doi:10.1007/s00125-009-1546-x)

Di Angelantonio, E. et al. (2009) Major lipids, apolipoproteins, and risk of vascular disease. JAMA: Journal of the American Medical Association, 302(18), pp. 1993-2000. (doi:10.1001/jama.2009.1619)

Preiss, D. et al. (2009) Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Diabetes Care, 32(5), pp. 915-920. (doi:10.2337/dc08-1709) (PMID:19196892)

Stott, D.J., Welsh, P.I., Rumley, A., Robertson, M., Ford, I., Sattar, N.A., Westendorp, R.G.J., Jukema, J.W., Cobbe, S., and Lowe, G.D. (2009) Adipocytokines and risk of stroke in older people: a nested case-control study. International Journal of Epidemiology, 38(1), pp. 253-261. (doi:10.1093/ije/dyn215 )

Welsh, P. et al. (2009) Leptin Predicts Diabetes but Not Cardiovascular Disease Results from a large prospective study in an elderly population. Diabetes Care, 32(2), pp. 308-310. (doi:10.2337/dc08-1458)

Ang, D., Welsh, P., Watt, P., Nelson, S., Struthers, A., and Sattar, N. (2009) Serial changes in adiponectin and BNP in ACS patients: paradoxical associations with each other and with prognosis. Clinical Science, 117(1-2), pp. 41-48.

Asquith, D., Miller, A., Hueber, A., McKinnon, H., Sattar, N., Graham, G., and McInnes, I. (2009) Liver X Receptor Agonism Promotes Articular Inflammation in Murine Collagen-Induced Arthritis. Arthritis and Rheumatism, 60(9), pp. 2655-2665. (doi:10.1002/art.24717 )

Choy, E., and Sattar, N. (2009) Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Annals of the Rheumatic Diseases, 68(4), pp. 460-469.

Deans, K.A. et al. (2009) Differences in atherosclerosis according to area level socioeconomic deprivation: cross sectional, population based study. British Medical Journal, 339, b4170. (doi:10.1136/bmj.b4170)

Di Angelantonio, E., Chowdhury, R., Sarwar, N., Ray, K.K., Gobin, R., Saleheen, D., Thompson, A., Gudnason, V., Sattar, N.A., and Danesh, J. (2009) B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation, 120(22), 2177-2U39. (doi:10.1161/CIRCULATIONAHA.109.884866)

Ford, I. et al. (2009) Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis. PLoS Medicine, 6(1), e1000016. (doi:10.1371/journal.pmed.1000016 )

Fraser, A., Harris, R., Sattar, N., Ebrahim, S., Davey Smith, G., and Lawlor, D. (2009) Alanine Aminotransferase, gamma-Glutamyltransferase, and Incident Diabetes. Diabetes Care, 32(4), pp. 741-750. (doi:10.2337/dc08-1870)

Huda, S., Sattar, N., and Freeman, D. (2009) Lipoprotein metabolism and vascular complications in pregnancy. Clinical Lipidology, 4(1), pp. 91-102.

Jick, S., Choi, H., Li, L., Mclnnes, I., and Sattar, N. (2009) Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis. Annals of the Rheumatic Diseases, 68(4), pp. 546-551.

Kanagalingam, M.G., Nelson, S., Freeman, D., Ferrell, W.R., Cherry, L.M., Lowe, G.D.O., Greer, I.A., and Sattar, N.A. (2009) Vascular dysfunction and alteration of novel and classic cardiovascular risk factors in mothers of growth restricted offspring. Atherosclerosis, 205(1), pp. 244-250. (doi:10.1016/j.atherosclerosis.2008.10.006)

McKellar, G., McCarey, D., Sattar, N., and McInnes, I. (2009) Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nature Reviews Cardiology, 6(6), pp. 410-417.

Mullan, A., and Sattar, N. (2009) More knocks to the oxidation hypothesis for vascular disease? Clinical Science, 116(1-2), pp. 41-43.

Nelson, S., Freeman, D., Sattar, N., and Lindsay, R. (2009) Erythrocytosis in offspring of mothers with Type 1 diabetes-are factors other than insulin critical determinants? Diabetic Medicine, 26(9), pp. 887-892. (doi:10.1111/j.1464-5491.2009.02797.x )

Preiss, D.J., and Sattar, N.A. (2009) Metformin and lactic acidosis Metformin: framed again? British Medical Journal, 339, b5570. (doi:10.1136/bmj.b5570)

Preiss, D., and Sattar, N. (2009) Authors' reply to: Statin therapy as the fundamental therapy for cardiovascular prevention: be careful. Clinical Endocrinology, 71(3), pp. 456-457.

Preiss, D., and Sattar, N. (2009) Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. Clinical Endocrinology, 70(6), pp. 815-828.

Preiss, D., and Sattar, N. (2009) Metabolic syndrome: collapsing under its own weight? Diabetic Medicine, 26(5), pp. 457-459.

Preiss, D. et al. (2009) Predictors of Development in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Diabetes Care, 32(5), pp. 915-920.

Ray, K., and Sattar, N. (2009) DIABETES Which risk engines should be used to assess patients with diabetes? Nature Reviews Endocrinology, 5(6), pp. 302-303.

Ray, K., Seshasai, S., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Preiss, D., Erqou, S., and Sattar, N. (2009) Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet, 373(9677), pp. 1765-1772. (doi:10.1016/S0140-6736(09)60697-8)

Richards, J.B. et al. (2009) A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genetics, 5(12), e1000768. (doi:10.1371/journal.pgen.1000768)

Sarwar, N., and Sattar, N. (2009) Triglycerides and coronary heart disease: have recent insights yielded conclusive answers? Current Opinion in Lipidology, 20(4), pp. 275-281.

Sattar, N.A. et al. (2009) Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? PLoS Medicine, 6(6), e1000099 . (doi:10.1371/journal.pmed.1000099)

Sattar, N., and Hingorani, A. (2009) C-Reactive Protein and Prognosis in Diabetes: Getting to the Heart of the Matter. Diabetes, 58(4), pp. 798-799.

Sattar, N. et al. (2009) Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly. Diabetologia, 52(2), pp. 235-239.

Sattar, N., Wannamethee, G., Sarwar, N., Chernova, J., Lawlor, D., Kelly, A., Kelly, A., Wallace, A., Danesh, J., and Whincup, P. (2009) Leptin and Coronary Heart Disease Prospective Study and Systematic Review. Journal of the American College of Cardiology, 53(2), pp. 167-175.

Trompet, S., de Craen, A.J.M., Mooijaart, S., Stott, D.J., Ford, I., Sattar, N.A., Jukema, W., and Westendorp, R.G.J. (2009) High innate production capacity of proinflammatory cytokines increases risk for death from cancer: results of the PROSPER study. Clinical Cancer Research, 15(24), pp. 7744-7748. (doi:10.1158/1078-0432.CCR-09-2152)

Wannamethee, S., Thomas, M., Whincup, P., and Sattar, N. (2009) Associations Between Dietary Fiber and Inflammation, Hepatic Function, and Risk of Type 2 Diabetes in Older Men Potential mechanisms for the benefits of fiber on diabetes risk. Diabetes Care, 32(10), pp. 1823-1825.

2008

Huda, S. S., MacKenzie, S. M., Sattar, N., Fraser, R., Connell, J. M. C., and Davies, E. (2008) Depot-specific steroidogenic gene transcription in human adipose tissue. Clinical Endocrinology, 69(6), pp. 848-854. (doi:10.1111/j.1365-2265.2008.03262.x )

Muir, S.W., Harrow, C., Dawson, J., Lees, K.R., Weir, C.J., Sattar, N., and Walters, M.R. (2008) Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial. Stroke, 39(12), pp. 3303-3307. (doi:10.1161/STROKEAHA.108.519793)

Sattar, N. et al. (2008) Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet, 371(9628), pp. 1927-1935. (doi:10.1016/S0140-6736(08)60602-9)

Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N., Baker, A. H., McInnes, I. B., and Liew, F. Y. (2008) IL-33 reduces the development of atherosclerosis. Journal of Experimental Medicine, 205(2), pp. 339-346. (doi:10.1084/jem.20071868 )

Campbell, F. M., Ingram, A., Monaghan, P., Cooper, J., Sattar, N., Eckersall, P. D., and Graham, D. (2008) SERRS immunoassay for quantitative human CRP analysis. Analyst, 133(10), pp. 1355-1357. (doi:10.1039/b808087a )

Ford, E., Li, C., and Sattar, N. (2008) Metabolic syndrome and incident diabetes - Current state of the evidence. Diabetes Care, 31(9), pp. 1898-1904.

Fraser, A., Fraser, A., Sattar, N.A., Ebrahim, S., and Lawlor, D.A. (2008) Is serum-glutamylatransferase a biomarker of xenobiotics which are conjugated by glutathione? Response. Arteriosclerosis, Thrombosis and Vascular Biology, 28(4), E29-E29.

Hall, L.M.L., Sattar, N., and Gill, J.M.R. (2008) Risk of metabolic and vascular disease in South Asians: potential mechanisms for increased insulin resistance. Future Lipidology, 3(4), pp. 411-424. (doi:10.2217/17460875.3.4.411)

Hothersall, E. et al. (2008) Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax, 63(12), pp. 1070-1075. (doi:10.1136/thx.2008.100198)

Jeffery, A., Murphy, M., Metcalf, B., Hosking, J., Voss, L., English, P., Sattar, N., and Wilkin, T. (2008) Adiponectin in childhood. International Journal of Pediatric Obesity, 3(3), pp. 130-140. (doi:10.1080/17477160801954538 )

Lawlor, D., Ebrahim, S., Davey Smith, G., Cherry, L., Watt, P., and Sattar, N. (2008) The association of insulin-like-growth factor 1 (IGF-1) with incident coronary heart disease in women: Findings from the prospective British Women's Heart and Health Study. Atherosclerosis, 201(1), pp. 198-204. (doi:10.1016/j.atherosclerosis.2007.12.061 )

Logue, J., and Sattar, N. (2008) Food, fatness and facts: the need for a standard message. International Journal of Clinical Practice, 62(5), pp. 677-678. (doi:10.1111/j.1742-1241.2008.01738.x )

Mackinnon, B., Deighan, C., Ferrell, W., Sattar, N., and Fox, J. (2008) Endothelial function in patients with proteinuric primary glomerulonephritis. Nephron Clinical Practice, 109(1), C40-C47.

Mackinnon, B., Deighan, C. J., Ferrell, W.R., Sattar, N., and Fox, J. G. (2008) Endothelial Function in Patients with Proteinuric Primary Glomerulonephritis. Nephron Clinical Practice, 109(1), c40-c47. (doi:10.1159/000135632)

Nelson, S., Freeman, D.J., Sattar, N., and Lindsay, R.S. (2008) Role of adiponectin in matching of fetal and placental weight in mothers with type 1 diabetes. Diabetes Care, 31(6), pp. 1123-1125. (doi:10.2337/dc07-2195)

Preiss, D., Sattar, N., Harborne, L., Norman, J.E., and Fleming, R. (2008) The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome. International Journal of Clinical Practice, 62(9), pp. 1337-1343. (doi:10.1111/j.1742-1241.2008.01825.x)

Preiss, D., and Sattar, N. (2008) Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clinical Science, 115(5-6), pp. 141-150.

Sattar, N. (2008) Why metabolic syndrome criteria have not made prime time: a view from the clinic. International Journal of Obesity, 32, S30-S34.

Sattar, N., and Nelson, S. (2008) Adiponectin, diabetes, and coronary heart disease in older persons: Unraveling the paradox. Journal of Clinical Endocrinology and Metabolism, 93(9), pp. 3299-3301.

Sattar, N., and Wannamethee, S. (2008) Ankle brachial index vs metabolic syndrome for risk prediction - Reply. Lancet, 372(9645), pp. 1221-1222.

Sattar, N., Wannamethee, S., and Forouhi, N. (2008) Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? Diabetologia, 51(6), pp. 926-940.

Sattar, N., Watt, P., Cherry, L., Ebrahim, S., Davey Smith, G., and Lawlor, D. (2008) High molecular weight adiponectin is not associated with incident coronary heart disease in older women: A nested prospective case-control study. Journal of Clinical Endocrinology and Metabolism, 93(5), pp. 1846-1849. (doi:10.1210/jc.2007-2603)

Stott, D., Falconer, A., Kerr, G., Murray, H., Trompet, S., Westendorp, R., Buckley, B., De Craen, A., Sattar, N., and Ford, I. (2008) Does Low to Moderate Alcohol Intake Protect Against Cognitive Decline in Older People? Journal of the American Geriatrics Society, 56(12), pp. 2217-2224. (doi:10.1111/j.1532-5415.2008.02007.x )

Velupillai, Y.N. et al. (2008) Psychological, social and biological determinants of ill health (pSoBid): study protocol of a population-based study. BMC Public Health, 8(126), (doi:10.1186/1471-2458-8-126)

Wannamethee, S., Sattar, N., Rumley, A., Whincup, P., Lennon, L., and Lowe, G. (2008) Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men. Diabetes Care, 31(5), pp. 995-1000.

Welsh, P., Packard, C., and Sattar, N. (2008) Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar. Current Opinion in Lipidology, 19(6), pp. 563-571.

2007

Berry, C., Murphy, N., De Vito, G., Galloway, S., Seed, A., Fisher, C., Sattar, N., Vallance, P., Hillis, W. S., and McMurray, J. (2007) Corrigendum to “Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker” [European Journal of Heart Failure 9/4 (2007) 429-434]. European Journal of Heart Failure, 9(10), p. 1074. (doi:10.1016/j.ejheart.2007.08.003)

Gill, J.M., Al-Mamari, A., Ferrell, W.R., Cleland, S.J., Perry, C.G., Sattar, N., Packard, C.J., Caslake, M.J., and Petrie, J.R. (2007) Effect of prior moderate exercise on postprandial metabolism in men with type 2 diabetes: Heterogeneity of responses. Atherosclerosis, 194(1), pp. 134-143. (doi:10.1016/j.atherosclerosis.2006.10.007)

Lara, J.J., Economou, M., Wallace, A.M., Rumley, A., Lowe, G., Slater, C., Caslake, M., Sattar, N., and Lean, M.E.J. (2007) Benefits of salmon eating on traditional and novel vascular risk factors in young, non-obese healthy subjects. Atherosclerosis, 193(1), pp. 213-221. (doi:10.1016/j.atherosclerosis.2006.06.018)

Murphy, C.L., Fitzsimons, E.J., Jardine, A.J., Sattar, N., and McMurray, J.J.V. (2007) 103 routine assessment of iron status in all patients with heart failure may identify those at risk of developing anaemia. European Journal of Heart Failure, 6(1), p. 24. (doi:10.1016/s1567-4215(07)60065-4)

Sattar, N., McConnachie, A., Ford, I., Gaw, A., Cleland, S.J., Forouhi, N.G., Macfarlane, P., Shepherd, J., Cobbe, S., and Packard, C. (2007) Serial metabolic measurements and conversion to type 2 diabetes in the West of Scotland Coronary Prevention Study - Specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes, 56(4), pp. 984-991. (doi:10.2337/db06-1256)

Kernohan, A. F. B., Sattar, N., Hilditch, T., Cleland, S. J., Small, M., Lumsden, M. A., Connell, J. M. C., and Petrie, J. R. (2007) Effects of low-dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes. Clinical Endocrinology, 66(1), pp. 27-34. (doi:10.1111/j.1365-2265.2006.02679.x)

Berry, C., Murphy, N., De Vito, G., Galloway, S., Seed, A., Fisher, C., Sattar, N., Vallance, P., Hillis, W., and McMurray, J. (2007) Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker. European Journal of Heart Failure, 9, pp. 429-434. (doi:10.1016/j.ejheart.2006.10.005)

Brown, K., Cherry, L., Lowe, G., Rumley, A., Sattar, N., Tchernova, J., Wannamethee, S., and Whincup, P. (2007) Associations of adiponectin with metabolic and vascular risk parameters in the British Regional Heart Study reveal stronger links to insulin resistance-related than to coronory heart disease risk-related parameters. International Journal of Obesity, 31, pp. 1089-1098. (doi:10.1038/sj.ijo.0803544)

Cherry, L., Lowe, G., Rumley, A., Sattar, N., Wannamethee, S., and Whincup, P. (2007) Adipokines and risk of type 2 diabetes in older men. Diabetes Care, 30, pp. 1200-1205.

Datta, D., Ferrell, W., Jadhav, S., Sattar, N., and Sturrock, R. (2007) Inflammatory suppression rapidly attenuates microvascular dysfunction in rheumatoid arthritis. Atherosclerosis, 192, pp. 391-395. (doi:10.1016/j.atherosclerosis.2006.05.034)

Fraser, A., Harris, R., Sattar, N., Ebrahim, S., Davey Smith, G., and Lawlor, D.A. (2007) Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake analysis of the British women's heart and health study and meta-analysis. Arteriosclerosis, Thrombosis and Vascular Biology, 27(12), pp. 2729-2735. (doi:10.1161/ATVBAHA.107.152298)

Jadhav, S., Sattar, N., Petrie, J., Cobbe, S., and Ferrell, W. (2007) Reproducibility and repeatability of peripheral microvascular assessment using lontophoresis in conjunction with laser doppler imaging. Journal of Cardiovascular Pharmacology, 50(3), pp. 343-349. (doi:10.1097/FJC.0b013e3180dca094)

Jeffery, A., Alba, S., Murphy, M., Voss, L., Metcalf, B., Hosking, J., Gardner, D., Sattar, N., and Wilkin, T. (2007) Behavior of insuling resistance and its metabolic correlates in prepubertal children: A longitudinal study (EarlyBird 32). Diabetes Care, 30, pp. 2962-2964. (doi:10.2337/dc07-0178)

Kelly, A., Lowe, G., Rumley, A., Sattar, N., Tchernova, J., Wallace, A., Wannamethee, S., and Whincup, P. (2007) Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis, 191, pp. 418-426. (doi:10.1016/j.atherosclerosis.2006.04.012)

Lawlor, D., Davey Smith, G., Kelly, A., Sattar, N., and Ebrahim, S. (2007) Leptin and coronary heart disease risk: Prospective case control study of British women. Obesity, 15(7), pp. 1694-1701. (doi:10.1038/oby.2007.202)

McEntegart, M., Awede, B., Petrie, M., Sattar, N., Dunn, F., MacFarlane, N., and McMurray, J. (2007) Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. European Heart Journal, 28, pp. 829-835. (doi:10.1093/eurheartj/ehm033)

Muir, K., Sattar, N., Tyrrell, P., and Warburton, E. (2007) Inflammation and ischaemic stroke. Current Opinion in Neurology, 20, pp. 334-342.

Nelson, S., Freeman, D., Lindsay, R.S., and Sattar, N. (2007) Preeclampsia and screening for cardiovascular disease. BMJ Rapid Response,

Nelson, S.M., Freeman, D.J., Sattar, N., Johnstone, F.D., and Lindsay, R.S. (2007) IGF-1 and leptin associate with fetal HDL cholesterol at birth: Examination in offspring of mothers with type 1 diabetes. Diabetes, 56, pp. 2705-2709. (doi:10.2337/db07-0585)

Nelson, S., Sattar, N., Freeman, D., Walker, J., and Lindsay, R. (2007) Inflammation and endothelial activation is evident at birth in offspring of mothers with type 1 diabetes. Diabetes, 56, pp. 2697-2704. (doi:10.2337/db07-0662)

Preiss, D.J., and Sattar, N. (2007) Vascular cell adhesion molecule-1: a viable therapeutic target for atherosclerosis? International Journal of Clinical Practice, 61(4), pp. 697-701. (doi:10.1111/j.1742-1241.2007.01330.x)

Sarwar, N., Sattar, N., Gudnason, V., and Danesh, J. (2007) Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies. European Heart Journal, 28, pp. 2491-2497. (doi:10.1093/eurheartj/ehm115)

Sattar, N., Crompton, P., Cherry, L., Kane, D., Lowe, G., and McInnes, I. (2007) Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis - A double-blind, placebo-controlled study. Arthritis and Rheumatism, 56, pp. 831-839. (doi:10.1002/art.22447)

Sattar, N. et al. (2007) C-reactive protein and prediction of coronary heart disease and global vascular events in the prospective study of pravastatin in the elderly at risk (PROSPER). Circulation, 115(8), pp. 981-989. (doi:10.1161/CIRCULATIONAHA.106.643114)

Theobald, H., Goodall, A., Sattar, N., Talbot, D., Chowienczyk, P., and Sanders, T. (2007) Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. Journal of Nutrition, 137, pp. 973-978.

Tomaszewski, M., Charchar, F., Maric, C., McClure, J., Crawford, L., Grzeszczak, W., Sattar, N., Zukowska-Szczechowska, E., and Dominiczak, A. (2007) Glomerular hyperfiltration: A new marker of metabolic risk. Kidney International, 71(8), pp. 816-821. (doi:10.1038/sj.ki.5002160)

Wannamethee, S., Whincup, P., Lennon, L., and Sattar, N. (2007) Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Archives of Internal Medicine, 167, pp. 1510-1517.

2006

Almushatat, A.S.K., Talwar, D., McArdle, P.A., Williamson, C., Sattar, N., O'Reiliy, D.S., Underwood, M.A., and McMillan, D.C. (2006) Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer. International Journal of Cancer, 118(4), pp. 1051-1053. (doi:10.1002/ijc.21451)

Alberti, G., Gruer, L., Lean, M., and Sattar, N. (2006) ABC of obesity - Obesity - can we turn the tide? British Medical Journal, 333, pp. 1261-1264.

Avenell, A., Lean, M., and Sattar, N. (2006) ABC of obesity - Management: Part I - Behaviour change, diets and activity. British Medical Journal, 333, pp. 740-743.

Deans, K., and Sattar, N. (2006) "Anti-Inflammatory" drugs and their effects on type 2 diabetes. Diabetes Technology and Therapeutics, 8, pp. 18-27.

Forouhi, N., and Sattar, N. (2006) CVD risk factors and ethnicity - A homogeneous relationship? Atherosclerosis Supplements, 7, pp. 11-19. (doi:10.1016/j.atherosclerosissup.2006.01.003)

Forouhi, N., Sattar, N., Tillin, T., McKeigue, P., and Chaturvedi, N. (2006) Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK. Diabetologia, 49, pp. 2580-2588. (doi:10.1007/s00125-006-0393-2)

Gill, J., Al-Mamari, A., Ferrell, W., Cleland, S., Sattar, N., Packard, C., Petrie, J., and Caslake, M. (2006) Effects of a moderate exercise session on postprandial lipoproteins, apolipoproteins and lipoprotein remnants in middle-aged men. Atherosclerosis, 185(1), pp. 87-96. (doi:10.1016/j.atherosclerosis.2005.06.009)

Han, T., Lean, M., and Sattar, N. (2006) ABC of obesity - Assessment of obesity and its clinical implications. British Medical Journal, 333, pp. 695-698.

Haslam, D., Lean, M., and Sattar, N. (2006) ABC of obesity - Obesity - time to wake up. British Medical Journal, 333, pp. 640-642.

Jadhav, S., Ferrell, W., Greer, I., Petrie, J., Cobbe, S., and Sattar, N. (2006) Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries - A randomized, double-blind, placebo-controlled study. Journal of the American College of Cardiology, 48(5), pp. 956-963. (doi:10.1016/j.jacc.2006.04.088)

Jadhav, S., Ferrell, W., Petrie, J., Scherbakova, O., Greer, I., Cobbe, S., and Sattar, N. (2006) Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X. American Journal of Cardiology, 97(12), pp. 1727-1731. (doi:10.1016/j.amjcard.2005.12.069)

Lawlor, D., Lean, M., and Sattar, N. (2006) ABC of obesity - Obesity and vascular disease. British Medical Journal, 333, pp. 1060-1063.

Lean, M., McArdle, C., McMillan, D., and Sattar, N. (2006) ABC of obesity - Obesity and cancer. British Medical Journal, 333, pp. 1109-1111. (doi:10.1136/bmj.39042.565035.BE1)

Lowe, G., and Sattar, N. (2006) High sensitivity C-reactive protein and cardiovascular disease: an association built on unstable foundations? Annals of Clinical Biochemistry, 43, pp. 252-256.

McKenzie, J., Fisher, B., Jaap, A., Stanley, A., Paterson, K., and Sattar, N. (2006) Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clinical Endocrinology, 65, pp. 40-44. (doi:10.1111/j.1365-2265.2006.02543.x)

Mukhopadhyay, B., Forouhi, N., Fisher, B., Kesson, C., and Sattar, N. (2006) A comparison of glycaemic and metabolic control over time among South Asian and European patients with Type 2 diabetes: results from follow-up in a routine diabetes clinic. Diabetic Medicine, 23, pp. 94-98. (doi:10.1111/j.1464-5491.2005.01735.x)

Pietilainen, K., Bergholm, R., Rissanen, A., Kaprio, J., Hakkinen, A., Sattar, N., and Yki-Jarvinen, H. (2006) Effects of acquired obesity on endothelial function in monozygotic twin's. Obesity, 14, pp. 826-837.

Preiss, D., and Sattar, N. (2006) Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence. Heart, 93(12), pp. 1493-1496. (doi:10.1136/hrt.2007.130849)

Ramsay, J., Greer, I., and Sattar, N. (2006) ABC of obesity - Obesity and reproduction. British Medical Journal, 333, pp. 1159-1162.

Sattar, N., Wannamethee, G., Sarwar, N., Tchernova, J., Cherry, L., Wallace, A., Danesh, J., and Whincup, P. (2006) Adiponectin and coronary heart disease: A prospective study and meta-analysis. Circulation, 114, pp. 623-629. (doi:10.1161/CIRCULATIONHA.106.618918)

2005

Cleland, S., and Sattar, N. (2005) Impact of ethnicity on metabolic disturbance, vascular dysfunction and atherothrombotic cardiovascular disease. Diabetes Obesity and Metabolism, 7, pp. 463-470. (doi:10.1111/j.1463-1326.2004.00401.x)

Elahi, M., McMillan, D., McArdle, C., Angerson, W., Soukop, M., Johnstone, J., and Sattar, N. (2005) The systemic inflammatory response predicts overall and cancer specific survival in patients with malignant lymphoma. Medical Science Monitor, 11, CR75-CR78.

Fleming, R., Harborne, L., MacLaughlin, D., Ling, D., Norman, J., Sattar, N., and Seifer, D. (2005) Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment. Fertility and Sterility, 83(1), pp. 130-136. (doi:10.1016/j.fertnstert.2004.05.098)

Harborne, L., Sattar, N., Norman, J., and Fleming, R. (2005) Metformin and weight loss in obese women with polycystic ovary syndrome: Comparison of doses. Journal of Clinical Endocrinology and Metabolism, 90(8), pp. 4593-4598.

Kanagalingam, M., Forouhi, N., Greer, I., and Sattar, N. (2005) Changes in booking body mass index over a decade: retrospective analysis from a Glasgow Maternity Hospital. BJOG: An International Journal of Obstetrics and Gynaecology, 112, pp. 1431-1433. (doi:10.1111/j.1471-0528.2005.00685.x)

Lawlor, D., Davey Smith, G., Ebrahim, S., Thompson, C., and Sattar, N. (2005) Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. Journal of Clinical Endocrinology and Metabolism, 90(10), pp. 5677-5683. (doi:10.1210/jc.2005-0825)

Lawlor, D., Sattar, N., Davey Smith, G., and Ebrahim, S. (2005) The associations of physical activity and adiposity with alanine aminotransferase and gamma-glutamyltransferase. American Journal of Epidemiology, 161(11), pp. 1081-1088. (doi:10.1093/aje/kwi125)

Mackinnon, B., Deighan, C., Norrie, J., Boulton-Jones, J., Sattar, N., and Fox, J. (2005) The link between circulating markers of endothelial function and proteinuria in patients with primary glomerulonephritis. Clinical Nephrology, 63, pp. 173-180.

McCallum, R., Sainsbury, C., Spiers, A., Dominiczak, A., Petrie, J., Sattar, N., and Connell, J. (2005) Growth hormone replacement reduces C-reactive protein and large-artery stiffness but does not alter endothelial function in patients with adult growth hormone deficiency. Clinical Endocrinology, 62(4), pp. 473-479. (doi:10.1111/j.1365-2265.2005.02245.x)

McCarey, D.W., Sattar, N., and McInnes, I.B. (2005) Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases? Arthritis Research and Therapy(7), pp. 55-61. (doi:10.1186/ar1496)

McInnes, I., and Sattar, N. (2005) Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions. Current Opinion in Rheumatology, 17, pp. 286-292.

Rodie, V., Young, A., Jordan, F., Sattar, N., Greer, I., and Freeman, D. (2005) Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. Journal of the Society For Gynecologic Investigation, 12, pp. 320-329. (doi:10.1016/j.jsgi.2005.03.004)

Singhal, A., Jamieson, N.B., Fewtrell, M., Deanfield, J., Lucas, A., and Sattar, N. (2005) Adiponectin predicts insulin resistance but not endothelial function in young, healthy adolescents. Journal of Clinical Endocrinology and Metabolism, 90(8), pp. 4615-4621. (doi:10.1210/jc.2005-0131)

Song, H., Grant, I., Rotondo, D., Mohede, I., Sattar, N., Heys, S., and Wahle, K. (2005) Effect of CLA supplementation on immune function in young healthy volunteers. European Journal of Clinical Nutrition, 59, pp. 508-517. (doi:10.1038/sj.ejcn.1602102)

Strahorn, P., Graham, D., Charchar, F., Sattar, N., McBride, M., and Dominiczak, A. (2005) Genetic determinants of metabolic syndrome components in the stroke-prone spontaneously hypertensive rat. Journal of Hypertension, 23(12), pp. 2179-2186.

Whincup, P., Owen, C., Sattar, N., and Cook, D. (2005) School dinners and markers of cardiovascular health and type 2 diabetes in 13-16 year olds: cross sectional study. British Medical Journal, 331, pp. 1060-1061. (doi:10.1136/bmj.38618.540729.AE)

2004

McCarey, D.W., McInnes, I.B., Madhok, R., Hampson, R., Scherbakov, O., Ford, I., Capell, H., and Sattar, N. (2004) Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet, 363(9426), pp. 2015-2021. (doi:10.1016/S0140-6736(04)16449-0)

Elahi, M., McMillan, D., McArdle, C., Angerson, W., and Sattar, N. (2004) Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutrition and Cancer, 48, pp. 171-173.

Freeman, D., McManus, F., Brown, E., Cherry, L., Norrie, J., Ramsay, J., Clark, P., Walker, I., Sattar, N., and Greer, I. (2004) Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension, 44, pp. 708-714. (doi:10.1161/01.HYP.0000143849.67254.ca)

Gill, J.M.R., Al-Mamari, A., Ferrell, W.R., Cleland, S.J., Packard, C.J., Sattar, N., Petrie, J.R., and Caslake, M.J. (2004) Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men. Journal of the American College of Cardiology, 44(12), pp. 2375-2382. (doi:10.1016/j.jacc.2004.09.035)

Jadhav, S., Petrie, J., Ferrell, W., Cobbe, S., and Sattar, N. (2004) Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation? Heart, 90(12), pp. 1379-1383. (doi:10.1136/hrt.2004.035170)

McArdle, P., McMillan, D., Sattar, N., Underwood, M., and Wallace, A. (2004) The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease. British Journal of Cancer, 91, pp. 1755-1757. (doi:10.1038/sj.bjc.6602211)

McEleavy, O., McCallum, R., Petrie, J., Small, M., Connell, J., Sattar, N., and Cleland, S. (2004) Higher carotid-radial pulse wave velocity in healthy offspring of patients with Type 2 diabetes. Diabetic Medicine, 21(3), pp. 262-266. (doi:10.1111/j.1464-5491.2004.01127.x)

McInnes, I.B., McCarey, D., and Sattar, N. (2004) Do statins offer therapeutic potential in inflammatory arthritis? Annals of the Rheumatic Diseases, 63(12), pp. 1535-1537. (doi:10.1136/ard.2004.022061)

Muth, S., Norman, J., Sattar, N., and Fleming, R. (2004) Women with polycystic ovary syndrome (PCOS) often undergo protracted treatment with metformin and are disinclined to stop: indications for a change in licensing arrangements? Human Reproduction, 19(12), pp. 2718-2720. (doi:10.1093/humrep/deh530)

Perry, C., Cleland, S., Connell, J., Petrie, J., and Sattar, N. (2004) Low grade inflammation is notably suppressed by conventional anti-inflammatory treatment: a randomised crossover trial. Heart, 90(7), pp. 804-805. (doi:10.1136/hrt.2003.022129 )

Ramsay, J., Ferrell, W., Crawford, L., Wallace, A., Greer, I., and Sattar, N. (2004) Divergent metabolic and vascular phenotypes in pre-eclampsia and intrauterine growth restriction: Relevance of adiposity. Journal of Hypertension, 22(11), pp. 2177-2183. (doi:10.1097/00004872-200411000-00021)

Rodie, V., Caslake, M., Stewart, F., Sattar, N., Ramsay, J., Greer, I., and Freeman, D. (2004) Fetal cord plasma lipoprotein status in uncomplicated human pregnancies and in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Atherosclerosis, 176, pp. 181-187. (doi:10.1016/j.atherosclerosis.2004.04.026)

Rodie, V., Freeman, D., Sattar, N., and Greer, I. (2004) Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis, 175, pp. 189-202. (doi:10.1016/j.atherosclerosis.2004.01.038)

Sainsbury, C., Sattar, N., Connell, J., Hillier, C., and Petrie, J. (2004) Non-esterified fatty acids impair endothelium-dependent vasodilation in rat mesenteric resistance vessels. Clinical Science, 107(6), pp. 625-629.

Sattar, N., Scherbakova, O., Ford, I., O'Reilly, D., Stanley, A., Forrest, E., MacFarlane, P., Packard, C., Cobbe, S., and Shepherd, J. (2004) Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study. Diabetes, 53(11), pp. 2855-2860. (doi:10.2337/diabetes.53.11.2855)

Sattar, N., McConnachie, A., O'Reilly, D., Upton, M.N., Greer, I., Davey Smith, G., and Watt, G.C.M. (2004) Inverse association between birth weight and C-reactive protein concentrations in the MIDSPAN family study. Arteriosclerosis, Thrombosis and Vascular Biology, 24, pp. 583-587. (doi:10.1161/01.ATV.0000118277.41584.63)

Sattar, N. et al. (2004) Metabolic syndrome and diabetes mellitus - Response. Circulation, 109(3), E23-E23.

Tomaszewski, M., Charchar, F., Crawford, L., Zukowska-Sczechowska, E., Grzeszczak, W., Sattar, N., and Dominiczak, A. (2004) Serum C-reactive protein and lipids in ultra-marathon runners. American Journal of Cardiology, 94(1), pp. 125-126. (doi:10.1016/j.amjcard.2004.03.043)

2003

Sattar, N., McCarey, D.W., Capell, H., and McInnes, I.B. (2003) Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation, 108(24), pp. 2957-2963. (doi:10.1161/01.CIR.0000099844.31524.05)

Campbell, C. et al. (2003) A novel anti-inflammatory role for simvastatin in inflammatory arthritis. Journal of Immunology, 170, pp. 1524-1530.

Clark, P., Freeman, D., Streja, E., Sattar, N., Walker, I., and Greer, I. (2003) The G-to-T point mutation in codon 34 of the factor XIII gene and the risk of pre-eclampsia. Blood Coagulation and Fibrinolysis, 14, pp. 155-157. (doi:10.1097/01.mbc.0000046189.72384.5a)

Clark, P., Jordan, F., Pearson, C., Walker, I., Sattar, N., Ellison, J., and Greer, I. (2003) Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated by thrombin in human monocytes and THP-1 cells in vitro and in pregnant subjects in vivo. Thrombosis and Haemostasis, 89, 1043-+.

Forouhi, N.G., Rumley, A., Lowe, G.D., McKeigue, P., and Sattar, N. (2003) Specific elevation in plasma tissue plasminogen activator antigen concentrations in South Asians relative to Europeans. Blood Coagulation and Fibrinolysis, 14(8), pp. 755-760.

Harborne, L., Fleming, R., Lyall, H., Norman, J., and Sattar, N. (2003) Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet, 361, pp. 1894-1901. (doi:10.1016/S0140-6736(03)13493-9 )

Harborne, L., Fleming, R., Lyall, H., Sattar, N., and Norman, J. (2003) Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 88(9), pp. 4116-4123. (doi:10.1210/jc.2003-030424)

Kinsella, J., McMillan, D., O'Reilly, D., Quasim, T., Sattar, N., and Talwar, D. (2003) Lower concentrations of carotenoids in the critically-ill patient are related to a systemic inflammatory response and increased lipid peroxidation. Clinical Nutrition, 22, pp. 459-462. (doi:10.1016/S0261-5614(03)00044-X)

McDougall, C., Perry, C., Sattar, N., and Petrie, J. (2003) Statins in the era of evidence-based medicine - who will not 'prosper'? Scottish Medical Journal, 48(3), pp. 64-68.

McKenzie, J. et al. (2003) Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? Clinical Endocrinology, 59(6), pp. 682-689. (doi:10.1046/j.1365-2265.2003.01906.x)

Montgomery, C., Speake, B., Cameron, A., Sattar, N., and Weaver, L. (2003) Maternal docosahexaenoic acid supplementation and fetal accretion. British Journal of Nutrition, 90, pp. 135-145. (doi:10.1079/BJN2003888)

Quasim, T., McMillan, D.C., Talwar, D., Sattar, N., O'Reilly, J., and Kinsella, J. (2003) Lower concentrations of carotenoids in the critically ill patient are related to a systemic inflammatory response and increased lipid peroxidation. Clinical Nutrition, 22(5), pp. 459-462. (doi:10.1016/S0261-5614(03)00044-X)

Ramsay, J.E., Jamieson, N.B., Greer, I.A., and Sattar, N. (2003) Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension, 42(5), pp. 891-894. (doi:10.1161/01.HYP.0000095981.92542.F6)

Ramsay, J., Simms, R., Ferrell, W., Crawford, L., Greer, I., Lumsden, M., and Sattar, N. (2003) Enhancement of endothelial function by pregnancy - Inadequate response in women with type 1 diabetes. Diabetes Care, 26, pp. 475-479.

Ramsay, J., Stewart, F., Greer, I., and Sattar, N. (2003) Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease. BJOG: An International Journal of Obstetrics and Gynaecology, 110, pp. 1029-1031.

Sattar, N. et al. (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation, 108(4), pp. 414-419. (doi:10.1161/01.CIR.0000080897.52664.94)

Sattar, N., Ramsay, J., Crawford, L., Cheyne, H., and Greer, I. (2003) Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension, 42, pp. 39-42. (doi:10.1161/01.HYP.0000074428.11168.EE)

Weir, C., Sattar, N., Walters, M., and Lees, K. (2003) Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke. Cerebrovascular Diseases, 16, pp. 76-82. (doi:10.1159/000070119)

2002

Bain, C., Lumsden, M.A., Sattar, N., and Greer, I.A. (2002) The Menopause in Practice. Series: In practice. Royal Society of Medicine Press: London, UK. ISBN 9781853155161

Ferrell, W., Ramsay, J., Brooks, N., Lockhart, J., Dickson, S., McNeece, G., Greer, I., and Sattar, N. (2002) Elimination of electrically induced iontophoretic artefacts: Implications for non-invasive assessment of peripheral microvascular function. Journal of Vascular Research, 39(5), pp. 447-455. (doi:10.1159/000064515)

Fleming, R., Hopkinson, Z., Wallace, A., Greer, I., and Sattar, N. (2002) Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism, 87, pp. 569-574.

Freeman, D.J., Norrie, J., Caslake, M.J., Gaw, A., Ford, I., Lowe, G.D.O., O'Reilly, D. S. J.,, Packard, C.J., and Sattar, N. (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 51(5), pp. 1596-1600. (doi:10.2337/diabetes.51.5.1596)

Freeman, D.J., Norrie, J., Caslake, M.J., Gaw, A., Ford, I., Lowe, G.D.O., O'Reilly, D.S., Packard, C.J., and Sattar, N. (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 51(5), pp. 1596-1600.

Galloway, P., Greer, I.A., and Sattar, N. (2002) Statins as novel therapies for osteoporosis? European Journal of Obstetrics and Gynecology and Reproductive Biology, 101(1), pp. 4-5.

Gonzalez-Villalpando, C., Haffner, S., Han, T., Lean, M., Sattar, N., and Williams, K. (2002) Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care, 25, pp. 2016-2021.

Haffner, S., Han, T., Hunt, K., Lean, M., Sattar, N., and Williams, K. (2002) Analysis of obesity and Hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obesity Research, 10, pp. 923-931.

Jones, G., Latif, Z., McMillan, D.C., Mir, K., Sattar, N., Underwood, M.A., and Wallace, A.M. (2002) The relationship of circulating insulin-like growth factor 1, its binding protein-3, prostate-specific antigen and C-reactive protein with disease stage in prostate cancer. BJU International, 89, pp. 396-399.

Kelly, C.J.G., Lyall, H., Petrie, J.R., Gould, G.W., Connell, J.M.C., Rumley, A., Lowe, G.D.O., and Sattar, N. (2002) A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism, 87(7), pp. 3287-3290. (doi:10.1210/jc.87.7.3287)

McArdle, C., McMillan, D., O'Reilly, D., Sattar, N., Talwar, D., and Underwood, M. (2002) The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours. Clinical Nutrition, 21, pp. 161-164. (doi:10.1054/clnu.2001.0527)

Perera, M., Petrie, J., Hillier, C., Small, M., Sattar, N., Connell, J., and Lumsden, M. (2002) Hormone replacement therapy can augment vascular relaxation in post-menopausal women with type 2 diabetes. Human Reproduction, 17(2), pp. 497-502. (doi:10.1093/humrep/17.2.497)

Pirwany, I., Sattar, N., Greer, I., Packard, C., and Fleming, R. (2002) Supraphysiological concentrations of estradiol in menopausal women given repeated implant therapy do not adversely affect lipid profiles. Human Reproduction, 17, pp. 825-829.

Ramsay, J., Ferrell, W., Crawford, L., Wallace, A., Greer, I., and Sattar, N. (2002) Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. Journal of Clinical Endocrinology and Metabolism, 87, pp. 4231-4237. (doi:10.1210/jc.2002-020311)

Ramsay, J., Ferrell, W., Greer, I., and Sattar, N. (2002) Factors critical to iontophoretic assessment of vascular reactivity: Implications for clinical studies of endothelial dysfunction. Journal of Cardiovascular Pharmacology, 39(1), pp. 9-17.

Sattar, N., and Greer, I. (2002) Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? British Medical Journal, 325, pp. 157-160. (doi:10.1136/bmj.325.7356.157)

Wallace, A., Kelly, A., Sattar, N., McArdle, C., and McMillan, D. (2002) Circulating concentrations of "free" leptin in relation to fat mass and appetite in gastrointestinal cancer patients. Nutrition and Cancer, 44, pp. 156-160.

2001

Jhund, P. S., Dawson, N., Davie, A. P., Sattar, N., Norrie, J., O’Kane, K. P.J., and McMurray, J. J.V. (2001) Attenuation of endothelin-1 induced vasoconstriction by 17β estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease. Journal of the American College of Cardiology, 37(5), pp. 1367-1373. (doi:10.1016/s0735-1097(01)01168-8) (PMID:11300448)

Berry, C., Montgomery, C., Norrie, J., Sattar, N., and Weaver, L. (2001) Fatty acid status of women of reproductive age. European Journal of Clinical Nutrition, 55, pp. 518-524.

Clark, P., Sattar, N., Walker, I., and Greer, I. (2001) The Glasgow outcome, APCR and lipid (GOAL) pregnancy study: Significance of pregnancy associated activated protein C resistance. Thrombosis and Haemostasis, 85, pp. 30-35.

Forouhi, N., Sattar, N., and McKeigue, P. (2001) Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. International Journal of Obesity, 25, pp. 1327-1331.

Freeman, D. et al. (2001) Pravastatin and the development of diabetes mellitus - Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation, 103(3), pp. 357-362.

Gaw, A., Kelly, A., McMahon, A., Packard, C., Sattar, N., Shepherd, J., and Wallace, A. (2001) Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).[see comment]. Circulation, 104(25), pp. 3052-3056.

Kelly, C., Lyall, H., Petrie, J., Gould, G., Connell, J., and Sattar, N. (2001) Low grade chronic inflammation in women with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism, 86(6), pp. 2453-2455. (doi:10.1210/jc.86.6.2453)

McMillan, D., Elahi, M., Sattar, N., Angerson, W., Johnstone, J., and McArdle, C. (2001) Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutrition and Cancer, 41, pp. 64-69.

Perera, M., Sattar, N., Petrie, J.R., Hillier, C., Small, M., Connell, J.M.C., Lowe, G.D.O., and Lumsden, M.A. (2001) The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism, 86(3), pp. 1140-1143. (doi:10.1210/jc.86.3.1140)

Pirwany, I.R., Fleming, R., Sattar, N., Greer, I.A., and Wallace, A.M. (2001) Circulating leptin concentrations and ovarian function in polycystic ovary syndrome. Trends in Parasitology, 145, pp. 289-294.

Pirwany, I., Fleming, R., Greer, I., Packard, C., and Sattar, N. (2001) Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clinical Endocrinology, 54(4), pp. 447-453.

Sattar, N., Clark, P., Holmes, A., Lean, M., Walker, I., and Greer, I. (2001) Antenatal waist circumference and hypertension risk. Obstetrics and Gynecology, 97, pp. 268-271.

Wallace, A., McMahon, A., Packard, C., Kelly, A., Shepherd, J., Gaw, A., Sattar, N., and WOSCOPS Executive Comm, (2001) Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation, 104, pp. 3052-3056.

2000

Galloway, P., McMillan, D., and Sattar, N. (2000) Effect of the inflammatory response on trace element and vitamin status. Annals of Clinical Biochemistry, 37(3), pp. 289-297. (doi:10.1258/0004563001899429)

This list was generated on Thu Jul 30 14:49:20 2015 BST.
Number of items: 504.

Articles

Mccallum, L. et al. (2015) Longitudinal blood pressure control, long-term mortality and predictive utility of serum liver enzymes and bilirubin in hypertensive patients. Hypertension, 66(1), pp. 37-43. 25941342. (doi:10.1161/HYPERTENSIONAHA.114.04915)

Mccallum, L. et al. (2015) Longitudinal blood pressure control, long-term mortality, and predictive utility of serum liver enzymes and bilirubin in hypertensive patients. Hypertension, (doi:10.1161/HYPERTENSIONAHA.114.04915) (PMID:25941342) (PMCID:PMC4461392)

Ferguson, L., and Sattar, N. (2015) Endothelial function measures: not for clinical prime time? International Journal of Clinical Practice, 69(6), pp. 624-625. (doi:10.1111/ijcp.12642) (PMID:26010940)

Anderson, E.L., Howe, L.D., Fraser, A., Macdonald-Wallis, C., Callaway, M.P., Sattar, N., Day, C., Tilling, K., and Lawlor, D.A. (2015) Childhood energy intake is associated with nonalcoholic fatty liver disease in adolescents. Journal of Nutrition, 145(5), pp. 983-989. (doi:10.3945/jn.114.208397) (PMID:25788585) (PMCID:PMC4410498)

Tillin, T. et al. (2015) Diabetes risk and amino acid profiles: cross-sectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall And Brent REvisited) study. Diabetologia, 58(5), pp. 968-979. (doi:10.1007/s00125-015-3517-8) (PMID:25693751) (PMCID:PMC4392114)

Malik, M. O. et al. (2015) Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland. Diabetologia, 58(4), pp. 716-725. (doi:10.1007/s00125-015-3492-0)

Ghouri, N., Purves, D., Deans, K. A., Logan, G., McConnachie, A., Wilson, J., Gill, J. M. R., and Sattar, N. (2015) An investigation of two-dimensional ultrasound carotid plaque presence and intima media thickness in middle-aged South Asian and European men living in the United Kingdom. PLoS ONE, 10(4), e0123317. (doi:10.1371/journal.pone.0123317) (PMID:25884221) (PMCID:PMC4401566)

McInnes, I. B. et al. (2015) Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study. Annals of the Rheumatic Diseases, 74(4), pp. 694-702. (doi:10.1136/annrheumdis-2013-204345) (PMID:24368514) (PMCID:PMC4392313)

Santangeli, L., Sattar, N., and Huda, S. H. (2015) Impact of maternal obesity on perinatal and childhood outcomes. Best Practice and Research: Clinical Obstetrics and Gynaecology, 29(3), pp. 438-448. (doi:10.1016/j.bpobgyn.2014.10.009) (PMID:25497183)

Eastwood, S. V., Tillin, T., Dehbi, H.-M., Wright, A., Forouhi, N. G., Godsland, I., Whincup, P., Sattar, N., Hughes, A. D., and Chaturvedi, N. (2015) Ethnic differences in associations between fat deposition and incident diabetes and underlying mechanisms: The SABRE study. Obesity, 23(3), pp. 699-706. (doi:10.1002/oby.20997) (PMID:25645144)

Nightingale, C. M. et al. (2015) Birthweight and risk markers for type 2 diabetes and cardiovascular disease in childhood: the child heart and health study in England (CHASE). Diabetologia, 58(3), pp. 474-484. (doi:10.1007/s00125-014-3474-7) (PMID:25520157) (PMCID:4320299)

Patel, S., Lawlor, D. A., Ferreira, D. L.S., Hughes, A. D., Chaturvedi, N., Callaway, M., Day, C., Sattar, N., and Fraser, A. (2015) The association of nonalcoholic fatty liver disease with central and peripheral blood pressure in adolescence. Journal of Hypertension, 33(3), pp. 546-553. (doi:10.1097/HJH.0000000000000445) (PMID:25426570) (PMCID:PMC4318641)

Wurtz, P. et al. (2015) Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation, 131(9), pp. 774-785. (doi:10.1161/CIRCULATIONAHA.114.013116) (PMID:25573147)

Jani, B. D., McLean, G., Nicholl, B. I., Barry, S. J.E., Sattar, N., Mair, F. S., and Cavanagh, J. (2015) Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers. Frontiers in Human Neuroscience, 9(Art 18), (doi:10.3389/fnhum.2015.00018)

Preiss, D., and Sattar, N. (2015) Classification of reported statin intolerance. Current Opinion in Lipidology, 26(1), pp. 65-66. (doi:10.1097/MOL.0000000000000149) (PMID:25551804)

Livingstone, S. J. et al. (2015) Estimated life expectancy in a Scottish cohort With type 1 diabetes, 2008-2010. JAMA: Journal of the American Medical Association, 313(1), pp. 37-44. (doi:10.1001/jama.2014.16425)

Wade, K. H. et al. (2015) Variation in the SLC23A1 gene does not influence cardiometabolic outcomes to the extent expected given its association with L-ascorbic acid. American Journal of Clinical Nutrition, 101(1), pp. 202-209. (doi:10.3945/ajcn.114.092981)

Jones, R., Hardy, R., Sattar, N., Deanfield, J. E., Hughes, A., Kuh, D., Murray, E. T., Whincup, P. H., and Thomas, C. (2015) Novel coronary heart disease risk factors at 60–64 years and life course socioeconomic position: the 1946 British birth cohort. Atherosclerosis, 238(1), pp. 70-76. (doi:10.1016/j.atherosclerosis.2014.11.011)

Swerdlow, D. I. et al. (2015) HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet, 385(9965), pp. 351-361. (doi:10.1016/S0140-6736(14)61183-1)

Brown, C. E. et al. (2015) Urinary proteomic biomarkers to predict cardiovascular events. Proteomics Clinical Applications, 9(5-6), pp. 610-617. (doi:10.1002/prca.201400195) (PMID:25786980)

Burska, A.N., Sakthiswary, R., and Sattar, N. (2015) Effects of tumour necrosis factor antagonists on insulin sensitivity/resistance in rheumatoid arthritis: a systematic review and meta-analysis. PLoS ONE, 10(6), e0128889. (doi:10.1371/journal.pone.0128889) (PMID:26110878) (PMCID:PMC4482317)

Carrick, D. et al. (2015) Pathophysiology of left ventricular remodeling in survivors of ST-segment elevation myocardial infarction. JACC: Cardiovascular Imaging, (In Press)

Carrick, D. et al. (2015) Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison to contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. European Heart Journal, (Accepted for Publication)

Jackson, C. et al. (2015) Combined free light chains are novel predictors of prognosis in heart failure. JACC: Heart Failure, (In Press)

Kristensen, S. L., McInnes, I., and Sattar, N. (2015) Psoriasis, psoriatic arthritis and cardiovascular risk: are we closer to a clinical recommendation? Annals of the Rheumatic Diseases, 74(2), pp. 321-322. (doi:10.1136/annrheumdis-2014-206617)

Locke, A. E. et al. (2015) Genetic studies of body mass index yield new insights for obesity biology. Nature, 518(7538), pp. 197-206. (doi:10.1038/nature14177) (PMID:25673413) (PMCID:PMC4382211)

Logue, J. et al. (2015) SurgiCal Obesity Treatment Study (SCOTS): protocol for a national prospective cohort study of patients undergoing bariatric surgery in Scotland. BMJ Open, 5(5), e008106. (doi:10.1136/bmjopen-2015-008106) (PMID:26002692) (PMCID:PMC4442215)

Poortvliet, R. K.E. et al. (2015) Biological correlates of blood pressure variability in elderly at high risk of cardiovascular disease. American Journal of Hypertension, 28(4), pp. 469-479. (doi:10.1093/ajh/hpu181) (PMID:25298176)

Preiss, D. et al. (2015) The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. European Heart Journal, (doi:10.1093/eurheartj/ehv072) (PMID:25802390) (Early Online Publication)

Preiss, D., and Sattar, N. (2015) Does the LDL receptor play a role in the risk of developing type 2 diabetes? JAMA: Journal of the American Medical Association, 313(10), pp. 1016-1017. (doi:10.1001/jama.2015.1275) (PMID:25756436)

van Leeuwen, E. M. et al. (2015) Genome of the Netherlands population-specific imputations identify an ABCA6 variant associated with cholesterol levels. Nature Communications, 6, 6065. (doi:10.1038/ncomms7065) (PMID:25751400) (PMCID:PMC4366498)

Lawlor, D. A., West, J., Fairley, L., Nelson, S. M., Bhopal, R. S., Tuffnell, D., Freeman, D. J., Wright, J., Whitelaw, D. C., and Sattar, N. (2014) Pregnancy glycaemia and cord-blood levels of insulin and leptin in Pakistani and white British mother–offspring pairs: findings from a prospective pregnancy cohort. Diabetologia, 57(12), pp. 2492-2500. (doi:10.1007/s00125-014-3386-6)

Preiss, D. et al. (2014) Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR study. Diabetes, Obesity and Metabolism, 16(12), pp. 1265-1268. (doi:10.1111/dom.12320) (PMID:24861892)

Price, A. H., Welsh, P., Weir, C. J., Feinkohl, I., Robertson, C. M., Morling, J. R., McLachlan, S., Strachan, M. W. J., Sattar, N., and Price, J. F. (2014) N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetologia, 57(12), pp. 2505-2512. (doi:10.1007/s00125-014-3375-9)

Robertson, J., McInnes, I., and Sattar, N. (2014) Response to ‘Interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders’ by Hassan et al. Cytokine, 70(2), p. 198. (doi:10.1016/j.cyto.2014.05.028)

Welsh, P. et al. (2014) Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up. Diabetologia, 57(12), pp. 2513-2520. (doi:10.1007/s00125-014-3383-9)

Preiss, D., McMurray, J. J., and Sattar, N. (2014) Treatment of severe hypertriglyceridaemia. Lancet Diabetes and Endocrinology, 2(11), p. 860. (doi:10.1016/s2213-8587(14)70052-x) (PMID:25439459)

Rankin, N. J., Preiss, D., Welsh, P., Burgess, K. E.V., Nelson, S. M., Lawlor, D. A., and Sattar, N. (2014) The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective. Atherosclerosis, 237(1), pp. 287-300. (doi:10.1016/j.atherosclerosis.2014.09.024)

Welsh, P., and Sattar, N. (2014) Vitamin D genes and mortality. British Medical Journal, 349, g6599. (doi:10.1136/bmj.g6599)

Graves, L., Garnett, S.P., Cowell, C.T., Baur, L.A., Ness, A., Sattar, N., and Lawlor, D.A. (2014) Waist-to-height ratio and cardiometabolic risk factors in adolescence: findings from a prospective birth cohort. Pediatric Diabetes, 9(5), pp. 327-338. (doi:10.1111/j.2047-6310.2013.00192.x) (PMID:23894119) (PMCID:PMC4238826)

Anderson, E. L., Howe, L. D., Fraser, A., Callaway, M. P., Sattar, N., Day, C., Tilling, K., and Lawlor, D. A. (2014) Weight trajectories through infancy and childhood and risk of non-alcoholic fatty liver disease in adolescence: the ALSPAC study. Journal of Hepatology, 61(3), pp. 626-632. (doi:10.1016/j.jhep.2014.04.018)

Lim, S., Choi, S.H., Kim, K.M., Choi, S.I., Chun, E.J., Kim, M.J., Park, K.S., Jang, H.C., and Sattar, N. (2014) The association of rate of weight gain during early adulthood with the prevalence of subclinical coronary artery disease in recently diagnosed type 2 diabetes: the maxwel-cad study. Diabetes Care, 37(9), pp. 2491-2499. (doi:10.2337/dc13-2365)

Ntuk, U., Gill, J., Mackay, D., Sattar, N., and Pell, J. (2014) Ethnic specific obesity cut-offs for diabetes risk: cross-sectional study of 490, 288 UK Biobank participants. Diabetes Care, 37(9), pp. 2500-2507. (doi:10.2337/dc13-2966)

Bell, D., McAllister, D. A., Hughes, K. A., Lone, N., Mills, N. L., Sattar, N., McKnight, J., and Wild, S. H. (2014) Stress hyperglycaemia in hospitalised patients and their 3-year risk of diabetes: a Scottish retrospective cohort study. PLoS Medicine, 11(8), e1001708. (doi:10.1371/journal.pmed.1001708)

Charakida, M., Khan, T., Johnson, W., Finer, N., Woodside, J., Whincup, P. H., Sattar, N., Kuh, D., Hardy, R., and Deanfield, J. (2014) Lifelong patterns of BMI and cardiovascular phenotype in individuals aged 60–64 years in the 1946 British birth cohort study: an epidemiological study. Lancet Diabetes and Endocrinology, 2(8), pp. 648-654. (doi:10.1016/S2213-8587(14)70103-2)

Johnsson, H., Panarelli, M., Cameron, A., and Sattar, N. (2014) Analysis and modelling of cholesterol and high-density lipoprotein cholesterol changes across the range of C-reactive protein levels in clinical practice as an aid to better understanding of inflammation-lipid interactions. Annals of the Rheumatic Diseases, 73(8), pp. 1495-1499. (doi:10.1136/annrheumdis-2013-203293)

Maitland, R.A., Seed, P.T., Briley, A.L., Homsy, M., Thomas, S., Pasupathy, D., Robson, S.C., Nelson, S.M., Sattar, N., and Poston, L. (2014) Prediction of gestational diabetes in obese pregnant women from the UK Pregnancies Better Eating and Activity (UPBEAT) pilot trial. Diabetic Medicine, 31(8), pp. 963-970. (doi:10.1111/dme.12482)

Welsh, P. et al. (2014) Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients With type 2 diabetes? Results from the ADVANCE Trial. Diabetes Care, 37(8), pp. 2202-2210. (doi:10.2337/dc13-2625)

Wijsman, L. W. et al. (2014) N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk. Annals of Neurology, 76(2), pp. 213-222. (doi:10.1002/ana.24203)

Postmus, I. et al. (2014) In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study. Atherosclerosis, 235(1), pp. 58-64. (doi:10.1016/j.atherosclerosis.2014.04.009)

Schernthaner, G., and Sattar, N. (2014) Lessons from SAVOR and EXAMINE: some important answers, but many open questions. Journal of Diabetes and its Complications, 28(4), pp. 430-433. (doi:10.1016/j.jdiacomp.2014.02.011)

Gill, J.M.R., and Sattar, N. (2014) Fruit juice: just another sugary drink? Lancet Diabetes and Endocrinology, 2(6), pp. 444-446. (doi:10.1016/S2213-8587(14)70013-0)

Hillis, G. S., Welsh, P., Chalmers, J., Woodward, M., and Sattar, N. (2014) Response to comment on Hillis et al. The relative and combined ability of high-sensitivity cardiac troponin T and N-Terminal Pro-B-Type natriuretic peptide to predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care 2014;37:295-303. Diabetes Care, 37(6), e154-e154. (doi:10.2337/dc14-0485)

Jones, N.R.V., Fischbacher, C.M., Guthrie, B., Leese, G., Lindsay, R.S., McKnight, J.A., Pearson, D., Philip, S., Sattar, N., and Wild, S.H. (2014) Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008. Diabetic Medicine, 31(6), pp. 640-646. (doi:10.1111/dme.12409) (PMID:24533646) (PMCID:PMC4232871)

Sattar, N. A. et al. (2014) The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice. Atherosclerosis Supplements, 15(1), pp. 1-15. (doi:10.1016/j.atherosclerosissup.2014.04.001)

Estampador, A. C., Pomeroy, J., Renstrom, F., Nelson, S. M., Mogren, I., Persson, M., Sattar, N., Domellof, M., and Franks, P. W. (2014) Infant body composition and adipokine concentrations in relation to maternal gestational weight gain. Diabetes Care, 37(5), pp. 1432-1438. (doi:10.2337/dc13-2265) (PMID:24623025) (PMCID:PMC3994936)

Maki, K. C., Ridker, P. M., Brown, W. V., Grundy, S. M., and Sattar, N. (2014) An assessment by the Statin Diabetes Safety Task Force: 2014 update. Journal of Clinical Lipidology, 8(3), S17-S29. (doi:10.1016/j.jacl.2014.02.012) (PMID:24793439)

Nurmohamed, M. T., Jamnitski, A., Symmons, D., Peters, M. J. L., Sattar, N., and McInnes, I. (2014) Response to: 'The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis' by Gonzalez-Gay et al. Annals of the Rheumatic Diseases, 73(5), e28. (doi:10.1136/annrheumdis-2014-205174)

Welsh, P., and Sattar, N. (2014) Vitamin D and chronic disease prevention. BMJ, 348, g2280. (doi:10.1136/bmj.g2280)

Park, C. M. et al. (2014) Hyperglycemia has a greater impact on left ventricle function in South Asians than in Europeans. Diabetes Care, 37(4), pp. 1124-1131. (doi:10.2337/dc13-1864)

Tillin, T., Sattar, N., Forouhi, N., Hughes, A. D., and Chaturvedi, N. (2014) Comment on Shah et al. Cardiovascular complications and mortality after diabetes diagnosis for South Asian and Chinese patients: a population-based cohort study. Diabetes Care, 37(4), e78-e79. (doi:10.2337/dc13-2490)

Bhopal, R. S. et al. (2014) Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial. Lancet Diabetes and Endocrinology, 2(3), pp. 218-227. (doi:10.1016/S2213-8587(13)70204-3)

Welsh, P., Poulter, N. R. , Chang, C. L., Sever, P. S., and Sattar, N. (2014) The Value of N-Terminal Pro–B-Type Natriuretic Peptide in Determining Antihypertensive Benefit: Observations From the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Hypertension, 63(3), pp. 507-513. (doi:10.1161/HYPERTENSIONAHA.113.02204)

Di Angelantonio, E. et al. (2014) Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA: Journal of the American Medical Association, 311(12), pp. 1225-1233. (doi:10.1001/jama.2014.1873) (PMID:24668104) (PMCID:PMC4386007)

Lawlor, D. A., Callaway, M., Macdonald-Wallis, C., Anderson, E., Fraser, A., Howe, L. D., Day, C., and Sattar, N. (2014) Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a Cross-sectional study of 1874 general population adolescents. Journal of Clinical Endocrinology and Metabolism, 99(3), E410-E417. (doi:10.1210/jc.2013-3612) (PMID:24471572) (PMCID:PMC3955251)

Tillin, T., Hughes, A. D., Whincup, P., Mayet, J., Sattar, N., McKeigue, P. M., and Chaturvedi, N. (2014) QRISK2 validation by ethnic group. Heart, 100(5), p. 437. (doi:10.1136/heartjnl-2013-305333)

Preiss, D., Lloyd, S.M., Ford, I., McMurray, J.J.V., Holman, R.R., Welsh, P., Fisher, M., Packard, C.J., and Sattar, N. (2014) Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes and Endocrinology, 2(2), pp. 116-124. (doi:10.1016/S2213-8587(13)70152-9)

Drewes, Y.M. et al. (2014) Homocysteine levels and treatment effect in the prospective study of pravastatin in the elderly at risk. Journal of the American Geriatrics Society, 62(2), pp. 213-221. (doi:10.1111/jgs.12660)

Sabayan, B., Westendorp, R. G., Grond, J. v. d., Stott, D. J., Sattar, N., van Osch, M. J.P., van Buchem, M. A., and de Craen, A. J.M. (2014) Markers of endothelial dysfunction and cerebral blood flow in older adults. Neurobiology of Aging, 35(2), pp. 373-377. (doi:10.1016/j.neurobiolaging.2013.08.020) (PMID:24054993)

Tillin, T., Sattar, N., Godsland, I.F., Hughes, A.D., Chaturvedi, N., and Forouhi, N.G. (2014) Ethnicity-specific obesity cut-points in the development of Type 2 diabetes - a prospective study including three ethnic groups in the United Kingdom. Diabetic Medicine, 32(2), pp. 226-234. (doi:10.1111/dme.12576) (PMID:25186015)

Wannamethee, S.G., Shaper, A.G., Whincup, P.H., Lennon, L., Papacosta, O., and Sattar, N. (2014) The obesity paradox in men with coronary heart disease and heart failure: the role of muscle mass and leptin. International Journal of Cardiology, 171(1), pp. 49-55. (doi:10.1016/j.ijcard.2013.11.043) (PMID:24331120) (PMCID:PMC3909461)

Goya Wannamethee, S., Welsh, P., Whincup, P. H., Lennon, L., Papacosta, O., and Sattar, N. (2014) N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study. European Journal of Heart Failure, 16(1), pp. 25-32. (doi:10.1093/eurjhf/hft124)

Hillis, G. S. et al. (2014) The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care, 37(1), pp. 295-303. (doi:10.2337/dc13-1165)

Looker, H.C. et al. (2014) Risk stratification for diabetic eye screening: reply to Stratton I. M. and Aldington S. J. Diabetologia, 57(1), pp. 260-261. (doi:10.1007/s00125-013-3099-2)

Tillin, T. et al. (2014) Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a UK tri-ethnic prospective cohort study (SABRE--Southall And Brent revisited). Heart, 100(1), pp. 60-67. (doi:10.1136/heartjnl-2013-304474)

Avery, C.L. et al. (2014) Drug–gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval. Pharmacogenomics Journal, 14(1), pp. 6-13. (doi:10.1038/tpj.2013.4)

Baumert, J. et al. (2014) No evidence for genome-wide interactions on plasma fibrinogen by smoking, alcohol consumption and body mass index: results from meta-analyses of 80,607 subjects. PLoS ONE, 9(12), e111156. (doi:10.1371/journal.pone.0111156)

Bodicoat, D. H. et al. (2014) Body mass index and waist circumference cut-points in multi-ethnic populations from the UK and India: the addition-Leicester, Jaipur heart watch and New Delhi cross-sectional studies. PLoS ONE, 9(3), e90813. (doi:10.1371/journal.pone.0090813)

Briley, A. L. et al. (2014) A complex intervention to improve pregnancy outcome in obese women; the UPBEAT randomised controlled trial. BMC Pregnancy and Childbirth, 14, 74. (doi:10.1186/1471-2393-14-74) (PMID:24533897) (PMCID:PMC3938821)

Deelen, J. et al. (2014) Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age. Human Molecular Genetics, 23(16), pp. 4420-4432. (doi:10.1093/hmg/ddu139)

Donin, A. S., Nightingale, C. M., Owen, C. G., Rudnicka, A. R., Perkin, M. R., Jebb, S. A., Stephen, A. M., Sattar, N., Cook, D. G., and Whincup, P. H. (2014) Regular breakfast consumption and Type 2 Diabetes risk markers in 9- to 10-year-old children in the Child Heart and Health Study in England (CHASE): a cross-sectional analysis. PLoS Medicine, 11(9), e1001703. (doi:10.1371/journal.pmed.1001703)

Holmes, M. V. et al. (2014) Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ, 349, g4164. (doi:10.1136/bmj.g4164)

Huang, J. et al. (2014) Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2. Arteriosclerosis, Thrombosis and Vascular Biology, 34(5), pp. 1093-1101. (doi:10.1161/ATVBAHA.113.302088)

Huda, S. S., Forrest, R., Paterson, N., Jordan, F., Sattar, N., and Freeman, D. J. (2014) In preeclampsia, maternal third trimester subcutaneous adipocyte lipolysis is more resistant to suppression by insulin than in healthy pregnancy. Hypertension, 63(5), pp. 1094-1101. (doi:10.1161/​HYPERTENSIONAHA.113.01824) (PMID:24591340)

Jani, B., Cavanagh, J., Barry, S. J.E., Der, G., Sattar, N., and Mair, F. S. (2014) Revisiting the J shaped curve, exploring the association between cardiovascular risk factors and concurrent depressive symptoms in patients with cardiometabolic disease: findings from a large cross-sectional study. BMC Cardiovascular Disorders, 14, p. 139. (doi:10.1186/1471-2261-14-139)

McArthur, L., Johnston, L., Sattar, N., Logue, J., and Welsh, P. (2014) Preanalytical study of fetuin-A: effect of sample type, processing speed and freeze-thaw cycles. Annals of Clinical Biochemistry, 52(1), pp. 165-168. (doi:10.1177/0004563214529550)

McCallum, L. et al. (2014) Response to effect of serum chloride on mortality in hypertensive patients. Hypertension, 63(3), e15-e15. (doi:10.1161/HYPERTENSIONAHA.113.02926)

Mirjafari, H. et al. (2014) N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR). Annals of the Rheumatic Diseases, 73(4), pp. 684-690. (doi:10.1136/annrheumdis-2012-202848)

Porter, D., Dale, J., and Sattar, N. (2014) How low to aim in rheumatoid arthritis? Learning from other disciplines. Annals of the Rheumatic Diseases, 73(3), pp. 480-482. (doi:10.1136/annrheumdis-2013-204339)

Postmus, I. et al. (2014) Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins. Nature Communications, 5(5068), (doi:10.1038/ncomms6068)

Sattar, N., Forrest, E., and Preiss, D. (2014) Non-alcoholic fatty liver disease. British Medical Journal, 2014(349), g4596. (doi:10.1136/bmj.g4596) (PMID:25239614) (PMCID:PMC4168663)

Sattar, N., and Gill, J. (2014) Type 2 diabetes as a disease of ectopic fat? BMC Medicine, 12, 123. (doi:10.1186/s12916-014-0123-4) (PMID:25159817) (PMCID:PMC4143560)

Silverwood, R. J., Richards, M., Pierce, M., Hardy, R., Sattar, N., Ferro, C., Savage, C., Kuh, D., and Nitsch, D. (2014) Cognitive and kidney function: results from a British birth cohort reaching retirement age. PLoS ONE, 9(1), e86743. (doi:10.1371/journal.pone.0086743) (PMID:24482683) (PMCID:PMC3901795)

Taylor, A. E. et al. (2014) Stratification by smoking status reveals an association of CHRNA5-A3-B4 genotype with body mass index in never smokers. PLoS Genetics, 10(12), e1004799. (doi:10.1371/journal.pgen.1004799)

Uversky, V.N. et al. (2014) The relation of rapid changes in obesity measures to lipid profile - insights from a nationwide metabolic health survey in 444 Polish cities. PLoS ONE, 9(1), e86837. (doi:10.1371/journal.pone.0086837)

Wallia, S. et al. (2014) Culturally adapting the prevention of diabetes and obesity in South Asians (PODOSA) trial. Health Promotion International, 29(4), pp. 768-779. (doi:10.1093/heapro/dat015)

Wannamethee, S. G., Welsh, P., Papacosta, O., Lennon, L., Whincup, P. H., and Sattar, N. (2014) Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circulation: Heart Failure, 7(5), pp. 732-739. (doi:10.1161/CIRCHEARTFAILURE.114.001272)

West, J., Wright, J., Fairley, L., Sattar, N., Whincup, P., and Lawlor, D. A. (2014) Do ethnic differences in cord blood leptin levels differ by birthweight category? Findings from the Born in Bradford cohort study. International Journal of Epidemiology, 43(1), pp. 249-254. (doi:10.1093/ije/dyt225)

van den Oever, I.A.M., Sattar, N., and Nurmohamed, M.T. (2014) Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system. Annals of the Rheumatic Diseases, 73(6), pp. 954-957. (doi:10.1136/annrheumdis-2013-204767) (PMID:24431395)

Cavanagh, J. et al. (2013) Socioeconomic status and the cerebellar grey matter volume. Data from a well-characterised population sample. Cerebellum, 12(6), pp. 882-891. (doi:10.1007/s12311-013-0497-4)

Preiss, D., and Sattar, N. (2013) Choice of medical therapy to lower triglycerides in those at risk of pancreatitis. Current Opinion in Lipidology, 24(6), pp. 532-533. (doi:10.1097/MOL.0000000000000029)

Sattar, N., and Kitas, G.D. (2013) Rheumatoid arthritis: testing the inflammation–insulin resistance link in clinical trials. Nature Reviews Rheumatology, 9(12), pp. 702-703. (doi:10.1038/nrrheum.2013.178)

Silverwood, R.J., Pierce, M., Hardy, R., Sattar, N., Whincup, P., Ferro, C., Savage, C., Kuh, D., and Nitsch, D. (2013) Low birth weight, later renal function, and the roles of adulthood blood pressure, diabetes, and obesity in a British birth cohort. Kidney International, 84(6), pp. 1262-1270. (doi:10.1038/ki.2013.223)

Sabayan, B., van der Grond, J., Westendorp, R.G., Jukema, J.W., Ford, I., Buckley, B.M., Sattar, N., van Osch, M.J.P., van Buchem, M.A., and de Craen, A.J.M. (2013) Total cerebral blood flow and mortality in old age: a 12-year follow-up study. Neurology, 81(22), pp. 1922-1929. (doi:10.1212/01.wnl.0000436618.48402.da)

Holmes, M.V. et al. (2013) Secretory phospholipase A2-IIA and cardiovascular disease. Journal of the American College of Cardiology, 62(21), pp. 1966-1976. (doi:10.1016/j.jacc.2013.06.044)

McCallum, L. et al. (2013) Serum chloride is an independent predictor of mortality in hypertensive patients. Hypertension, 62(5), pp. 836-843. (doi:10.1161/HYPERTENSIONAHA.113.01793)

Ghouri, N., Purves, D., McConnachie, A., Wilson, J., Gill, J.M.R., and Sattar, N. (2013) Lower cardiorespiratory fitness contributes to increased insulin resistance and fasting glycaemia in middle-aged South Asian compared with European men living in the UK. Diabetologia, 56(10), pp. 2238-2249. (doi:10.1007/s00125-013-2969-y)

Feinkohl, I. et al. (2013) Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care, 36(9), pp. 2779-2786. (doi:10.2337/dc12-2241)

Krishnadas, R. et al. (2013) Socioeconomic deprivation and cortical morphology: psychological, social, and biological determinants of ill health study. Psychosomatic Medicine, 75(7), pp. 616-623. (doi:10.1097/PSY.0b013e3182a151a7)

Logue, J., and Sattar, N. (2013) Body weight and mortality in type 2 diabetes: weighing up the evidence. Diabetes and Metabolism, 39(4), pp. 287-288. (doi:10.1016/j.diabet.2013.06.002)

Robertson, J., Peters, M.J., McInnes, I.B., and Sattar, N. (2013) Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm. Nature Reviews Rheumatology, 9(9), pp. 513-523. (doi:10.1038/nrrheum.2013.91)

Scott, R.A. et al. (2013) Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nature Genetics, 44(9), pp. 991-1005. (doi:10.1038/ng.2385)

Sever, P.S., Poulter, N.R., Chang, C.L., Thom, S.A.M., Hughes, A.D., Welsh, P., and Sattar, N. (2013) Evaluation of C-reactive protein before and on-treatment as a predictor of benefit of atorvastatin. Journal of the American College of Cardiology, 62(8), pp. 717-729. (doi:10.1016/j.jacc.2013.02.098)

Looker, H.C. et al. (2013) Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia, 56(8), pp. 1716-1725. (doi:10.1007/s00125-013-2928-7)

Sattar, N. (2013) Gender aspects in type 2 diabetes mellitus and cardiometabolic risk. Best Practice and Research: Clinical Endocrinology and Metabolism, 27(4), pp. 501-507. (doi:10.1016/j.beem.2013.05.006)

Cleland, S.J., Fisher, B.M., Colhoun, H.M., Sattar, N., and Petrie, J.R. (2013) Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks? Diabetologia, 56(7), pp. 1462-1470. (doi:10.1007/s00125-013-2904-2)

Mooijaart, S.P., Sattar, N., Trompet, S., Lucke, J., Stott, D.J., Ford, I., Jukema, J.W., Westendorp, R.G.J., and de Craen, A.J.M. (2013) Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study. Journal of Internal Medicine, 274(1), pp. 77-85. (doi:10.1111/joim.12052)

Ghouri, N., Gatrad, R., Sattar, N., Dhami, S., and Sheikh, A. (2013) Summer-winter switching of the Ramadan fasts in people with diabetes living in temperate regions. Diabetic Medicine, 29(6), pp. 696-697. (doi:10.1111/j.1464-5491.2011.03519.x)

Nanchen, D. et al. (2013) Resting heart rate and incident heart failure and cardiovascular mortality in older adults: role of inflammation and endothelial dysfunction: the PROSPER study. European Journal of Heart Failure, 15(5), pp. 581-588. (doi:10.1093/eurjhf/hfs195)

Ferguson, L.D., and Sattar, N. (2013) Reducing cardiovascular disease risk in type 2 diabetes: is the focus on glycaemia warranted? Diabetes, Obesity and Metabolism, 15(5), pp. 387-391. (doi:10.1111/dom.12018)

Wannamethee, S.G., Sattar, N., Papcosta, O., Lennon, L., and Whincup, P.H. (2013) Alkaline phosphatase, serum phosphate, and incident cardiovascular disease and total mortality in older men. Arteriosclerosis, Thrombosis and Vascular Biology, 33(5), pp. 1070-1076. (doi:10.1161/ATVBAHA.112.300826)

Tillin, T., Hughes, A.D., Mayet, J., Whincup, P., Sattar, N., Forouhi, N.G., McKeigue, P.M., and Chaturvedi, N. (2013) The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans. Journal of the American College of Cardiology, 61(17), pp. 1777-1786. (doi:10.1016/j.jacc.2012.12.046)

Logue, J., Walker, J.J., Leese, G., Lindsay, R., McKnight, J., Morris, A., Philip, S., Wild, S., and Sattar, N. (2013) Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care, 36(4), pp. 887-893. (doi:10.2337/dc12-0944)

Sattar, N. (2013) Revisiting the links between glycaemia, diabetes and cardiovascular disease. Diabetologia, 56(4), pp. 686-695. (doi:10.1007/s00125-012-2817-5)

Smolen, J.S. et al. (2013) Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions. Annals of the Rheumatic Diseases, 72(4), pp. 482-492. (doi:10.1136/annrheumdis-2012-202469)

Saunders, C., Byrne, C.D., Guthrie, B., Lindsay, R.S., McKnight, J.A., Philip, S., Sattar, N., Walker, J.J., and Wild, S.H. (2013) External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants? Diabetic Medicine, 30(3), pp. 300-308. (doi:10.1111/dme.12047)

Postmus, I., Trompet, S., de Craen, A.J.M., Buckley, B.M., Ford, I., Stott, D.J., Sattar, N., Slagboom, P.E., Westendorp, R.G.J., and Jukema, J.W. (2013) PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population. Journal of Lipid Research, 54(2), pp. 561-566. (doi:10.1194/jlr.P033969)

Sattar, N. (2013) Lipid metabolism. Current Opinion in Lipidology, 24(1), pp. 101-102. (doi:10.1097/MOL.0b013e32835c9495)

Tillin, T., Hughes, A.D., Godsland, I.F., Whincup, P., Forouhi, N.G., Welsh, P., Sattar, N., McKeigue, P.M., and Chaturvedi, N. (2013) Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall and Brent REvisited (SABRE) cohort. Diabetes Care, 36(2), pp. 383-393. (doi:10.2337/dc12-0544)

Peters, M.J.L., Ghouri, N., McKeigue, P., Forouhi, N.G., and Sattar, N. (2013) Circulating IL-6 concentrations and associated anthropometric and metabolic parameters in South Asian men and women in comparison to European whites. Cytokine, 61(1), pp. 29-32. (doi:10.1016/j.cyto.2012.09.002)

Anderson, E.L., Fraser, A., McNally, W., Sattar, N., Lashen, H., Fleming, R., Nelson, S.M., and Lawlor, D.A. (2013) Anti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females. PLoS ONE, 8(5), e64510. (doi:10.1371/journal.pone.0064510)

Celis-Morales, C. A., Ghouri, N., Bailey, M.E.S., Sattar, N., and Gill, J. M.R. (2013) Should physical activity recommendations be ethnicity-specific? Evidence from a cross-sectional study of south Asian and European men. PLoS ONE, 8(12), e82568. (doi:10.1371/journal.pone.0082568)

Douglas, A. et al. (2013) Design and baseline characteristics of the PODOSA (prevention of diabetes and obesity in South Asians) trial: a cluster, randomised lifestyle intervention in Indian and Pakistani adults with impaired glycaemia at high risk of developing type 2 diabetes. BMJ Open, 3(2), e002226-e002226. (doi:10.1136/bmjopen-2012-002226)

Fraser, A., McNally, W., Sattar, N., Anderson, E.L., Lashen, H., Fleming, R., Lawlor, D.A., and Nelson, S.M. (2013) Prenatal exposures and anti-mullerian hormone in female adolescents: the avon longitudinal study of parents and children. American Journal of Epidemiology, 178(9), pp. 1414-1423. (doi:10.1093/aje/kwt137)

Fraser, A., Nelson, S.M., Macdonald-Wallis, C., Sattar, N., and Lawlor, D.A. (2013) Hypertensive disorders of pregnancy and cardiometabolic health in adolescent offspring. Hypertension, 62(3), pp. 614-620. (doi:10.1161/HYPERTENSIONAHA.113.01513)

Jamnitski, A., Symmons, D., Peters, M.J.L., Sattar, N., McInnes, I., and Nurmohamed, M.T. (2013) Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Annals of the Rheumatic Diseases, 72(2), pp. 211-216. (doi:10.1136/annrheumdis-2011-201194)

Krishnadas, R. et al. (2013) Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: results from the psychological, social and biological determinants of ill health (pSoBid) study. NeuroImage: Clinical, 2(2013), pp. 646-657. (doi:10.1016/j.nicl.2013.04.012)

Lloyd, S.M. et al. (2013) Long-term effects of statin treatment in elderly people: Extended follow-up of the PROspective study of Pravastatin in the elderly at risk (PROSPER). PLoS ONE, 8(9), e72642. (doi:10.1371/journal.pone.0072642)

McCarthy, M.I. et al. (2013) A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genetics, 9(2), e1003266. (doi:10.1371/journal.pgen.1003266)

Millar, K. et al. (2013) Personality, socio-economic status and inflammation: cross-sectional, population-based study. PLoS ONE, 8(3), e58256. (doi:10.1371/journal.pone.0058256)

Negandhi, P.H., Ghouri, N., Colhoun, H.M., Fischbacher, C.M., Lindsay, R.S., McKnight, J.A., Petrie, J., Philip, S., Sattar, N., and Wild, S.H. (2013) Ethnic differences in Glycaemic control in people with type 2 diabetes mellitus living in Scotland. PLoS ONE, 8(12), e83292. (doi:10.1371/journal.pone.0083292)

Poston, L. et al. (2013) Developing a complex intervention for diet and activity behaviour change in obese pregnant women (the UPBEAT trial); assessment of behavioural change and process evaluation in a pilot randomised controlled trial. BMC Pregnancy and Childbirth, 13(148), (doi:10.1186/1471-2393-13-148)

Rutter, M.K. et al. (2013) Epidemiological evidence against a role for C-reactive protein causing leptin resistance. European Journal of Endocrinology, 168(1), pp. 101-106. (doi:10.1530/EJE-12-0348)

Sabater-Lleal, M. et al. (2013) Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease. Circulation, 128(12), pp. 1310-1324. (doi:10.1161/CIRCULATIONAHA.113.002251)

Sabayan, B. et al. (2013) Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study. BMJ Open, 347, f4600. (doi:10.1136/bmj.f4600)

Sattar, N., and Taskinen, M.-R. (2013) Statins are diabetogenic – Myth or reality? Atherosclerosis Supplements, 13(1), pp. 1-10. (doi:10.1016/j.atherosclerosissup.2012.06.001)

Verschuren, J.J.W. et al. (2013) Non-homologous end-joining pathway associated with occurrence of myocardial infarction: gene set analysis of genome-wide association study data. PLoS ONE, 8(2), e56262. (doi:10.1371/journal.pone.0056262)

Wannamethee, S.G., Shaper, A.G., Whincup, P.H., Lennon, L., and Sattar, N. (2013) Adiposity, adipokines, and risk of incident stroke in older men. Stroke, 44(1), pp. 3-8. (doi:10.1161/STROKEAHA.112.670331)

Welsh, P., Doolin, O., Willeit, P., Packard, C., Macfarlane, P., Cobbe, S., Gudnason, V., Di Angelantonio, E., Ford, I., and Sattar, N. (2013) N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS. European Heart Journal, 34(6), pp. 443-450. (doi:10.1093/eurheartj/ehs239)

West, J., Lawlor, D.A., Fairley, L., Bhopal, R., Cameron, N., McKinney, P.A., Sattar, N., and Wright, J. (2013) UK-born Pakistani-origin infants are relatively more adipose than white British infants: findings from 8704 mother-offspring pairs in the Born-in-Bradford prospective birth cohort. Journal of Epidemiology and Community Health, 67(7), pp. 544-551. (doi:10.1136/jech-2012-201891)

Charakida, M., Jones, A., Falaschetti, E., Khan, T., Finer, N.,, Sattar, N., Hingorani, A., Lawlor, D.A., Smith, G.D., and Deanfield, J.E. (2012) Childhood obesity and vascular phenotypes. Journal of the American College of Cardiology, 60(25), pp. 2643-2650. (doi:10.1016/j.jacc.2012.08.1017)

Heslehurst, N., Sattar, N., Rajasingam, D., Wilkinson, J., Summerbell, C.D., and Rankin, J. (2012) Existing maternal obesity guidelines may increase inequalities between ethnic groups: a national epidemiological study of 502,474 births in England. BMC Pregnancy and Childbirth, 12, p. 156. (doi:10.1186/1471-2393-12-156)

Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N., Baker, A. H., McInnes, I. B., and Liew, F. Y. (2012) IL-33 reduces the development of atherosclerosis (vol 205, pg 339, 2008). Journal of Experimental Medicine, 209(13), p. 2515. (doi:10.1084/jem.2007186820913c)

McLean, J. et al. (2012) Early life socioeconomic status, chronic physiological stress and hippocampal N-acetyl aspartate concentrations. Behavioural Brain Research, 235(2), pp. 225-230. (doi:10.1016/j.bbr.2012.08.013)

Kennon, B. et al. (2012) Reduced incidence of lower-extremity amputations in people with diabetes in Scotland: a nationwide study. Diabetes Care, 35(12), pp. 2588-2590. (doi:10.2337/dc12-0511)

Labad, J., Price, J.F., Strachan, M.W.J., Deary, I.J., Seckl, J.R., Sattar, N., and Reynolds, R.M. (2012) Serum leptin and cognitive function in people with Type 2 diabetes. Neurobiology of Aging, 33(12), pp. 2938-2941. (doi:10.1016/j.neurobiolaging.2012.02.026)

Packard, C. et al. (2012) Interaction of personality traits with social deprivation in determining mental wellbeing and health behaviours. Journal of Public Health, 34(4), pp. 615-624. (doi:10.1093/pubmed/fds030)

Welsh, P. et al. (2012) Circulating 250HD, dietary vitamin D, PTH, and calcium associations with incident cardiovascular disease and mortality: The MIDSPAN Family Study. Journal of Clinical Endocrinology and Metabolism, 97(12), pp. 4578-4587. (doi:10.1210/jc.2012-2272)

Colhoun, H.M. et al. (2012) Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs. Diabetologia, 55(11), pp. 2929-2937. (doi:10.1007/s00125-012-2668-0)

Jackson, C.A. et al. (2012) Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland. Diabetologia, 55(11), pp. 2938-2945. (doi:10.1007/s00125-012-2667-1)

Lawlor, D.A., Relton, C., Sattar, N., and Nelson, S.M. (2012) Maternal adiposity—a determinant of perinatal and offspring outcomes? Nature Reviews Endocrinology, 8(11), pp. 679-688. (doi:10.1038/nrendo.2012.176)

MacRitchie, N. et al. (2012) Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein e-deficient mice. Arteriosclerosis, Thrombosis and Vascular Biology, 32(11), pp. 2569-2579. (doi:10.1161/ATVBAHA.112.251314)

Miller, A. M. et al. (2012) Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes? PLoS ONE, 7(10), e47830. (doi:10.1371/journal.pone.0047830)

Kaptoge, S. et al. (2012) C-reactive protein, fibrinogen, and cardiovascular disease prediction. New England Journal of Medicine, 367(14), pp. 1310-1320. (doi:10.1056/NEJMoa1107477)

Randeva, H.S., Tan, B.K., Weickert, M.O., Lois, K., Nestler, J.E., Sattar, N., and Lehnert, H. (2012) Cardiometabolic aspects of the polycystic ovary syndrome. Endocrine Reviews, 33(5), pp. 812-841. (doi:10.1210/er.2012-1003)

Livingstone, S.J. et al. (2012) Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Medicine, 9(10), e1001321. (doi:10.1371/journal.pmed.1001321)

Feinkohl, I., Sattar, N., Welsh, P., Reynolds, R. M., Deary, I. J., Strachan, M. W.J., and Price, J. F. (2012) Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes. PLoS ONE, 7(9), e44569. (doi:10.1371/journal.pone.0044569)

Hingorani, A.D., Sofat, R., Morris, R.W., Whincup, P., Lowe, G.D., Mindell, J., Sattar, N., Casas, J.P., and Shah, T. (2012) Is it important to measure or reduce C-reactive protein in people at risk of cardiovascular disease? European Heart Journal, 33(18), pp. 2258-2264. (doi:10.1093/eurheartj/ehs168)

Looker, H.C. et al. (2012) Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia, 55(9), pp. 2335-2342. (doi:10.1007/s00125-012-2596-z)

Knox, S. et al. (2012) 25-hydroxyvitamin D is lower in deprived groups, but is not associated with carotid intima media thickness or plaques: results from pSoBid. Atherosclerosis, 223(2), pp. 437-441. (doi:10.1016/j.atherosclerosis.2012.05.001)

McInnes, I., Lee, J.S., Thompson, L., Giles, J.T., Bathton, J.M., Salmon, J.E., Beaulieu, A.D., Codding, C.E., Delles, C., and Sattar, N. (2012) The effects of tocilizumab treatment on lipids and inflammatory/prothrombotic markers in patients (pts) with rheumatoid arthritis (RA): data from the randomized, controlled, measure study. European Heart Journal, 33(Sup 1), p. 281. (doi:10.1093/eurheartj/ehs281)

Preiss, D. et al. (2012) Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA: Journal of the American Medical Association, 308(8), pp. 804-811. (doi:10.1001/jama.2012.8439)

Sassarini, J., Fox, H., Ferrell, W., Sattar, N., and Lumsden, M.A. (2012) Hot flushes, vascular reactivity and the role of the α-adrenergic system. Climacteric, 15(4), pp. 332-338. (doi:10.3109/13697137.2011.636847)

Di Angelantonio, E. et al. (2012) Lipid-related markers and cardiovascular disease prediction. JAMA: Journal of the American Medical Association, 307(23), pp. 2499-2506. (doi:10.1001/jama.2012.6571)

Sattar, N., Welsh, P., Panarelli, M., and Forouhi, N.G. (2012) Vitamin D testing – authors' reply. Lancet, 379(9827), pp. 1700-1701. (doi:10.1016/S0140-6736(12)60713-2)

Williams, D.M., Fraser, A., Sayers, A., Fraser, W.D., Hingorani, A., Deanfield, J., Davey Smith, G., Sattar, N., and Lawlor, D.A. (2012) Associations of 25-hydroxyvitamin D2 and D3 with cardiovascular risk factors in childhood: cross-sectional findings from the Avon Longitudinal Study of Parents and Children. Journal of Clinical Endocrinology and Metabolism, 97(5), pp. 1563-1571. (doi:10.1210/jc.2011-2335)

Swerdlow, D.I. et al. (2012) The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet, 379(9822), pp. 1214-1224. (doi:10.1016/S0140-6736(12)60110-X)

Verschuren, J.J.W., Wessels, J.A., Trompet, S., Stott, D.J., Sattar, N., Buckley, B., Guchelaar, H.-J., and Jukema, J. (2012) Genetic variation in the SMARCA2 gene is associated with cardiovascular events. Journal of the American College of Cardiology, 59(13), E1393. (doi:10.1016/S0735-1097(12)61394-1)

Nanchen, D. et al. (2012) Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. Journal of Clinical Endocrinology and Metabolism, 97(3), pp. 852-861. (doi:10.1210/jc.2011-1978)

Rao, V. U., Pavlov, A., Klearman, M., Musselman, D., Giles, J., Bathon, J. M., Sattar, N., and Lee, J. S. (2012) Risk factors for major adverse cardiovascular events in rheumatoid arthritis patients treated with the interleukin-6 receptor inhibitor tocilizumab. Journal of the American College of Cardiology, 59(13), E1648. (doi:10.1016/S0735-1097(12)61649-0)

Sayers, A., Lawlor, D.A., Sattar, N., and Tobias, J.H. (2012) The association between insulin levels and cortical bone: findings from a cross-sectional analysis of pQCT parameters in adolescents. Journal of Bone and Mineral Research, 27(3), pp. 610-618. (doi:10.1002/jbmr.1467)

Sever, P. S., Poulter, N. R., Chang, C. L., Hingorani, A., Thom, S. A., Hughes, A. D., Welsh, P., and Sattar, N. (2012) Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial. European Heart Journal, 33(4), pp. 486-494. (doi:10.1093/eurheartj/ehr262)

McGuinness, D. et al. (2012) Socio-economic status is associated with epigenetic differences in the pSoBid cohort. International Journal of Epidemiology, 41(1), pp. 151-160. (doi:10.1093/ije/dyr215)

Talens, R.P., Jukema, J.W., Trompet, S., Kremer, D., Westendorp, R.G.J., Lumey, L.H., Sattar, N., Putter, H., Slagboom, P.E., and Heijmans, B.T. (2012) Hypermethylation at loci sensitive to the prenatal environment is associated with increased incidence of myocardial infarction. International Journal of Epidemiology, 41(1), pp. 106-115. (doi:10.1093/ije/dyr153)

Sattar, N., Welsh, P., Panarelli, M., and Forouhi, N. G. . (2012) Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet, 379(9811), pp. 95-96. (doi:10.1016/S0140-6736(11)61816-3)

Goldenberg, D., Miller, E., Perna, M., Sattar, N., Welsh, P., Roman, M. J., and Salmon, J. E. (2012) Association of N-terminal pro-brain natriuretic peptide with cardiac disease, but not with vascular disease, in systemic lupus erythematosus. Arthritis and Rheumatism, 64(1), pp. 316-317. (doi:10.1002/art.33374)

Johnson, P.C.D., Logue, J., McConnachie, A., Abu-Rmeileh, N.M.E., Hart, C., Upton, M.N., Lean, M.E.J., Sattar, N., and Watt, G. (2012) Intergenerational change and familial aggregation of body mass index. European Journal of Epidemiology, 27(1), pp. 53-61. (doi:10.1007/s10654-011-9639-5)

Patel, S., Fraser, A., Davey Smith, G., Lindsay, R.S., Sattar, N., Nelson, S.M., and Lawlor, D.A. (2012) Associations of gestational diabetes, existing diabetes, and glycosuria with offspring obesity and cardiometabolic outcomes. Diabetes Care, 35(1), pp. 63-71. (doi:10.2337/dc11-1633)

Fraser, A., Nelson, S.M., Macdonald-Wallis, C., Cherry, L., Butler, E., Sattar, N., and Lawlor, D.A. (2012) Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon longitudinal study of parents and children. Circulation, 125(11), pp. 1367-1380. (doi:10.1161/CIRCULATIONAHA.111.044784)

Govan, L. et al. (2012) The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes. Diabetologia, 55(9), pp. 2356-2360. (doi:10.1007/s00125-012-2601-6)

Johnsson, H., McInnes, I.B., and Sattar, N. (2012) Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence. Annals of the Rheumatic Diseases, 71(4), pp. 480-483. (doi:10.1136/annrheumdis-2011-200567)

Labad, J., Price, J.F., Strachan, M.W.J., Fowkes, F.G.R., Deary, I.J., Seckl, J.R., Walker, B.R., Sattar, N., and Reynolds, R.M. (2012) Leptin levels and depressive symptoms in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study. Psychosomatic Medicine, 74(1), pp. 39-45. (doi:10.1097/PSY.0b013e31823ba8af)

Lawlor, D.A., Sattar, N., Sayers, A., and Tobias, J.H. (2012) The association of fasting insulin, glucose, and lipids with bone mass in adolescents: findings from a cross-sectional study. Journal of Clinical Endocrinology and Metabolism, 97(6), pp. 2068-2076. (doi:10.1210/jc.2011-2721)

Logue, J., and Sattar, N. (2012) Don't rush into testing and treating children. British Medical Journal, 345, e6899. (doi:10.1136/bmj.e6899)

Manning, A.K. et al. (2012) A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nature Genetics, 44, pp. 659-669. (doi:10.1038/ng.2274)

Mullen, W., Gonzalez, J., Siwy, J., Franke, J., Sattar, N., Mullan, A., Roberts, S., Delles, C., Mischak, H., and Albalat, A. (2012) A pilot study on the effect of short-term consumption of a polyphenol rich drink on biomarkers of coronary artery disease defined by urinary proteomics. Journal of Agricultural and Food Chemistry, 59(24), pp. 12850-12857. (doi:10.1021/jf203369r)

Poortvliet, R.K.E. et al. (2012) Blood pressure variability and cardiovascular risk in the PROspective study of pravastatin in the elderly at risk (PROSPER). PLoS ONE, 7(12), e52438. (doi:10.1371/journal.pone.0052438)

Preiss, D., and Sattar, N. (2012) Pharmacotherapy: statins and new-onset diabetes—the important questions. Nature Reviews Cardiology, 9(4), pp. 190-192. (doi:10.1038/nrcardio.2012.15)

Preiss, D. et al. (2012) Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). European Journal of Heart Failure, 14(8), pp. 909-915. (doi:10.1093/eurjhf/hfs067)

Sattar, N. (2012) Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities. Diabetic Medicine, 29(1), pp. 5-13. (doi:10.1111/j.1464-5491.2011.03480.x)

Sattar, N., and Preiss, D. (2012) HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards. Diabetologia, 55(6), pp. 1564-1567. (doi:10.1007/s00125-012-2510-8)

Seshasai, S.R.K., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Erqou, S., Sattar, N., and Ray, K.K. (2012) Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Archives of Internal Medicine, 172(3), pp. 209-216. (doi:10.1001/archinternmed.2011.628)

Wannamethee, S.G., Whincup, P.H., Shaper, A.G., Lennon, L., and Sattar, N. (2012) Gamma-glutamyltransferase, hepatic enzymes, and risk of incident heart failure in older men. Arteriosclerosis, Thrombosis and Vascular Biology, 32(3), pp. 830-835. (doi:10.1161/ATVBAHA.111.240457)

Whincup, P.H., Cook, D.G., and Sattar, N. (2012) Response to Letter by Mascitelli et al Regarding Ethnic Differences in Carotid Intima-Media Thickness Between UK Children of Black African-Caribbean and White European Origin. Stroke, 43(10), e104. (doi:10.1161/STROKEAHA.112.666438)

Whincup, P.H. et al. (2012) Ethnic differences in carotid intima-media thickness between UK children of black African-Caribbean and white European origin. Stroke, 43(7), pp. 1747-1754. (doi:10.1161/STROKEAHA.111.644955)

Whiteley, W., Wardlaw, J., Dennis, M., Lowe, G., Rumley, A., Sattar, N., Welsh, P., Green, A., Andrews, M., and Sandercock, P. (2012) The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke, 43(1), pp. 86-91. (doi:10.1161/STROKEAHA.111.634089)

van Sijl, A., Peters, M.J.L., Knol, D.L., Sattar, N., Smulders, Y.M., de Vet, H.C.A., and Nurmohamed, M.T. (2012) Comment on: Letter to the Editor from Payet, Pereira, Soubrier, and Mathieu. Seminars in Arthritis and Rheumatism, 41(4), e6-e6. (doi:10.1016/j.semarthrit.2011.10.001)

Ford, I. et al. (2011) The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. International Journal of Epidemiology, 40(6), pp. 1530-1538. (doi:10.1093/ije/dyr172)

Freathy, R.M. et al. (2011) Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index. International Journal of Epidemiology, 40(6), pp. 1617-28. (doi:10.1093/ije/dyr077)

van Sijl, A.M., Peters, M.J.M., Knol, D.L., de Vet, R.H.C., Sattar, N., Dijkmans, B.A.C., Smulders, Y.M., and Nurmohamed, M.T. (2011) The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis. Seminars in Arthritis and Rheumatism, 41(3), pp. 393-400. (doi:10.1016/j.semarthrit.2011.04.003)

Shyangdan, D., Clar, C., Ghouri, N., Henderson, R., Gurung, T., Preiss, D., Sattar, N., Fraser, A., and Waugh, N. (2011) Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health Technology Assessment, 15(38), pp. 1-110. (doi:10.3310/hta15380)

Pfister, R. et al. (2011) Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies. PLoS Medicine, 8(10), e1001112. (doi:10.1371/journal.pmed.1001112)

Trompet, S. et al. (2011) Replication of LDL SWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses. BMC Medical Genetics, 12, p. 131. (doi:10.1186/1471-2350-12-131)

Welsh, P. et al. (2011) Circulating interleukin-10 and risk of cardiovascular events: a prospective study in the elderly at risk. Arteriosclerosis, Thrombosis and Vascular Biology, 31(10), pp. 2338-2344. (doi:10.1161/ATVBAHA.111.231795)

Mooijaart, S.P. et al. (2011) C-Reactive protein and genetic variants and cognitive decline in old age: the PROSPER Study. PLoS ONE, 6(9), e23890. (doi:10.1371/journal.pone.0023890)

Govan, L. et al. (2011) Achieved levels of HbA1c and likelihood of hospital admission in people with type 1 diabetes in the Scottish population: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetes Care, 34(9), pp. 1992-1997. (doi:10.2337/dc10-2099)

Kooter, A.J., Kostense, P.J., Groenewold, J., Thijs, A., Sattar, N., and Smulders, Y.M. (2011) Integrating information from novel risk factors with calculated risks: the critical impact of risk factor prevalence. Circulation, 124(6), pp. 741-745. (doi:10.1161/CIRCULATIONAHA.111.035725)

Wormser, D., Di Angelantonio, E., Sattar, N., Collins, R., Thompson, S., and Danesh, J. (2011) Body-mass index, abdominal adiposity, and cardiovascular risk – Authors' reply. Lancet, 378(9787), p. 228. (doi:10.1016/S0140-6736(11)61122-7)

Wannamethee, S. G., Welsh, P., Lowe, G. D., Gudnason, V., Di Angelantonio, E., Lennon, L., Rumley, A., Whincup, P. H., and Sattar, N. (2011) N-terminal pro-brain natriuretic peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. Journal of the American College of Cardiology, 58(1), pp. 56-64. (doi:10.1016/j.jacc.2011.02.041)

Welsh, P. et al. (2011) Vitamin D deficiency is common in patients with RA and linked to disease activity, but circulating levels are unaffected by TNF blockade: results from a prospective cohort study. Annals of the Rheumatic Diseases, 70(6), pp. 1165-1167. (doi:10.1136/ard.2010.137265)

Ghouri, N. A., Preiss, D., and Sattar, N. (2011) Reply (Need for a Three-Focused Approach to Nonalcoholic Fatty Liver Disease). Hepatology, 53(5), p. 1774. (doi:10.1002/hep.24138)

Logue, J., Murray, H.M., Welsh, P., Shepherd, J., Packard, C., Macfarlane, P., Cobbe, S., Ford, I., and Sattar, N. (2011) Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation. Heart, 97(7), pp. 564-568. (doi:10.1136/hrt.2010.211201)

Rahimi, K. et al. (2011) Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. British Medical Journal, 342, d1250. (doi:10.1136/bmj.d1250)

Wannamethee, S. G., Shaper, A. G., Whincup, P. H., Lennon, L., and Sattar, N. (2011) Impact of Diabetes on Cardiovascular Disease Risk and All-Cause Mortality in Older Men: Influence of Age at Onset, Diabetes Duration, and Established and Novel Risk Factors. Archives of Internal Medicine, 171(5), pp. 404-410. (doi:10.1001/archinternmed.2011.2)

Wensley, F. et al. (2011) Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ, 342, d548-d548. (doi:10.1136/bmj.d548)

Toms, T. E., Panoulas, V. F., Douglas, K. M. J., Nightingale, P., Smith, J. P., Griffiths, H., Sattar, N., Symmons, D. P. M., and Kitas, G. D. (2011) Are Lipid Ratios Less Susceptible to Change With Systemic Inflammation Than Individual Lipid Components in Patients With Rheumatoid Arthritis? Angiology, 62(2), pp. 167-175. (doi:10.1177/0003319710373749)

Wannamethee, S.G., Welsh, P., Whincup, P.H., Sawar, N., Thomas, M.C., Gudnarsson, V., and Sattar, N. (2011) High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? European Journal of Cardiovascular Prevention and Rehabilitation, 18(1), pp. 65-71. (doi:10.1097/HJR.0b013e32833b09d9)

Khunti, K., Walker, N., Sattar, N., and Davies, M. (2011) Unanswered questions over NHS health checks. British Medical Journal, 2011(342), c6312. (doi:10.1136/bmj.c6312)

Sassarini, J., Fox, H., Ferrell, W., Sattar, N., and Lumsden, M.A. (2011) Vascular function and cardiovascular risk factors in women with severe flushing. Clinical Endocrinology, 74(1), pp. 97-103. (doi:10.1111/j.1365-2265.2010.03921.x)

Altmann-Schneider, I., Trompet, S., de Craen, A. J. M., van Es, A. C. G. M., Jukema, J. W., Stott, D.J., Sattar, N., Westendorp, R. G. J., van Buchem, M. A., and van der Grond, J. (2011) Cerebral Microbleeds Are Predictive of Mortality in the Elderly. Stroke, 42(3), pp. 638-644. (doi:10.1161/STROKEAHA.110.595611)

Asquith, D.L., Miller, A.M., Reilly, J.H., Kerr, S., Welsh, P., Sattar, N., and McInnes, I.B. (2011) Simultaneous activation of the liver X receptors (LXR and LXR) drives murine collagen-induced arthritis disease pathology. Annals of the Rheumatic Diseases, 70(12), pp. 2225-2228. (doi:10.1136/ard.2011.152652)

Barker, A. et al. (2011) Association of Genetic Loci With Glucose Levels in Childhood and Adolescence: A Meta-Analysis of Over 6,000 Children. Diabetes, 60(6), pp. 1805-1812. (doi:10.2337/db10-1575)

Berry, C., and Sattar, N. (2011) Stressed hearts in children with obesity and diabetes: a cause for concern? Diabetologia, 54(4), pp. 715-718. (doi:10.1007/s00125-010-2041-0)

Boyle, J.G., Logan, P.J., Jones, G.C., Small, M., Sattar, N., Connell, J.M.C., Cleland, S.J., and Salt, I.P. (2011) AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study. Diabetologia, 54(7), pp. 1799-1809. (doi:10.1007/s00125-011-2126-4)

Douglas, A. et al. (2011) Recruiting South Asians to a lifestyle intervention trial: experiences and lessons from PODOSA (Prevention of Diabetes & Obesity in South Asians). Trials, 12(220), (doi:10.1186/1745-6215-12-220)

Fraser, A., Tilling, K., Macdonald-Wallis, C., Hughes, R., Sattar, N., Nelson, S.M., and Lawlor, D.A. (2011) Associations of gestational weight gain with maternal body mass index, waist circumference, and blood pressure measured 16 y after pregnancy: the Avon Longitudinal Study of Parents and Children (ALSPAC). American Journal of Clinical Nutrition, 93(6), pp. 1285-1292. (doi:10.3945/ajcn.110.008326)

Freeman, D. et al. (2011) Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). BMC Geriatrics, 11(8), (doi:10.1186/1471-2318-11-8)

Gill, J.M.R. et al. (2011) Sitting time and waist circumference are associated with glycemia in U.K. South Asians: data from 1,228 adults screened for the PODOSA trial. Diabetes Care, 34(5), pp. 1214-1218. (doi:10.2337/dc10-2313)

Gill, J.M.R., and Sattar, N. (2011) Hepatic VLDL overproduction: is hyperinsulinemia or insulin resistance the culprit? Journal of Clinical Endocrinology and Metabolism, 96(7), pp. 2032-2034. (doi:10.1210/jc.2011-0690)

Govan, L. et al. (2011) Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia, 54(8), pp. 2000-2008. (doi:10.1007/s00125-011-2176-7)

Gray, L.J., Yates, T., Davies, M.J., Brady, E., Webb, D.R., Sattar, N., and Khunti, K. (2011) Defining obesity cut-off points for migrant South Asians. PLoS ONE, 6(10), e26464. (doi:10.1371/journal.pone.0026464)

Lawlor, D.A., Macdonald-Wallis, C., Fraser, A., Nelson, S.M., Hingorani, A., Davey Smith, G., Sattar, N., and Deanfield, J. (2011) Cardiovascular biomarkers and vascular function during childhood in the offspring of mothers with hypertensive disorders of pregnancy: findings from the Avon Longitudinal Study of Parents and Children. European Heart Journal, 33(3), pp. 335-345. (doi:10.1093/eurheartj/ehr300)

Logue, J., and Sattar, N. (2011) Childhood obesity: a ticking time bomb for cardiovascular disease? Clinical Pharmacology and Therapeutics, 90(1), pp. 174-178. (doi:10.1038/clpt.2011.88)

Macfarlane, P.W., Murray, H., Sattar, N., Stott, D.J., Ford, I., Buckley, B., Jukema, J.W., Westendorp, R.G.J., and Shepherd, J. (2011) The incidence and risk factors for new onset atrial fibrillation in the PROSPER study. Europace, 13(5), pp. 634-639. (doi:10.1093/europace/eur016)

Makgoba, M., Nelson, S.M., Savvidou, M., Messow, C.-M., Nicolaides, K., and Sattar, N. (2011) First-trimester circulating 25-hydroxyvitamin D levels and development of gestational diabetes mellitus. Diabetes Care, 34(5), pp. 1091-1093. (doi:10.2337/dc10-2264)

Owen, C. G., Rudnicka, A. R., Nightingale, C. M., Mullen, R., Barman, S. A., Sattar, N., Cook, D. G., and Whincup, P. H. (2011) Retinal Arteriolar Tortuosity and Cardiovascular Risk Factors in a Multi-Ethnic Population Study of 10-Year-Old Children; the Child Heart and Health Study in England (CHASE). Arteriosclerosis, Thrombosis and Vascular Biology, 31(8), pp. 1933-1938. (doi:10.1161/​ATVBAHA.111.225219)

Packard, C.J. et al. (2011) Early life socioeconomic adversity is associated in adult life with chronic inflammation, carotid atherosclerosis, poorer lung function and decreased cognitive performance: a cross-sectional, population-based study. BMC Public Health, 11, p. 42. (doi:10.1186/1471-2458-11-42)

Pons, D. et al. (2011) Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studies. Heart, 97(2), pp. 143-150. (doi:10.1136/hrt.2010.199927)

Preiss, D., Khunti, K., and Sattar, N. (2011) Combined cardiovascular and diabetes risk assessment in primary care. Diabetic Medicine, 28(1), pp. 19-22. (doi:10.1111/j.1464-5491.2010.03157.x)

Preiss, D., and Sattar, N. (2011) Statins and the risk of new-onset diabetes: a review of recent evidence. Current Opinion in Lipidology, 22(6), pp. 460-466. (doi:10.1097/MOL.0b013e32834b4994)

Preiss, D., and Sattar, N. (2011) The case for diabetes screening: ADDITION-Europe. Lancet, 378(9786), pp. 106-108. (doi:10.1016/S0140-6736(11)60819-2)

Preiss, D., Sattar, N., and McMurray, J.J. (2011) A systematic review of event rates in clinical trials in diabetes mellitus: The importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design. American Heart Journal, 161(1), p. 210. (doi:10.1016/j.ahj.2010.10.019)

Preiss, D. et al. (2011) Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA: Journal of the American Medical Association, 305(24), pp. 2556-2564. (doi:10.1001/jama.2011.860)

Rezai, M.-R., Wallace, A. M., Sattar, N., Finn, J. D., Wu, F. C. W., and Cruickshank, J. K. (2011) Ethnic Differences in Aortic Pulse Wave Velocity Occur in the Descending Aorta and May Be Related to Vitamin D. Hypertension, 58(2), pp. 247-253. (doi:10.1161/HYPERTENSIONAHA.111.174425)

Sattar, N. (2011) Adiponectin and raised mortality in type 1 diabetes: any credible explanatory mechanisms? Journal of Internal Medicine, 270(4), pp. 339-342. (doi:10.1111/j.1365-2796.2011.02408.x)

Shiels, P.G. et al. (2011) Accelerated telomere attrition is associated with relative household income, diet and inflammation in the pSoBid cohort. PLoS ONE, 6(7), e22521. (doi:10.1371/journal.pone.0022521)

Taylor, A.E., Guthrie, P.A.I., Smith, G.D., Golding, J., Sattar, N., Hingorani, A.D., Deanfield, J.E., and Day, I.N.M. (2011) IQ, Educational Attainment, Memory and Plasma Lipids: Associations with Apolipoprotein E Genotype in 5995 Children. Biological Psychiatry, 70(2), pp. 152-158. (doi:10.1016/j.biopsych.2010.10.033)

Walker, J. J., Livingstone, S. J., Colhoun, H. M., Lindsay, R.S., McKnight, J. A., Morris, A. D., Petrie, J. R., Philip, S., Sattar, N., and Wild, S. H. (2011) Effect of Socioeconomic Status on Mortality Among People With Type 2 Diabetes: A study from the Scottish Diabetes Research Network Epidemiology Group. Diabetes Care, 34(5), pp. 1127-1132. (doi:10.2337/dc10-1862)

Wannamethee, S. G., Papacosta, O., Whincup, P. H., Thomas, M. C., Carson, C., Lawlor, D. A., Ebrahim, S., and Sattar, N. (2011) The potential for a two-stage diabetes risk algorithm combining non-laboratory-based scores with subsequent routine non-fasting blood tests: results from prospective studies in older men and women. Diabetic Medicine, 28(1), pp. 23-30. (doi:10.1111/j.1464-5491.2010.03171.x)

Wannamethee, S.G., Shaper, A.G., Whincup, P.H., Lennon, L., and Sattar, N. (2011) Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease. Journal of the American College of Cardiology, 58(18), pp. 1870-1877. (doi:10.1016/j.jacc.2011.06.057)

Welsh, P., Peters, M.J.L., and Sattar, N. (2011) Is vitamin D in rheumatoid arthritis a magic bullet or a mirage? The need to improve the evidence base prior to calls for supplementation. Arthritis and Rheumatism, 63(7), pp. 1763-1769. (doi:10.1002/art.30341)

Welsh, P., Peters, M.J.L., and Sattar, N. (2011) Vitamin D insufficiency. New England Journal of Medicine, 364(14), pp. 1378-1379.

Whiteley, W. et al. (2011) Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study. Cerebrovascular Diseases, 32(2), pp. 141-147. (doi:10.1159/000328517)

Sharma, G., Wilson, K., van der Walle, C.F., Sattar, N., Petrie, J.R., and Ravi Kumar, M.N.V. (2010) Microemulsions for oral delivery of insulin: Design, development and evaluation in streptozotocin induced diabetic rats. European Journal of Pharmaceutics and Biopharmaceutics, 76(2), pp. 159-169. (doi:10.1016/j.ejpb.2010.07.002)

Miller, A. M., Asquith, D. L., Hueber, A. J., Anderson, L. A., Holmes, W. M., McKenzie, A. N., Xu, D., Sattar, N., McInnes, I. B., and Liew, F. Y. (2010) Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circulation Research, 107(5), pp. 650-658. (doi:10.1161/CIRCRESAHA.110.218867)

Timpson, N.J. et al. (2010) Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-ascorbic acid (vitamin C): evidence from 5 independent studies with >15,000 participants. American Journal of Clinical Nutrition, 92(2), pp. 375-382. (doi:10.3945/ajcn.2010.29438)

Sattar, N. et al. (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet, 375(9716), pp. 735-742. (doi:10.1016/S0140-6736(09)61965-6)

Preiss, D., Sattar, N., and McMurray, J.J. (2010) Event rates in trials of patients with Type 2 diabetes. JAMA: Journal of the American Medical Association, 303(8), pp. 732-733. (doi:10.1001/jama.2010.137)

Asquith, D. L., Miller, A. M., Hueber, A. J., Liew, F. Y., Sattar, N., and McInnes, I. B. (2010) Apolipoprotein E-deficient mice are resistant to the development of collagen-induced arthritis. Arthritis and Rheumatism, 62(2), pp. 472-477. (doi:10.1002/art.27205)

Lawlor, D.A., Fraser, A., Lindsay, R.S., Ness, A., Dabelea, D., Catalano, P., Davey Smith, G., Sattar, N.A., and Nelson, S. (2010) Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort. Diabetologia, 53(1), pp. 89-97. (doi:10.1007/s00125-009-1560-z)

Trompet, S. et al. (2010) Pravastatin and cognitive function in the elderly. Results of the PROSPER study. Journal of Neurology, 257(1), pp. 85-90. (doi:10.1007/s00415-009-5271-7)

Welsh, P. et al. (2010) Unraveling the directional link between adiposity and inflammation: a bidirectional mendelian randomization approach. Journal of Clinical Endocrinology and Metabolism, 95(1), pp. 93-99. (doi:10.1210/jc.2009-1064)

Davidovici, B. B. et al. (2010) Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions. Journal of Investigative Dermatology, 130(7), pp. 1785-1796. (doi:10.1038/jid.2010.103)

Euser, S. M., Sattar, N., Witteman, J. C. M., Bollen, E. L. E. M., Sijbrands, E. J. G., Hofman, A., Perry, I. J., Breteler, M. M. B., and Westendorp, R. G. J. (2010) A Prospective Analysis of Elevated Fasting Glucose Levels and Cognitive Function in Older People: Results From PROSPER and the Rotterdam Study. Diabetes, 59(7), pp. 1601-1607. (doi:10.2337/db09-0568)

Falaschetti, E., Hingorani, A. D., Jones, A., Charakida, M., Finer, N., Whincup, P., Lawlor, D. A., Davey Smith, G., Sattar, N., and Deanfield, J. E. (2010) Adiposity and cardiovascular risk factors in a large contemporary population of pre-pubertal children. European Heart Journal, 31(24), pp. 3063-3072. (doi:10.1093/eurheartj/ehq355)

Fraser, A. et al. (2010) Association of Maternal Weight Gain in Pregnancy With Offspring Obesity and Metabolic and Vascular Traits in Childhood. Circulation, 121(23), pp. 2557-2564. (doi:10.1161/CIRCULATIONAHA.109.906081)

Geelhoed, J. J. M., Fraser, A., Tilling, K., Benfield, L., Davey Smith, G., Sattar, N., Nelson, S. M., and Lawlor, D. A. (2010) Preeclampsia and Gestational Hypertension Are Associated With Childhood Blood Pressure Independently of Family Adiposity Measures: The Avon Longitudinal Study of Parents and Children. Circulation, 122(12), pp. 1192-1199. (doi:10.1161/CIRCULATIONAHA.110.936674)

Ghouri, N., Preiss, D., and Sattar, N. (2010) Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data. Hepatology, 52(3), pp. 1156-1161. (doi:10.1002/hep.23789)

Hall, L.M.L., Moran, C.N., Milne, G.R., MacFarlane, N.G., Forouhi, N.G., Hariharan, N., Salt, I.P., Sattar, N., and Gill, J.M.R. (2010) Fat oxidation, fitness and skeletal muscle expression of oxidative/lipid metabolism genes in South Asians: implications for insulin resistance? PLoS ONE, 5(12), e14197. (doi:10.1371/journal.pone.0014197)

Hernandez, A.V., Howe, L.D., Tilling, K., Benfield, L., Logue, J., Sattar, N., Ness, A.R., Davey Smith, G., and Lawlor, D.A. (2010) Changes in ponderal index and body mass index across childhood and their associations with fat mass and cardiovascular risk factors at age 15. PLoS ONE, 5(12), e15186. (doi:10.1371/journal.pone.0015186)

Howe, L.D., Galobardes, B., Sattar, N., Hingorani, A.D., Deanfield, J., Ness, A.R., Davey-Smith, G., and Lawlor, D.A. (2010) Are there socioeconomic inequalities in cardiovascular risk factors in childhood, and are they mediated by adiposity? Findings from a prospective cohort study. International Journal of Obesity, 34(7), pp. 1149-1159. (doi:10.1038/ijo.2010.52)

Huda, S. S., Brodie, L.E., and Sattar, N. (2010) Obesity in pregnancy: prevalence and metabolic consequences. Seminars in Fetal and Neonatal Medicine, 15(2), pp. 70-76. (doi:10.1016/j.siny.2009.09.006)

Jarvie, E., Hauguel‑de‑Mouzon, S., Nelson, S.M., Sattar, N., Catalano, P.M., and Freeman, D.J. (2010) Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clinical Science, 119(3), pp. 123-129. (doi:10.1042/CS20090640)

Lawlor, D.A. et al. (2010) Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study. British Medical Journal, 341, c6224. (doi:10.1136/bmj.c6224)

Lindsay, R. S., Nelson, S. M., Walker, J. D., Greene, S. A., Milne, G., Sattar, N., and Pearson, D. W. (2010) Programming of Adiposity in Offspring of Mothers With Type 1 Diabetes at Age 7 Years. Diabetes Care, 33(5), pp. 1080-1085. (doi:10.2337/dc09-1766)

Logue, J., and Sattar, N. (2010) Obesity in Children and Future Cardiometabolic Risk: Are blood tests necessary? Diabetes Care, 33(12), pp. 2711-2712. (doi:10.2337/dc10-1748)

Logue, J., and Sattar, N. (2010) Tackling obesity in adult primary care. Practitioner, 254(1730), pp. 31-32.

Logue, J., Thompson, L., Romanes, F., Wilson, D.C., Thompson, J., and Sattar, N. (2010) Management of obesity: summary of SIGN guideline. British Medical Journal, 340, c154-c154. (doi:10.1136/bmj.c154)

Owen, C.G., Nightingale, C.M., Rudnicka, A. R., Sattar, N., Cook, D. G., Ekelund, U., and Whincup, P. H. (2010) Physical activity, obesity and cardiometabolic risk factors in 9-to 10-year-old UK children of white European, South Asian and black African-Caribbean origin: the Child Heart And health Study in England (CHASE). Diabetologia, 53(8), pp. 1620-1630. (doi:10.1007/s00125-010-1781-1)

Padmanabhan, S. et al. (2010) Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genetics, 6(10), e1001177. (doi:10.1371/journal.pgen.1001177)

Peters, M. J. L. et al. (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Annals of the Rheumatic Diseases, 69(2), pp. 325-331. (doi:10.1136/ard.2009.113696)

Preiss, D., and Sattar, N. (2010) HbA1c: a useful cardiovascular risk marker in those without diabetes? Diabetologia, 53(12), pp. 2468-2469. (doi:10.1007/s00125-010-1902-x)

Preiss, D., Welsh, P., Murray, H., Shepherd, J., Packard, C., Macfarlane, P., Cobbe, S., Ford, I., and Sattar, N. (2010) Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up(dagger). European Heart Journal, 31(10), pp. 1230-1236. (doi:10.1093/eurheartj/ehq095)

Ray, K. K., Seshasai, S. R. K., Erqou, S., Sever, P., Jukema, J. W., Ford, I., and Sattar, N. (2010) Statins and All-Cause Mortality in High-Risk Primary Prevention: A Meta-analysis of 11 Randomized Controlled Trials Involving 65 229 Participants. Archives of Internal Medicine, 170(12), pp. 1024-1031. (doi:10.1001/archinternmed.2010.182)

Ray, K. K., Seshasai, S. R. K., Jukema, W., and Sattar, N. (2010) Are Statins Effective in High-Risk Primary Prevention?--Reply. Archives of Internal Medicine, 170(22), pp. 2043-2044. (doi:10.1001/archinternmed.2010.459)

Ray, K.K., and Sattar, N. (2010) Which risk engines are best to assess CVD risk in diabetes? Reply. Nature Reviews Endocrinology, 6(2), C2. (doi:10.1038/nrendo.2009.100-c2)

Sattar, N., Preiss, D., Welsh, P., Seshasai, S.R.K., and Ray, K.K. (2010) Statins and risk of incident diabetes Reply. Lancet, 375(9732), pp. 2141-2142.

Sattar, N., Welsh, P., Sarwar, N., Danesh, J., Di Angelantonio, E., Gudnason, V., Smith, G. D., Ebrahim, S., and Lawlor, D. A. (2010) NT-proBNP is associated with coronary heart disease risk in healthy older women but fails to enhance prediction beyond established risk factors: Results from the British Women's Heart and Health Study. Atherosclerosis, 209(1), pp. 295-299. (doi:10.1016/j.atherosclerosis.2009.09.016)

Savvidou, M., Nelson, S.M., Makgoba, M., Messow, C.-M., Sattar, N., and Nicolaides, K. (2010) First-trimester prediction of gestational diabetes mellitus: Examining the potential of combining maternal characteristics and laboratory measures. Diabetes, 59(12), pp. 3017-3022. (doi:10.2337/db10-0688)

Sayers, A., Timpson, N.J., Sattar, N., Deanfield, J., Hingorani, A.D., Davey Smith, G., and Tobias, J.H. (2010) Adiponectin and its association with bone mass accrual in childhood. Journal of Bone and Mineral Research, 25(10), pp. 2212-2220. (doi:10.1002/jbmr.116)

Sofat, R. et al. (2010) Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms. Circulation, 121(1), pp. 52-62. (doi:10.1161/CIRCULATIONAHA.109.865444)

Stott, D.J. et al. (2010) Activation of Hemostasis and Decline in Cognitive Function in Older People. Arteriosclerosis, Thrombosis and Vascular Biology, 30(3), pp. 605-611. (doi:10.1161/ATVBAHA.109.199448)

Talwar, D., McConnachie, A., Welsh, P., Upton, M., O'Reilly, D., Davey Smith, G., Watt, G., and Sattar, N. (2010) Which circulating antioxidant vitamins are confounded by socioeconomic deprivation? The MIDSPAN family study. PLoS ONE, 5(6), e11312. (doi:10.1371/journal.pone.0011312)

Wallace, S.M.L., Mäki-Petäjä, K.M., Cheriyan, J., Davidson, E.H., Cherry, L., McEniery, C.M., Sattar, N., Wilkinson, I.B., and Kharbanda, R.K. (2010) Simvastatin prevents inflammation-induced aortic stiffening and endothelial dysfunction. British Journal of Clinical Pharmacology, 70(6), pp. 799-806. (doi:10.1111/j.1365-2125.2010.03745.x)

Wannamethee, S. G., Papacosta, O., Whincup, P. H., Carson, C., Thomas, M. C., Lawlor, D. A., Ebrahim, S., and Sattar, N. (2010) Assessing prediction of diabetes in older adults using different adiposity measures: a 7 year prospective study in 6,923 older men and women. Diabetologia, 53(5), pp. 890-898. (doi:10.1007/s00125-010-1670-7)

Wannamethee, S. G., Shaper, A. G., Rumley, A., Sattar, N., Whincup, P. H., Thomas, M. C., and Lowe, G.D. (2010) Lung Function and Risk of Type 2 Diabetes and Fatal and Nonfatal Major Coronary Heart Disease Events: Possible Associations With Inflammation. Diabetes Care, 33(9), pp. 1990-1996. (doi:10.2337/dc10-0324)

Whincup, P.H., Nightingale, C.M., Owen, C.G., Rudnicka, A.R., Gibb, I., McKay, C.M., Donin, A.S., Sattar, N., Alberti, K.G.M.M., and Cook, D.G. (2010) Early emergence of ethnic differences in type 2 diabetes precursors in the UK: the Child Heart and Health Study in England (CHASE Study). PLoS Medicine, 7(4), e1000263. (doi:10.1371/journal.pmed.1000263)

Yates, T., Davies, M. J., Gorely, T., Talbot, D., Bull, F., Sattar, N., and Khunti, K. (2010) The effect of increased ambulatory activity on markers of chronic low-grade inflammation: evidence from the PREPARE programme randomized controlled trial. Diabetic Medicine, 27(11), pp. 1256-1263. (doi:10.1111/j.1464-5491.2010.03091.x)

Yates, T., Davies, M.J., Gray, L.J., Webb, D., Henson, J., Gill, J.M.R., Sattar, N., and Khunti, K. (2010) Levels of physical activity and relationship with markers of diabetes and cardiovascular disease risk in 5474 white European and South Asian adults screened for type 2 diabetes. Preventive Medicine, 51(3-4), pp. 290-294. (doi:10.1016/j.ypmed.2010.06.011)

Yates, T., Davies, M.J., Gray, L.J., Webb, D., Henson, J., Gill, J.M.R., Sattar, N., and Khunti, K. (2010) Levels of physical activity and relationship with markers of diabetes and cardiovascular disease risk in 5474 white European and South Asian adults screened for type 2 diabetes. Preventive Medicine, 51(3-4), pp. 290-294. (doi:10.1016/j.ypmed.2010.06.011)

Trompet, S. et al. (2009) Apolipoprotein E genotype, plasma cholesterol, and cancer: a mendelian randomization study. American Journal of Epidemiology, 170(11), pp. 1415-1421. (doi:10.1093/aje/kwp294)

Gill, J.M.R., and Sattar, N. (2009) Ceramides: a new player in the inflammation-insulin resistance paradigm? Diabetologia, 52(12), pp. 2475-2477. (doi:10.1007/s00125-009-1546-x)

Di Angelantonio, E. et al. (2009) Major lipids, apolipoproteins, and risk of vascular disease. JAMA: Journal of the American Medical Association, 302(18), pp. 1993-2000. (doi:10.1001/jama.2009.1619)

Preiss, D. et al. (2009) Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Diabetes Care, 32(5), pp. 915-920. (doi:10.2337/dc08-1709) (PMID:19196892)

Stott, D.J., Welsh, P.I., Rumley, A., Robertson, M., Ford, I., Sattar, N.A., Westendorp, R.G.J., Jukema, J.W., Cobbe, S., and Lowe, G.D. (2009) Adipocytokines and risk of stroke in older people: a nested case-control study. International Journal of Epidemiology, 38(1), pp. 253-261. (doi:10.1093/ije/dyn215 )

Welsh, P. et al. (2009) Leptin Predicts Diabetes but Not Cardiovascular Disease Results from a large prospective study in an elderly population. Diabetes Care, 32(2), pp. 308-310. (doi:10.2337/dc08-1458)

Ang, D., Welsh, P., Watt, P., Nelson, S., Struthers, A., and Sattar, N. (2009) Serial changes in adiponectin and BNP in ACS patients: paradoxical associations with each other and with prognosis. Clinical Science, 117(1-2), pp. 41-48.

Asquith, D., Miller, A., Hueber, A., McKinnon, H., Sattar, N., Graham, G., and McInnes, I. (2009) Liver X Receptor Agonism Promotes Articular Inflammation in Murine Collagen-Induced Arthritis. Arthritis and Rheumatism, 60(9), pp. 2655-2665. (doi:10.1002/art.24717 )

Choy, E., and Sattar, N. (2009) Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Annals of the Rheumatic Diseases, 68(4), pp. 460-469.

Deans, K.A. et al. (2009) Differences in atherosclerosis according to area level socioeconomic deprivation: cross sectional, population based study. British Medical Journal, 339, b4170. (doi:10.1136/bmj.b4170)

Di Angelantonio, E., Chowdhury, R., Sarwar, N., Ray, K.K., Gobin, R., Saleheen, D., Thompson, A., Gudnason, V., Sattar, N.A., and Danesh, J. (2009) B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation, 120(22), 2177-2U39. (doi:10.1161/CIRCULATIONAHA.109.884866)

Ford, I. et al. (2009) Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis. PLoS Medicine, 6(1), e1000016. (doi:10.1371/journal.pmed.1000016 )

Fraser, A., Harris, R., Sattar, N., Ebrahim, S., Davey Smith, G., and Lawlor, D. (2009) Alanine Aminotransferase, gamma-Glutamyltransferase, and Incident Diabetes. Diabetes Care, 32(4), pp. 741-750. (doi:10.2337/dc08-1870)

Huda, S., Sattar, N., and Freeman, D. (2009) Lipoprotein metabolism and vascular complications in pregnancy. Clinical Lipidology, 4(1), pp. 91-102.

Jick, S., Choi, H., Li, L., Mclnnes, I., and Sattar, N. (2009) Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis. Annals of the Rheumatic Diseases, 68(4), pp. 546-551.

Kanagalingam, M.G., Nelson, S., Freeman, D., Ferrell, W.R., Cherry, L.M., Lowe, G.D.O., Greer, I.A., and Sattar, N.A. (2009) Vascular dysfunction and alteration of novel and classic cardiovascular risk factors in mothers of growth restricted offspring. Atherosclerosis, 205(1), pp. 244-250. (doi:10.1016/j.atherosclerosis.2008.10.006)

McKellar, G., McCarey, D., Sattar, N., and McInnes, I. (2009) Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nature Reviews Cardiology, 6(6), pp. 410-417.

Mullan, A., and Sattar, N. (2009) More knocks to the oxidation hypothesis for vascular disease? Clinical Science, 116(1-2), pp. 41-43.

Nelson, S., Freeman, D., Sattar, N., and Lindsay, R. (2009) Erythrocytosis in offspring of mothers with Type 1 diabetes-are factors other than insulin critical determinants? Diabetic Medicine, 26(9), pp. 887-892. (doi:10.1111/j.1464-5491.2009.02797.x )

Preiss, D.J., and Sattar, N.A. (2009) Metformin and lactic acidosis Metformin: framed again? British Medical Journal, 339, b5570. (doi:10.1136/bmj.b5570)

Preiss, D., and Sattar, N. (2009) Authors' reply to: Statin therapy as the fundamental therapy for cardiovascular prevention: be careful. Clinical Endocrinology, 71(3), pp. 456-457.

Preiss, D., and Sattar, N. (2009) Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. Clinical Endocrinology, 70(6), pp. 815-828.

Preiss, D., and Sattar, N. (2009) Metabolic syndrome: collapsing under its own weight? Diabetic Medicine, 26(5), pp. 457-459.

Preiss, D. et al. (2009) Predictors of Development in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Diabetes Care, 32(5), pp. 915-920.

Ray, K., and Sattar, N. (2009) DIABETES Which risk engines should be used to assess patients with diabetes? Nature Reviews Endocrinology, 5(6), pp. 302-303.

Ray, K., Seshasai, S., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Preiss, D., Erqou, S., and Sattar, N. (2009) Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet, 373(9677), pp. 1765-1772. (doi:10.1016/S0140-6736(09)60697-8)

Richards, J.B. et al. (2009) A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genetics, 5(12), e1000768. (doi:10.1371/journal.pgen.1000768)

Sarwar, N., and Sattar, N. (2009) Triglycerides and coronary heart disease: have recent insights yielded conclusive answers? Current Opinion in Lipidology, 20(4), pp. 275-281.

Sattar, N.A. et al. (2009) Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? PLoS Medicine, 6(6), e1000099 . (doi:10.1371/journal.pmed.1000099)

Sattar, N., and Hingorani, A. (2009) C-Reactive Protein and Prognosis in Diabetes: Getting to the Heart of the Matter. Diabetes, 58(4), pp. 798-799.

Sattar, N. et al. (2009) Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly. Diabetologia, 52(2), pp. 235-239.

Sattar, N., Wannamethee, G., Sarwar, N., Chernova, J., Lawlor, D., Kelly, A., Kelly, A., Wallace, A., Danesh, J., and Whincup, P. (2009) Leptin and Coronary Heart Disease Prospective Study and Systematic Review. Journal of the American College of Cardiology, 53(2), pp. 167-175.

Trompet, S., de Craen, A.J.M., Mooijaart, S., Stott, D.J., Ford, I., Sattar, N.A., Jukema, W., and Westendorp, R.G.J. (2009) High innate production capacity of proinflammatory cytokines increases risk for death from cancer: results of the PROSPER study. Clinical Cancer Research, 15(24), pp. 7744-7748. (doi:10.1158/1078-0432.CCR-09-2152)

Wannamethee, S., Thomas, M., Whincup, P., and Sattar, N. (2009) Associations Between Dietary Fiber and Inflammation, Hepatic Function, and Risk of Type 2 Diabetes in Older Men Potential mechanisms for the benefits of fiber on diabetes risk. Diabetes Care, 32(10), pp. 1823-1825.

Huda, S. S., MacKenzie, S. M., Sattar, N., Fraser, R., Connell, J. M. C., and Davies, E. (2008) Depot-specific steroidogenic gene transcription in human adipose tissue. Clinical Endocrinology, 69(6), pp. 848-854. (doi:10.1111/j.1365-2265.2008.03262.x )

Muir, S.W., Harrow, C., Dawson, J., Lees, K.R., Weir, C.J., Sattar, N., and Walters, M.R. (2008) Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial. Stroke, 39(12), pp. 3303-3307. (doi:10.1161/STROKEAHA.108.519793)

Sattar, N. et al. (2008) Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet, 371(9628), pp. 1927-1935. (doi:10.1016/S0140-6736(08)60602-9)

Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N., Baker, A. H., McInnes, I. B., and Liew, F. Y. (2008) IL-33 reduces the development of atherosclerosis. Journal of Experimental Medicine, 205(2), pp. 339-346. (doi:10.1084/jem.20071868 )

Campbell, F. M., Ingram, A., Monaghan, P., Cooper, J., Sattar, N., Eckersall, P. D., and Graham, D. (2008) SERRS immunoassay for quantitative human CRP analysis. Analyst, 133(10), pp. 1355-1357. (doi:10.1039/b808087a )

Ford, E., Li, C., and Sattar, N. (2008) Metabolic syndrome and incident diabetes - Current state of the evidence. Diabetes Care, 31(9), pp. 1898-1904.

Fraser, A., Fraser, A., Sattar, N.A., Ebrahim, S., and Lawlor, D.A. (2008) Is serum-glutamylatransferase a biomarker of xenobiotics which are conjugated by glutathione? Response. Arteriosclerosis, Thrombosis and Vascular Biology, 28(4), E29-E29.

Hall, L.M.L., Sattar, N., and Gill, J.M.R. (2008) Risk of metabolic and vascular disease in South Asians: potential mechanisms for increased insulin resistance. Future Lipidology, 3(4), pp. 411-424. (doi:10.2217/17460875.3.4.411)

Hothersall, E. et al. (2008) Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax, 63(12), pp. 1070-1075. (doi:10.1136/thx.2008.100198)

Jeffery, A., Murphy, M., Metcalf, B., Hosking, J., Voss, L., English, P., Sattar, N., and Wilkin, T. (2008) Adiponectin in childhood. International Journal of Pediatric Obesity, 3(3), pp. 130-140. (doi:10.1080/17477160801954538 )

Lawlor, D., Ebrahim, S., Davey Smith, G., Cherry, L., Watt, P., and Sattar, N. (2008) The association of insulin-like-growth factor 1 (IGF-1) with incident coronary heart disease in women: Findings from the prospective British Women's Heart and Health Study. Atherosclerosis, 201(1), pp. 198-204. (doi:10.1016/j.atherosclerosis.2007.12.061 )

Logue, J., and Sattar, N. (2008) Food, fatness and facts: the need for a standard message. International Journal of Clinical Practice, 62(5), pp. 677-678. (doi:10.1111/j.1742-1241.2008.01738.x )

Mackinnon, B., Deighan, C., Ferrell, W., Sattar, N., and Fox, J. (2008) Endothelial function in patients with proteinuric primary glomerulonephritis. Nephron Clinical Practice, 109(1), C40-C47.

Mackinnon, B., Deighan, C. J., Ferrell, W.R., Sattar, N., and Fox, J. G. (2008) Endothelial Function in Patients with Proteinuric Primary Glomerulonephritis. Nephron Clinical Practice, 109(1), c40-c47. (doi:10.1159/000135632)

Nelson, S., Freeman, D.J., Sattar, N., and Lindsay, R.S. (2008) Role of adiponectin in matching of fetal and placental weight in mothers with type 1 diabetes. Diabetes Care, 31(6), pp. 1123-1125. (doi:10.2337/dc07-2195)

Preiss, D., Sattar, N., Harborne, L., Norman, J.E., and Fleming, R. (2008) The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome. International Journal of Clinical Practice, 62(9), pp. 1337-1343. (doi:10.1111/j.1742-1241.2008.01825.x)

Preiss, D., and Sattar, N. (2008) Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clinical Science, 115(5-6), pp. 141-150.

Sattar, N. (2008) Why metabolic syndrome criteria have not made prime time: a view from the clinic. International Journal of Obesity, 32, S30-S34.

Sattar, N., and Nelson, S. (2008) Adiponectin, diabetes, and coronary heart disease in older persons: Unraveling the paradox. Journal of Clinical Endocrinology and Metabolism, 93(9), pp. 3299-3301.

Sattar, N., and Wannamethee, S. (2008) Ankle brachial index vs metabolic syndrome for risk prediction - Reply. Lancet, 372(9645), pp. 1221-1222.

Sattar, N., Wannamethee, S., and Forouhi, N. (2008) Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? Diabetologia, 51(6), pp. 926-940.

Sattar, N., Watt, P., Cherry, L., Ebrahim, S., Davey Smith, G., and Lawlor, D. (2008) High molecular weight adiponectin is not associated with incident coronary heart disease in older women: A nested prospective case-control study. Journal of Clinical Endocrinology and Metabolism, 93(5), pp. 1846-1849. (doi:10.1210/jc.2007-2603)

Stott, D., Falconer, A., Kerr, G., Murray, H., Trompet, S., Westendorp, R., Buckley, B., De Craen, A., Sattar, N., and Ford, I. (2008) Does Low to Moderate Alcohol Intake Protect Against Cognitive Decline in Older People? Journal of the American Geriatrics Society, 56(12), pp. 2217-2224. (doi:10.1111/j.1532-5415.2008.02007.x )

Velupillai, Y.N. et al. (2008) Psychological, social and biological determinants of ill health (pSoBid): study protocol of a population-based study. BMC Public Health, 8(126), (doi:10.1186/1471-2458-8-126)

Wannamethee, S., Sattar, N., Rumley, A., Whincup, P., Lennon, L., and Lowe, G. (2008) Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men. Diabetes Care, 31(5), pp. 995-1000.

Welsh, P., Packard, C., and Sattar, N. (2008) Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar. Current Opinion in Lipidology, 19(6), pp. 563-571.

Berry, C., Murphy, N., De Vito, G., Galloway, S., Seed, A., Fisher, C., Sattar, N., Vallance, P., Hillis, W. S., and McMurray, J. (2007) Corrigendum to “Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker” [European Journal of Heart Failure 9/4 (2007) 429-434]. European Journal of Heart Failure, 9(10), p. 1074. (doi:10.1016/j.ejheart.2007.08.003)

Gill, J.M., Al-Mamari, A., Ferrell, W.R., Cleland, S.J., Perry, C.G., Sattar, N., Packard, C.J., Caslake, M.J., and Petrie, J.R. (2007) Effect of prior moderate exercise on postprandial metabolism in men with type 2 diabetes: Heterogeneity of responses. Atherosclerosis, 194(1), pp. 134-143. (doi:10.1016/j.atherosclerosis.2006.10.007)

Lara, J.J., Economou, M., Wallace, A.M., Rumley, A., Lowe, G., Slater, C., Caslake, M., Sattar, N., and Lean, M.E.J. (2007) Benefits of salmon eating on traditional and novel vascular risk factors in young, non-obese healthy subjects. Atherosclerosis, 193(1), pp. 213-221. (doi:10.1016/j.atherosclerosis.2006.06.018)

Murphy, C.L., Fitzsimons, E.J., Jardine, A.J., Sattar, N., and McMurray, J.J.V. (2007) 103 routine assessment of iron status in all patients with heart failure may identify those at risk of developing anaemia. European Journal of Heart Failure, 6(1), p. 24. (doi:10.1016/s1567-4215(07)60065-4)

Sattar, N., McConnachie, A., Ford, I., Gaw, A., Cleland, S.J., Forouhi, N.G., Macfarlane, P., Shepherd, J., Cobbe, S., and Packard, C. (2007) Serial metabolic measurements and conversion to type 2 diabetes in the West of Scotland Coronary Prevention Study - Specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes, 56(4), pp. 984-991. (doi:10.2337/db06-1256)

Kernohan, A. F. B., Sattar, N., Hilditch, T., Cleland, S. J., Small, M., Lumsden, M. A., Connell, J. M. C., and Petrie, J. R. (2007) Effects of low-dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes. Clinical Endocrinology, 66(1), pp. 27-34. (doi:10.1111/j.1365-2265.2006.02679.x)

Berry, C., Murphy, N., De Vito, G., Galloway, S., Seed, A., Fisher, C., Sattar, N., Vallance, P., Hillis, W., and McMurray, J. (2007) Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker. European Journal of Heart Failure, 9, pp. 429-434. (doi:10.1016/j.ejheart.2006.10.005)

Brown, K., Cherry, L., Lowe, G., Rumley, A., Sattar, N., Tchernova, J., Wannamethee, S., and Whincup, P. (2007) Associations of adiponectin with metabolic and vascular risk parameters in the British Regional Heart Study reveal stronger links to insulin resistance-related than to coronory heart disease risk-related parameters. International Journal of Obesity, 31, pp. 1089-1098. (doi:10.1038/sj.ijo.0803544)

Cherry, L., Lowe, G., Rumley, A., Sattar, N., Wannamethee, S., and Whincup, P. (2007) Adipokines and risk of type 2 diabetes in older men. Diabetes Care, 30, pp. 1200-1205.

Datta, D., Ferrell, W., Jadhav, S., Sattar, N., and Sturrock, R. (2007) Inflammatory suppression rapidly attenuates microvascular dysfunction in rheumatoid arthritis. Atherosclerosis, 192, pp. 391-395. (doi:10.1016/j.atherosclerosis.2006.05.034)

Fraser, A., Harris, R., Sattar, N., Ebrahim, S., Davey Smith, G., and Lawlor, D.A. (2007) Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake analysis of the British women's heart and health study and meta-analysis. Arteriosclerosis, Thrombosis and Vascular Biology, 27(12), pp. 2729-2735. (doi:10.1161/ATVBAHA.107.152298)

Jadhav, S., Sattar, N., Petrie, J., Cobbe, S., and Ferrell, W. (2007) Reproducibility and repeatability of peripheral microvascular assessment using lontophoresis in conjunction with laser doppler imaging. Journal of Cardiovascular Pharmacology, 50(3), pp. 343-349. (doi:10.1097/FJC.0b013e3180dca094)

Jeffery, A., Alba, S., Murphy, M., Voss, L., Metcalf, B., Hosking, J., Gardner, D., Sattar, N., and Wilkin, T. (2007) Behavior of insuling resistance and its metabolic correlates in prepubertal children: A longitudinal study (EarlyBird 32). Diabetes Care, 30, pp. 2962-2964. (doi:10.2337/dc07-0178)

Kelly, A., Lowe, G., Rumley, A., Sattar, N., Tchernova, J., Wallace, A., Wannamethee, S., and Whincup, P. (2007) Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis, 191, pp. 418-426. (doi:10.1016/j.atherosclerosis.2006.04.012)

Lawlor, D., Davey Smith, G., Kelly, A., Sattar, N., and Ebrahim, S. (2007) Leptin and coronary heart disease risk: Prospective case control study of British women. Obesity, 15(7), pp. 1694-1701. (doi:10.1038/oby.2007.202)

McEntegart, M., Awede, B., Petrie, M., Sattar, N., Dunn, F., MacFarlane, N., and McMurray, J. (2007) Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. European Heart Journal, 28, pp. 829-835. (doi:10.1093/eurheartj/ehm033)

Muir, K., Sattar, N., Tyrrell, P., and Warburton, E. (2007) Inflammation and ischaemic stroke. Current Opinion in Neurology, 20, pp. 334-342.

Nelson, S., Freeman, D., Lindsay, R.S., and Sattar, N. (2007) Preeclampsia and screening for cardiovascular disease. BMJ Rapid Response,

Nelson, S.M., Freeman, D.J., Sattar, N., Johnstone, F.D., and Lindsay, R.S. (2007) IGF-1 and leptin associate with fetal HDL cholesterol at birth: Examination in offspring of mothers with type 1 diabetes. Diabetes, 56, pp. 2705-2709. (doi:10.2337/db07-0585)

Nelson, S., Sattar, N., Freeman, D., Walker, J., and Lindsay, R. (2007) Inflammation and endothelial activation is evident at birth in offspring of mothers with type 1 diabetes. Diabetes, 56, pp. 2697-2704. (doi:10.2337/db07-0662)

Preiss, D.J., and Sattar, N. (2007) Vascular cell adhesion molecule-1: a viable therapeutic target for atherosclerosis? International Journal of Clinical Practice, 61(4), pp. 697-701. (doi:10.1111/j.1742-1241.2007.01330.x)

Sarwar, N., Sattar, N., Gudnason, V., and Danesh, J. (2007) Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies. European Heart Journal, 28, pp. 2491-2497. (doi:10.1093/eurheartj/ehm115)

Sattar, N., Crompton, P., Cherry, L., Kane, D., Lowe, G., and McInnes, I. (2007) Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis - A double-blind, placebo-controlled study. Arthritis and Rheumatism, 56, pp. 831-839. (doi:10.1002/art.22447)

Sattar, N. et al. (2007) C-reactive protein and prediction of coronary heart disease and global vascular events in the prospective study of pravastatin in the elderly at risk (PROSPER). Circulation, 115(8), pp. 981-989. (doi:10.1161/CIRCULATIONAHA.106.643114)

Theobald, H., Goodall, A., Sattar, N., Talbot, D., Chowienczyk, P., and Sanders, T. (2007) Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. Journal of Nutrition, 137, pp. 973-978.

Tomaszewski, M., Charchar, F., Maric, C., McClure, J., Crawford, L., Grzeszczak, W., Sattar, N., Zukowska-Szczechowska, E., and Dominiczak, A. (2007) Glomerular hyperfiltration: A new marker of metabolic risk. Kidney International, 71(8), pp. 816-821. (doi:10.1038/sj.ki.5002160)

Wannamethee, S., Whincup, P., Lennon, L., and Sattar, N. (2007) Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Archives of Internal Medicine, 167, pp. 1510-1517.

Almushatat, A.S.K., Talwar, D., McArdle, P.A., Williamson, C., Sattar, N., O'Reiliy, D.S., Underwood, M.A., and McMillan, D.C. (2006) Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer. International Journal of Cancer, 118(4), pp. 1051-1053. (doi:10.1002/ijc.21451)

Alberti, G., Gruer, L., Lean, M., and Sattar, N. (2006) ABC of obesity - Obesity - can we turn the tide? British Medical Journal, 333, pp. 1261-1264.

Avenell, A., Lean, M., and Sattar, N. (2006) ABC of obesity - Management: Part I - Behaviour change, diets and activity. British Medical Journal, 333, pp. 740-743.

Deans, K., and Sattar, N. (2006) "Anti-Inflammatory" drugs and their effects on type 2 diabetes. Diabetes Technology and Therapeutics, 8, pp. 18-27.

Forouhi, N., and Sattar, N. (2006) CVD risk factors and ethnicity - A homogeneous relationship? Atherosclerosis Supplements, 7, pp. 11-19. (doi:10.1016/j.atherosclerosissup.2006.01.003)

Forouhi, N., Sattar, N., Tillin, T., McKeigue, P., and Chaturvedi, N. (2006) Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK. Diabetologia, 49, pp. 2580-2588. (doi:10.1007/s00125-006-0393-2)

Gill, J., Al-Mamari, A., Ferrell, W., Cleland, S., Sattar, N., Packard, C., Petrie, J., and Caslake, M. (2006) Effects of a moderate exercise session on postprandial lipoproteins, apolipoproteins and lipoprotein remnants in middle-aged men. Atherosclerosis, 185(1), pp. 87-96. (doi:10.1016/j.atherosclerosis.2005.06.009)

Han, T., Lean, M., and Sattar, N. (2006) ABC of obesity - Assessment of obesity and its clinical implications. British Medical Journal, 333, pp. 695-698.

Haslam, D., Lean, M., and Sattar, N. (2006) ABC of obesity - Obesity - time to wake up. British Medical Journal, 333, pp. 640-642.

Jadhav, S., Ferrell, W., Greer, I., Petrie, J., Cobbe, S., and Sattar, N. (2006) Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries - A randomized, double-blind, placebo-controlled study. Journal of the American College of Cardiology, 48(5), pp. 956-963. (doi:10.1016/j.jacc.2006.04.088)

Jadhav, S., Ferrell, W., Petrie, J., Scherbakova, O., Greer, I., Cobbe, S., and Sattar, N. (2006) Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X. American Journal of Cardiology, 97(12), pp. 1727-1731. (doi:10.1016/j.amjcard.2005.12.069)

Lawlor, D., Lean, M., and Sattar, N. (2006) ABC of obesity - Obesity and vascular disease. British Medical Journal, 333, pp. 1060-1063.

Lean, M., McArdle, C., McMillan, D., and Sattar, N. (2006) ABC of obesity - Obesity and cancer. British Medical Journal, 333, pp. 1109-1111. (doi:10.1136/bmj.39042.565035.BE1)

Lowe, G., and Sattar, N. (2006) High sensitivity C-reactive protein and cardiovascular disease: an association built on unstable foundations? Annals of Clinical Biochemistry, 43, pp. 252-256.

McKenzie, J., Fisher, B., Jaap, A., Stanley, A., Paterson, K., and Sattar, N. (2006) Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clinical Endocrinology, 65, pp. 40-44. (doi:10.1111/j.1365-2265.2006.02543.x)

Mukhopadhyay, B., Forouhi, N., Fisher, B., Kesson, C., and Sattar, N. (2006) A comparison of glycaemic and metabolic control over time among South Asian and European patients with Type 2 diabetes: results from follow-up in a routine diabetes clinic. Diabetic Medicine, 23, pp. 94-98. (doi:10.1111/j.1464-5491.2005.01735.x)

Pietilainen, K., Bergholm, R., Rissanen, A., Kaprio, J., Hakkinen, A., Sattar, N., and Yki-Jarvinen, H. (2006) Effects of acquired obesity on endothelial function in monozygotic twin's. Obesity, 14, pp. 826-837.

Preiss, D., and Sattar, N. (2006) Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence. Heart, 93(12), pp. 1493-1496. (doi:10.1136/hrt.2007.130849)

Ramsay, J., Greer, I., and Sattar, N. (2006) ABC of obesity - Obesity and reproduction. British Medical Journal, 333, pp. 1159-1162.

Sattar, N., Wannamethee, G., Sarwar, N., Tchernova, J., Cherry, L., Wallace, A., Danesh, J., and Whincup, P. (2006) Adiponectin and coronary heart disease: A prospective study and meta-analysis. Circulation, 114, pp. 623-629. (doi:10.1161/CIRCULATIONHA.106.618918)

Cleland, S., and Sattar, N. (2005) Impact of ethnicity on metabolic disturbance, vascular dysfunction and atherothrombotic cardiovascular disease. Diabetes Obesity and Metabolism, 7, pp. 463-470. (doi:10.1111/j.1463-1326.2004.00401.x)

Elahi, M., McMillan, D., McArdle, C., Angerson, W., Soukop, M., Johnstone, J., and Sattar, N. (2005) The systemic inflammatory response predicts overall and cancer specific survival in patients with malignant lymphoma. Medical Science Monitor, 11, CR75-CR78.

Fleming, R., Harborne, L., MacLaughlin, D., Ling, D., Norman, J., Sattar, N., and Seifer, D. (2005) Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment. Fertility and Sterility, 83(1), pp. 130-136. (doi:10.1016/j.fertnstert.2004.05.098)

Harborne, L., Sattar, N., Norman, J., and Fleming, R. (2005) Metformin and weight loss in obese women with polycystic ovary syndrome: Comparison of doses. Journal of Clinical Endocrinology and Metabolism, 90(8), pp. 4593-4598.

Kanagalingam, M., Forouhi, N., Greer, I., and Sattar, N. (2005) Changes in booking body mass index over a decade: retrospective analysis from a Glasgow Maternity Hospital. BJOG: An International Journal of Obstetrics and Gynaecology, 112, pp. 1431-1433. (doi:10.1111/j.1471-0528.2005.00685.x)

Lawlor, D., Davey Smith, G., Ebrahim, S., Thompson, C., and Sattar, N. (2005) Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. Journal of Clinical Endocrinology and Metabolism, 90(10), pp. 5677-5683. (doi:10.1210/jc.2005-0825)

Lawlor, D., Sattar, N., Davey Smith, G., and Ebrahim, S. (2005) The associations of physical activity and adiposity with alanine aminotransferase and gamma-glutamyltransferase. American Journal of Epidemiology, 161(11), pp. 1081-1088. (doi:10.1093/aje/kwi125)

Mackinnon, B., Deighan, C., Norrie, J., Boulton-Jones, J., Sattar, N., and Fox, J. (2005) The link between circulating markers of endothelial function and proteinuria in patients with primary glomerulonephritis. Clinical Nephrology, 63, pp. 173-180.

McCallum, R., Sainsbury, C., Spiers, A., Dominiczak, A., Petrie, J., Sattar, N., and Connell, J. (2005) Growth hormone replacement reduces C-reactive protein and large-artery stiffness but does not alter endothelial function in patients with adult growth hormone deficiency. Clinical Endocrinology, 62(4), pp. 473-479. (doi:10.1111/j.1365-2265.2005.02245.x)

McCarey, D.W., Sattar, N., and McInnes, I.B. (2005) Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases? Arthritis Research and Therapy(7), pp. 55-61. (doi:10.1186/ar1496)

McInnes, I., and Sattar, N. (2005) Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions. Current Opinion in Rheumatology, 17, pp. 286-292.

Rodie, V., Young, A., Jordan, F., Sattar, N., Greer, I., and Freeman, D. (2005) Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. Journal of the Society For Gynecologic Investigation, 12, pp. 320-329. (doi:10.1016/j.jsgi.2005.03.004)

Singhal, A., Jamieson, N.B., Fewtrell, M., Deanfield, J., Lucas, A., and Sattar, N. (2005) Adiponectin predicts insulin resistance but not endothelial function in young, healthy adolescents. Journal of Clinical Endocrinology and Metabolism, 90(8), pp. 4615-4621. (doi:10.1210/jc.2005-0131)

Song, H., Grant, I., Rotondo, D., Mohede, I., Sattar, N., Heys, S., and Wahle, K. (2005) Effect of CLA supplementation on immune function in young healthy volunteers. European Journal of Clinical Nutrition, 59, pp. 508-517. (doi:10.1038/sj.ejcn.1602102)

Strahorn, P., Graham, D., Charchar, F., Sattar, N., McBride, M., and Dominiczak, A. (2005) Genetic determinants of metabolic syndrome components in the stroke-prone spontaneously hypertensive rat. Journal of Hypertension, 23(12), pp. 2179-2186.

Whincup, P., Owen, C., Sattar, N., and Cook, D. (2005) School dinners and markers of cardiovascular health and type 2 diabetes in 13-16 year olds: cross sectional study. British Medical Journal, 331, pp. 1060-1061. (doi:10.1136/bmj.38618.540729.AE)

McCarey, D.W., McInnes, I.B., Madhok, R., Hampson, R., Scherbakov, O., Ford, I., Capell, H., and Sattar, N. (2004) Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet, 363(9426), pp. 2015-2021. (doi:10.1016/S0140-6736(04)16449-0)

Elahi, M., McMillan, D., McArdle, C., Angerson, W., and Sattar, N. (2004) Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutrition and Cancer, 48, pp. 171-173.

Freeman, D., McManus, F., Brown, E., Cherry, L., Norrie, J., Ramsay, J., Clark, P., Walker, I., Sattar, N., and Greer, I. (2004) Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension, 44, pp. 708-714. (doi:10.1161/01.HYP.0000143849.67254.ca)

Gill, J.M.R., Al-Mamari, A., Ferrell, W.R., Cleland, S.J., Packard, C.J., Sattar, N., Petrie, J.R., and Caslake, M.J. (2004) Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men. Journal of the American College of Cardiology, 44(12), pp. 2375-2382. (doi:10.1016/j.jacc.2004.09.035)

Jadhav, S., Petrie, J., Ferrell, W., Cobbe, S., and Sattar, N. (2004) Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation? Heart, 90(12), pp. 1379-1383. (doi:10.1136/hrt.2004.035170)

McArdle, P., McMillan, D., Sattar, N., Underwood, M., and Wallace, A. (2004) The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease. British Journal of Cancer, 91, pp. 1755-1757. (doi:10.1038/sj.bjc.6602211)

McEleavy, O., McCallum, R., Petrie, J., Small, M., Connell, J., Sattar, N., and Cleland, S. (2004) Higher carotid-radial pulse wave velocity in healthy offspring of patients with Type 2 diabetes. Diabetic Medicine, 21(3), pp. 262-266. (doi:10.1111/j.1464-5491.2004.01127.x)

McInnes, I.B., McCarey, D., and Sattar, N. (2004) Do statins offer therapeutic potential in inflammatory arthritis? Annals of the Rheumatic Diseases, 63(12), pp. 1535-1537. (doi:10.1136/ard.2004.022061)

Muth, S., Norman, J., Sattar, N., and Fleming, R. (2004) Women with polycystic ovary syndrome (PCOS) often undergo protracted treatment with metformin and are disinclined to stop: indications for a change in licensing arrangements? Human Reproduction, 19(12), pp. 2718-2720. (doi:10.1093/humrep/deh530)

Perry, C., Cleland, S., Connell, J., Petrie, J., and Sattar, N. (2004) Low grade inflammation is notably suppressed by conventional anti-inflammatory treatment: a randomised crossover trial. Heart, 90(7), pp. 804-805. (doi:10.1136/hrt.2003.022129 )

Ramsay, J., Ferrell, W., Crawford, L., Wallace, A., Greer, I., and Sattar, N. (2004) Divergent metabolic and vascular phenotypes in pre-eclampsia and intrauterine growth restriction: Relevance of adiposity. Journal of Hypertension, 22(11), pp. 2177-2183. (doi:10.1097/00004872-200411000-00021)

Rodie, V., Caslake, M., Stewart, F., Sattar, N., Ramsay, J., Greer, I., and Freeman, D. (2004) Fetal cord plasma lipoprotein status in uncomplicated human pregnancies and in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Atherosclerosis, 176, pp. 181-187. (doi:10.1016/j.atherosclerosis.2004.04.026)

Rodie, V., Freeman, D., Sattar, N., and Greer, I. (2004) Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis, 175, pp. 189-202. (doi:10.1016/j.atherosclerosis.2004.01.038)

Sainsbury, C., Sattar, N., Connell, J., Hillier, C., and Petrie, J. (2004) Non-esterified fatty acids impair endothelium-dependent vasodilation in rat mesenteric resistance vessels. Clinical Science, 107(6), pp. 625-629.

Sattar, N., Scherbakova, O., Ford, I., O'Reilly, D., Stanley, A., Forrest, E., MacFarlane, P., Packard, C., Cobbe, S., and Shepherd, J. (2004) Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study. Diabetes, 53(11), pp. 2855-2860. (doi:10.2337/diabetes.53.11.2855)

Sattar, N., McConnachie, A., O'Reilly, D., Upton, M.N., Greer, I., Davey Smith, G., and Watt, G.C.M. (2004) Inverse association between birth weight and C-reactive protein concentrations in the MIDSPAN family study. Arteriosclerosis, Thrombosis and Vascular Biology, 24, pp. 583-587. (doi:10.1161/01.ATV.0000118277.41584.63)

Sattar, N. et al. (2004) Metabolic syndrome and diabetes mellitus - Response. Circulation, 109(3), E23-E23.

Tomaszewski, M., Charchar, F., Crawford, L., Zukowska-Sczechowska, E., Grzeszczak, W., Sattar, N., and Dominiczak, A. (2004) Serum C-reactive protein and lipids in ultra-marathon runners. American Journal of Cardiology, 94(1), pp. 125-126. (doi:10.1016/j.amjcard.2004.03.043)

Sattar, N., McCarey, D.W., Capell, H., and McInnes, I.B. (2003) Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation, 108(24), pp. 2957-2963. (doi:10.1161/01.CIR.0000099844.31524.05)

Campbell, C. et al. (2003) A novel anti-inflammatory role for simvastatin in inflammatory arthritis. Journal of Immunology, 170, pp. 1524-1530.

Clark, P., Freeman, D., Streja, E., Sattar, N., Walker, I., and Greer, I. (2003) The G-to-T point mutation in codon 34 of the factor XIII gene and the risk of pre-eclampsia. Blood Coagulation and Fibrinolysis, 14, pp. 155-157. (doi:10.1097/01.mbc.0000046189.72384.5a)

Clark, P., Jordan, F., Pearson, C., Walker, I., Sattar, N., Ellison, J., and Greer, I. (2003) Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated by thrombin in human monocytes and THP-1 cells in vitro and in pregnant subjects in vivo. Thrombosis and Haemostasis, 89, 1043-+.

Forouhi, N.G., Rumley, A., Lowe, G.D., McKeigue, P., and Sattar, N. (2003) Specific elevation in plasma tissue plasminogen activator antigen concentrations in South Asians relative to Europeans. Blood Coagulation and Fibrinolysis, 14(8), pp. 755-760.

Harborne, L., Fleming, R., Lyall, H., Norman, J., and Sattar, N. (2003) Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet, 361, pp. 1894-1901. (doi:10.1016/S0140-6736(03)13493-9 )

Harborne, L., Fleming, R., Lyall, H., Sattar, N., and Norman, J. (2003) Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 88(9), pp. 4116-4123. (doi:10.1210/jc.2003-030424)

Kinsella, J., McMillan, D., O'Reilly, D., Quasim, T., Sattar, N., and Talwar, D. (2003) Lower concentrations of carotenoids in the critically-ill patient are related to a systemic inflammatory response and increased lipid peroxidation. Clinical Nutrition, 22, pp. 459-462. (doi:10.1016/S0261-5614(03)00044-X)

McDougall, C., Perry, C., Sattar, N., and Petrie, J. (2003) Statins in the era of evidence-based medicine - who will not 'prosper'? Scottish Medical Journal, 48(3), pp. 64-68.

McKenzie, J. et al. (2003) Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? Clinical Endocrinology, 59(6), pp. 682-689. (doi:10.1046/j.1365-2265.2003.01906.x)

Montgomery, C., Speake, B., Cameron, A., Sattar, N., and Weaver, L. (2003) Maternal docosahexaenoic acid supplementation and fetal accretion. British Journal of Nutrition, 90, pp. 135-145. (doi:10.1079/BJN2003888)

Quasim, T., McMillan, D.C., Talwar, D., Sattar, N., O'Reilly, J., and Kinsella, J. (2003) Lower concentrations of carotenoids in the critically ill patient are related to a systemic inflammatory response and increased lipid peroxidation. Clinical Nutrition, 22(5), pp. 459-462. (doi:10.1016/S0261-5614(03)00044-X)

Ramsay, J.E., Jamieson, N.B., Greer, I.A., and Sattar, N. (2003) Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension, 42(5), pp. 891-894. (doi:10.1161/01.HYP.0000095981.92542.F6)

Ramsay, J., Simms, R., Ferrell, W., Crawford, L., Greer, I., Lumsden, M., and Sattar, N. (2003) Enhancement of endothelial function by pregnancy - Inadequate response in women with type 1 diabetes. Diabetes Care, 26, pp. 475-479.

Ramsay, J., Stewart, F., Greer, I., and Sattar, N. (2003) Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease. BJOG: An International Journal of Obstetrics and Gynaecology, 110, pp. 1029-1031.

Sattar, N. et al. (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation, 108(4), pp. 414-419. (doi:10.1161/01.CIR.0000080897.52664.94)

Sattar, N., Ramsay, J., Crawford, L., Cheyne, H., and Greer, I. (2003) Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension, 42, pp. 39-42. (doi:10.1161/01.HYP.0000074428.11168.EE)

Weir, C., Sattar, N., Walters, M., and Lees, K. (2003) Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke. Cerebrovascular Diseases, 16, pp. 76-82. (doi:10.1159/000070119)

Ferrell, W., Ramsay, J., Brooks, N., Lockhart, J., Dickson, S., McNeece, G., Greer, I., and Sattar, N. (2002) Elimination of electrically induced iontophoretic artefacts: Implications for non-invasive assessment of peripheral microvascular function. Journal of Vascular Research, 39(5), pp. 447-455. (doi:10.1159/000064515)

Fleming, R., Hopkinson, Z., Wallace, A., Greer, I., and Sattar, N. (2002) Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism, 87, pp. 569-574.

Freeman, D.J., Norrie, J., Caslake, M.J., Gaw, A., Ford, I., Lowe, G.D.O., O'Reilly, D. S. J.,, Packard, C.J., and Sattar, N. (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 51(5), pp. 1596-1600. (doi:10.2337/diabetes.51.5.1596)

Freeman, D.J., Norrie, J., Caslake, M.J., Gaw, A., Ford, I., Lowe, G.D.O., O'Reilly, D.S., Packard, C.J., and Sattar, N. (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 51(5), pp. 1596-1600.

Galloway, P., Greer, I.A., and Sattar, N. (2002) Statins as novel therapies for osteoporosis? European Journal of Obstetrics and Gynecology and Reproductive Biology, 101(1), pp. 4-5.

Gonzalez-Villalpando, C., Haffner, S., Han, T., Lean, M., Sattar, N., and Williams, K. (2002) Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care, 25, pp. 2016-2021.

Haffner, S., Han, T., Hunt, K., Lean, M., Sattar, N., and Williams, K. (2002) Analysis of obesity and Hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obesity Research, 10, pp. 923-931.

Jones, G., Latif, Z., McMillan, D.C., Mir, K., Sattar, N., Underwood, M.A., and Wallace, A.M. (2002) The relationship of circulating insulin-like growth factor 1, its binding protein-3, prostate-specific antigen and C-reactive protein with disease stage in prostate cancer. BJU International, 89, pp. 396-399.

Kelly, C.J.G., Lyall, H., Petrie, J.R., Gould, G.W., Connell, J.M.C., Rumley, A., Lowe, G.D.O., and Sattar, N. (2002) A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism, 87(7), pp. 3287-3290. (doi:10.1210/jc.87.7.3287)

McArdle, C., McMillan, D., O'Reilly, D., Sattar, N., Talwar, D., and Underwood, M. (2002) The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours. Clinical Nutrition, 21, pp. 161-164. (doi:10.1054/clnu.2001.0527)

Perera, M., Petrie, J., Hillier, C., Small, M., Sattar, N., Connell, J., and Lumsden, M. (2002) Hormone replacement therapy can augment vascular relaxation in post-menopausal women with type 2 diabetes. Human Reproduction, 17(2), pp. 497-502. (doi:10.1093/humrep/17.2.497)

Pirwany, I., Sattar, N., Greer, I., Packard, C., and Fleming, R. (2002) Supraphysiological concentrations of estradiol in menopausal women given repeated implant therapy do not adversely affect lipid profiles. Human Reproduction, 17, pp. 825-829.

Ramsay, J., Ferrell, W., Crawford, L., Wallace, A., Greer, I., and Sattar, N. (2002) Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. Journal of Clinical Endocrinology and Metabolism, 87, pp. 4231-4237. (doi:10.1210/jc.2002-020311)

Ramsay, J., Ferrell, W., Greer, I., and Sattar, N. (2002) Factors critical to iontophoretic assessment of vascular reactivity: Implications for clinical studies of endothelial dysfunction. Journal of Cardiovascular Pharmacology, 39(1), pp. 9-17.

Sattar, N., and Greer, I. (2002) Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? British Medical Journal, 325, pp. 157-160. (doi:10.1136/bmj.325.7356.157)

Wallace, A., Kelly, A., Sattar, N., McArdle, C., and McMillan, D. (2002) Circulating concentrations of "free" leptin in relation to fat mass and appetite in gastrointestinal cancer patients. Nutrition and Cancer, 44, pp. 156-160.

Jhund, P. S., Dawson, N., Davie, A. P., Sattar, N., Norrie, J., O’Kane, K. P.J., and McMurray, J. J.V. (2001) Attenuation of endothelin-1 induced vasoconstriction by 17β estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease. Journal of the American College of Cardiology, 37(5), pp. 1367-1373. (doi:10.1016/s0735-1097(01)01168-8) (PMID:11300448)

Berry, C., Montgomery, C., Norrie, J., Sattar, N., and Weaver, L. (2001) Fatty acid status of women of reproductive age. European Journal of Clinical Nutrition, 55, pp. 518-524.

Clark, P., Sattar, N., Walker, I., and Greer, I. (2001) The Glasgow outcome, APCR and lipid (GOAL) pregnancy study: Significance of pregnancy associated activated protein C resistance. Thrombosis and Haemostasis, 85, pp. 30-35.

Forouhi, N., Sattar, N., and McKeigue, P. (2001) Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. International Journal of Obesity, 25, pp. 1327-1331.

Freeman, D. et al. (2001) Pravastatin and the development of diabetes mellitus - Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation, 103(3), pp. 357-362.

Gaw, A., Kelly, A., McMahon, A., Packard, C., Sattar, N., Shepherd, J., and Wallace, A. (2001) Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).[see comment]. Circulation, 104(25), pp. 3052-3056.

Kelly, C., Lyall, H., Petrie, J., Gould, G., Connell, J., and Sattar, N. (2001) Low grade chronic inflammation in women with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism, 86(6), pp. 2453-2455. (doi:10.1210/jc.86.6.2453)

McMillan, D., Elahi, M., Sattar, N., Angerson, W., Johnstone, J., and McArdle, C. (2001) Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutrition and Cancer, 41, pp. 64-69.

Perera, M., Sattar, N., Petrie, J.R., Hillier, C., Small, M., Connell, J.M.C., Lowe, G.D.O., and Lumsden, M.A. (2001) The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism, 86(3), pp. 1140-1143. (doi:10.1210/jc.86.3.1140)

Pirwany, I.R., Fleming, R., Sattar, N., Greer, I.A., and Wallace, A.M. (2001) Circulating leptin concentrations and ovarian function in polycystic ovary syndrome. Trends in Parasitology, 145, pp. 289-294.

Pirwany, I., Fleming, R., Greer, I., Packard, C., and Sattar, N. (2001) Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clinical Endocrinology, 54(4), pp. 447-453.

Sattar, N., Clark, P., Holmes, A., Lean, M., Walker, I., and Greer, I. (2001) Antenatal waist circumference and hypertension risk. Obstetrics and Gynecology, 97, pp. 268-271.

Wallace, A., McMahon, A., Packard, C., Kelly, A., Shepherd, J., Gaw, A., Sattar, N., and WOSCOPS Executive Comm, (2001) Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation, 104, pp. 3052-3056.

Galloway, P., McMillan, D., and Sattar, N. (2000) Effect of the inflammatory response on trace element and vitamin status. Annals of Clinical Biochemistry, 37(3), pp. 289-297. (doi:10.1258/0004563001899429)

Books

Bain, C., Lumsden, M.A., Sattar, N., and Greer, I.A. (2002) The Menopause in Practice. Series: In practice. Royal Society of Medicine Press: London, UK. ISBN 9781853155161

Book Sections

Sattar, N., and Freeman, D.J. (2012) Potential mechanisms contributing to gestational diabetes and pre-eclampsia in the obese woman. In: Gillman, M.W. and Poston, L. (eds.) Maternal Obesity. Series: Cambridge medicine. Cambridge University Press: Cambridge, UK, pp. 45-55. ISBN 978107003965 (doi:10.1017/CBO9780511782466)

Sattar, N., and Freeman, D.J. (2012) Potential mechanisms contributing to gestational diabetes and preeclampsia in the obese woman. In: Gillman, M.W. and Poston, L. (eds.) Maternal Obesity. Cambridge University Press . ISBN 9781107003965

Freeman, D.J., and Sattar, N. (2010) The effect of pregnancy on energy metabolism, body composition and endothelial function. In: Tsatsoulis, A., Wyckoff, J. and Brown, F.M. (eds.) Diabetes in Women. Series: Contemporary diabetes. Humana Press Inc., pp. 207-222. ISBN 9781603272506 (doi:10.1007/978-1-60327-250-6_11)

Conference Proceedings

Jani, B. D., Cavanagh, J., Barry, S., Der, G., Sattar, N., and Mair, F. S. (2014) Association between cardiovascular risk factors and concurrent depressive symptoms in cardiometabolic disease: a cross-sectional study. In: Public Health Science, Glasgow, UK, 19 Nov 2014, S40. (doi:10.1016/S0140-6736(14)62166-8)

This list was generated on Thu Jul 30 14:49:20 2015 BST.